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ABSTRACT 
Irene Castellano Pellicena 
 The role of photoreceptors in human skin physiology; potential targets for 
light-based wound healing treatments. 
Keywords: Human skin, keratinocytes, fibroblasts, opsins, cryptochromes, 
photobiomodulation, light, wound healing. 
The positive effect of photobiomodulation in wound healing has previously 
been reported, however there is a considerable lack of knowledge regarding the 
molecular mechanisms involved, and no consensus on light parameters. 
Cytochrome c oxidase (CCO) is established as the main photoreceptor in cells, 
but light also induces nitric oxide (NO), production of reactive oxygen species 
(ROS) and activation of ion channels. Emerging new molecular targets include 
the GPCRs opsins (OPNs) and the circadian clock transcription factors, 
cryptochromes (CRYs).  
Localisation of OPN1-SW, OPN3, OPN5, CRY1 and CRY2 was seen in 
female facial and abdominal human skin. Furthermore, expression of these 
photoreceptors was retained in primary epidermal keratinocytes and dermal 
fibroblasts in culture; both cell types expressed OPN1-SW, OPN3, CRY1 and 
CRY2, at the mRNA and protein level. OPN2 was only expressed in cultured 
dermal fibroblasts, while in line with in situ expression, OPN5 was only 
expressed in cultured keratinocytes. The photoreceptor-expressing cultured 
epidermal keratinocytes demonstrated a dose- and wavelength- dependent 
response in both metabolic activity and cell migration in a scratch-wound assay. 
Specifically, low dose (2 J/cm2) blue light (447 nm) increased metabolic activity, 
but it did not impact keratinocyte migration. In contrast, high dose (30 J/cm2) 
blue light had no effect on metabolism, but inhibited migration of epidermal 
keratinocytes. Red light (655 nm) at 30 J/cm2 stimulated metabolic activity but 
did not modulate migration, while a higher dose of 60 J/cm2 had no effect on 
keratinocyte metabolic activity.  
ii 
In order to study OPN3 and CRY1 function, they were silenced in 
keratinocytes using siRNA; additionally 8 µM KL001 was used to stabilize 
CRY1. KL001 inhibited migration, and induced KRT1 and KRT10, an effect 
which was abrogated by knockdown of OPN3. Interestingly, knockdown of 
OPN3 upregulated CRY1 expression, while KL001 upregulated OPN3 
expression, indicating a regulation by OPN3 of the molecular epidermal clock. 
Low levels of blue light increased early differentiation of epidermal 
keratinocytes, which was mediated by OPN3 and circadian clock mechanisms. 
However, low levels of blue light decreased keratinocyte DNA synthesis, which 
was mediated by circadian clock independently of OPN3. Translation of 
parameters ex vivo showed increasing re-epithelialisation and induction of 
OPN3 and CRY1 expression following exposure to 2 J/cm2 of blue light; 
however high doses of blue light inhibited re-epithelialisation. Red light, also 
increased re-epithelialisation, but had no effect on OPN3 or CRY1 expression.     
In conclusion, photoreceptors are expressed in human skin and they 
mediate DNA synthesis, migration and differentiation of epidermal 
keratinocytes. Furthermore, low dose of blue light interacts with OPN3 to induce 
epidermal differentiation, through the regulation of the circadian clock. A better 
understanding of the molecular mechanisms behind the photobiomodulation 
response in vitro will help to develop light based therapies for human wound 
healing. Interestingly, selected light parameters translated to human ex vivo 
skin showed a beneficial effect of low doses of blue (2 J/cm2) and red (30 J/cm2) 
light in re-epithelialisation.     
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RESUMEN 
Irene Castellano Pellicena 
 El papel de los fotoreceptores en la fisiología de la piel humana; 
potenciales dianas para terapias de luz para la regeneración de heridas 
Palabras clave: regeneración de heridas, fotoreceptores, ritmo circadiano, 
opsinas, criptocromo, fotobiomodulación, terapias basadas en luz, piel 
El efecto beneficioso de la fotobiomodulación para regeneración de 
heridas se ha mostrado anteriormente, sin embargo, los mecanismos 
moleculares implicados no están completamente estudiados y existe una falta 
de consenso en los parámetros de luz que se deben aplicar para el tratamiento 
de regeneración de heridas. El citocromo c oxidasa es uno de los principales 
fotoreceptores que existen en las células, aunque la luz también es capaz de 
producir óxido nítrico y especies oxidativas al oxigeno así como de activar 
canales iónicos. Nuevas dianas moleculares emergentes incluyen los 
receptores acoplados a proteínas G (RAPG) opsinas (OPNs) y los factores de 
transcripción criptocromos (CRYs), que forman parte del ritmo circadiano. 
OPN1-SW, OPN3, OPN5, CRY1 y CRY2 se localizaron en piel femenina 
facial y abdominal. Además, la expresión de éstos fotoreceptores se mantuvo 
en queratinocitos epidérmicos y fibroblastos dérmicos primarios en cultivo; 
ambos tipos celulares expresaron OPN1-SW, OPN3, CRY1 y CRY2, a nivel de 
mARN y proteína. OPN2 sólo se expresaba en cultivos de fibroblastos dérmics, 
mientras que en línea con la expresión en piel in situ, OPN5 sólo se expresaba 
en cultivos de queratinocitos epidérmicos. Los queratinocitos, los cuales 
expresan fotoreceptores, mostraron una respuesta dependiente de dosis y 
longitud de onda en actividad metabólica y migración celular. En concreto, 
dosis bajas (2 J/cm2) de luz azul (447 nm)  aumentaron la actividad metabólica 
en queratinocitos, pero no su capacidad de migración. Por otro lado, dosis altas 
(30 J/cm2) de luz azul no tuvieron ningún efecto en actividad metabólica, pero 
redujeron su migración. La luz roja (655 nm) a 30 J/cm2 estimuló la actividad 
metabólica pero no produjeron ningún efecto en la migración de los 
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queratinocitos, mientras que una dosis más alta, de 60 J/cm2, no afectó su 
actividad metabólica.  
El silenciamiento de OPN3 y CRY1 se realizó usando la tecnología de 
siARN para estudiar la función de ambos fotoreceptores en queratinocitos: 
además, 8 µM de KL001 se usó para estabilizar CRY1. KL001 inhibió la 
migración e indujo la expresión de KRT1 y KRT10. Estos efectos fueron 
anulados tras la rápida reducción de OPN3. Resulta interesante ver cómo tras 
knockdown OPN3, se indujo la expresión de CRY1, mientras que KL001 indujo 
la expresión de OPN3, indicando una regulación por parte de OPN3 del reloj 
circadiano molecular de la epidermis. Niveles bajos de luz azul incrementaron 
la diferenciación de queratinocitos epidérmicos, lo cual era mediado por PON3 
y el reloj circadiano molecular. Sin embargo, bajos niveles de luz azul 
disminuyó la síntesis de ADN en queratinocitos epidérmicos, efecto mediado 
por el reloj circadiano molecular independientemente de OPN3. La transmisión 
de parámetros ex vivo mostró un incremento en re-epitelización de la epidermis 
y un incremento en la expresión de OPN3 y CRY1 tras la exposición a 2 J/cm2 
de luz azul; sin embargo, altas dosis de luz azul, inhibió en grado de re-
epitelización de heridas ex vivo. La luz roja también mostró un incremento en 
re-epitelización de heridas, sin embargo no mostró cambios en la expresión de  
OPN3 o CRY1.     
En conclusión, se encuentra la expresión de fotoreceptores en piel 
humana. Estos fotoreceptores son capaces de controlar la síntesis de ADN, la 
migración y la diferenciación de queratinocitos epidérmicos. Además, una dosis 
baja de luz azul active OPN3 e induce la diferenciación de éstas células, a 
través de la acción del ritmo circadiano. Un mayor conocimiento de los 
mecanismos moleculares que están detrás de la respuesta a la 
fotobiomodulación in vitro ayudará a desarrollar terapias de luz para 
regeneración de heridas. Curiosamente, los parámetros seleccionados en éste 
estudio se usaron para la traducción a un modelo humano de regeneración de 
heridas ex vivo, lo cual mostró el efecto beneficioso de una baja dosis (2J/cm2) 
de luz azul y de luz roja (30 J/cm2) en el nivel de re-epitelización de heridas.   
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1 Introduction 
1.1 Skin structure and its appendages 
The skin is the largest organ in the human body covering a surface of 
between 1.5 and 2m2 and containing several appendages such as hair follicles, 
sebaceous glands, sweat glands and nails.  The main functions of the skin are 
to provide a protective water-proof barrier, which prevents the underlying 
structures from damage either because of injury or microbes; it is also 
responsible for the sensory system, e.g. pain, temperature and touch, and 
regulating the body temperature (Waugh and Grant 2010).  
The skin is structured in three main layers (Figure 1-1): the epidermis is 
the most superficial one; beneath the basal layer of the epidermis is a basement 
membrane, which separates it from the next layer, called the dermis, and finally 
below the dermis, the hypodermis is found. This is a layer of subcutaneous fat 
just before the inner structures of the fascia (Fuchs and Raghavan 2002). 
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Figure 1-1: Skin structure.  
Representation of the three main layers of the skin, the epidermis, the dermis and the 
hypodermis and the different appendages and cell types present. Taken from (Kendall and 
Nicolaou 2013). 
1.1.1 The epidermis 
The epidermis is the outer part of the skin and its thickness varies 
throughout the different parts of the human body. It is a self-renewing stratified, 
squamous, keratinizing epithelium first described by Marcello Malpigui (1628-
1694). It is mainly composed of keratinocytes derived from the embryonic 
ectoderm and arranged in different layers to form a stratified epithelium. Within 
each layer, cells have different shapes depending on their differentiation stage. 
The more differentiated they are, the higher up they are within the epidermis 
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(Montagna et al. 1992). Furthermore, dendritic cells such as melanocytes, 
Langerhans cells and Merkel cells, in addition to immune cells such as 
lymphocytes, are also present in the epidermis (Figure 1-1). Melanocytes are 
responsible for melanin production, which is a protective pigment transferred to 
surrounding keratinocytes (Singh et al. 2010; Tarafder et al. 2014). Langerhans 
cells are specialized immune cells whose function is to develop a quick 
response against antigens in contact with the skin (Romani et al. 2010). Merkel 
cells are neuroendocrine cells primarily localized in the basal layer of the 
epidermis, but are also found in the outer root sheath of hair follicles. They are 
more prevalent in touch-sensitive areas such as hands and in hairy skin 
(Boulais and Misery 2008). 
The outer layer of the epidermis is the horny layer also known as the 
stratum corneum, which functions as a barrier to the environment. It is made up 
of flattened corneocytes which are terminally differentiated keratinocytes (Figure 
1-2). They are non-nucleated cells and their cytoplasm has been replaced by 
fibres of keratin. Below this layer, there is the compact transitional layer or 
stratum lucidum only present in areas of thick skin such as palmar and plantar 
skin. Finally, the stratum malpighii is found in all types of skin and it is divided in 
three layers: the granular layer or stratum granulosum; the spinous layer or 
stratum spinosum, where keratinocytes remain attached to each other; and the 
basal layer from where undifferentiated keratinocytes rapidly divide and start to 
migrate to the upper layers (Figure 1-2). This is a heterogeneous mixture of 
cells with both differentiating and proliferative keratinocytes, stem cells, 
Langerhans cells, Merkel cells and melanocytes. Furthermore, the basal layer 
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connects the epidermis with the dermis through anchoring fibrils; type IV, VII 
collagen (Burgeson 1993), laminin and fibronectin proteins are its main protein 
component (Montagna et al. 1992). 
 
Figure 1-2: Representative image of the epidermis of human skin.  
Basal layer keratinocytes are attached to the basement membrane through 
hemidesmosomes and focal contacts. The next layer of the epidermis is the spinous layer, 
which shows adherent junctions and desmosomes, followed by the granular layer which only 
uses desmosomes for cell-cell junctions. Finally the stratum corenum is composed of 
corneocytes. Taken from Fuchs and Raghavan, (2002). 
Postmitotic human keratinocytes start to differentiate in the basal layer and 
it takes them around 31 days to move upwards and around 45 to become a 
non-viable cell of the stratum corneum and completely desquamate in human 
skin (Senoo 2013). The process of differentiation of keratinocytes consists of 
changes in cell size and shape, changes in the properties of the cell 
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membranes, appearance, reorganization or loss of different organelles, 
synthesis and modification of structural proteins such as keratins and 
dehydration (Montagna et al. 1992). The protein family of keratins (KRT) 
consists of more than 20 polypeptides which can be found throughout the 
epidermis depending on the differentiation state of the keratinocytes; for 
instance, basal cells express lower-molecular-weight keratins  (e.g. KRT8, 13, 
14, 15, 18) that are associated with proliferation, whereas the more 
differentiated the cells are, the higher the molecular weight of their keratins such 
as K1, 2, 10 and 11, which provide biomarkers for suprabasal keratinocytes 
(Sun et al. 1983).  
The basal layer serves both as a physical boundary for the epidermis and 
as a platform rich in extracellular matrix proteins and growth factors, which 
promote proliferation. Different kinds of keratinocytes can be found in the basal 
layer; on the one hand, basal keratinocytes are primarily found along the sides 
of the rete ridges that connect the epidermis with the dermal surface therefore, 
their cytoplasm exhibits extensions or serrations towards the dermis; on the 
other hand, epidermal stem cells are located at the base of the rete ridges 
(Fuchs and Raghavan 2002).  
1.1.1.1 Epidermal homeostasis 
Skin homeostasis is the physiological process that maintains a constant 
number of cells in renewing the skin (Blanpain and Fuchs 2009). Different 
models of self-renewal have been proposed over the years (Figure 1.3, A). A 
hypothesis which divides the skin tissue into “epidermal proliferative units” 
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(EPUs) is one of the oldest and most accepted (Mackenzie 1970) (Figure 1-3, 
A). This theory establishes that a single slow cycling stem cell sustains each 
EPU dividing asymmetrically to produce another stem cell and a transit-
amplifying (TA) cell.  Morphological and proliferation studies in murine skin were 
the ones to establish this theory (Mackenzie 1970), which was also supported 
later by other authors (Potten 1974). However, “the single progenitor model” 
(Senoo 2013) has since arisen to explain the homeostasis of the skin in a 
simpler way (Figure 1-3, B).  It is based on two factors; the fraction of 
proliferative cells in the basal layer and the probability of an asymmetric cell 
division occurring. A track of single-cells in vivo was made using genetic 
labelling in mouse tail epidermis, showing that stem cells from the basal layer 
give rise directly to committed spinous cells without going through a transient 
amplifying phase (Clayton et al. 2007). In spite of its simplicity, there are 
keratinocytes with different long-term proliferative potentials (Jones and Watt 
1993), which made scientists either revert back to the stem cell/TA cell theory, 
or join both theories such as Mascré, Dekoninck et al. (2012) who demonstrated 
the existence of two different types of progenitors within a hierarchical 
organization with different functions during homeostasis in tail IFE skin of mice: 
the slow-cycling stem cells (SC) and the rapidly cycling committed progenitor 
(CP) cells sharing an asymmetric self-renewal mechanism where a balance 
between proliferation and differentiation is achieved (Mascre et al. 2012) (Figure 
1-3, C). A recent review by Alcolea and Jones (2014) that focused on linage-
tracing studies concluded that the IFE is mainly maintained by cells termed 
progenitors in the basal layer, which are equally likely to become either another 
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progenitor or a differentiating cell; furthermore, rare slow cycling cells are also 
proposed to be present in the IFE. They are epidermal SCs which are able to 
become stem cell daughters, or progenitor cells similar to the transient 
amplifying cells proposed back in 1970 by Mackenzie, and seem to especially 
play a role in skin repair after injury (Alcolea and Jones 2014). However, 
knowledge about skin homeostasis in humans is lacking due to the limitations of 
working with human skin in vivo. Special care has to be taken when talking 
about any of these homeostatic models in human skin.  
 
Figure 1-3: Different theories to explain skin homeostasis in mouse skin.  
(A) Epidermal proliferative unit model. (B) Single progenitor model. (C) Stem/TA cell 
hierarchy model. From Senoo (2013). 
As previously discussed, there are hair follicle stem cells in human skin, so 
that not only epidermal stem cells ensure skin homeostasis. Murine studies 
demonstrated that after wounding 25-50% of cells in the repaired IFE come 
from the hair follicle (Levy et al. 2007). This is a highly regulated process which 
stops once the wound is healed and there is no further requirement for tissue 
regeneration (Levy et al. 2007; Blanpain and Fuchs 2009). However, it has 
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been shown that wound repair also takes place in hairless skin suggesting the 
involvement of other skin cells in wound repair (Senoo 2013). The SCs and TA 
cells from the basal layer of the epidermis are relatively undifferentiated cells 
with a slow cycle, which are easily available on demand to repair any kind of 
damage; for example, after injury (Lavker and Sun 1982). Despite their 
contribution to the IFE, the role of SCs and TA cells from the basal layer of the 
epidermis in wound healing has not been studied in detail.  
1.1.2 The dermis 
At the dermal-epidermal junction, a basement membrane follows the 
contour of the epidermal basal cells separating both physically and functionally 
the epidermis from the dermis (Yurchenco 2011). The dermis is the connective 
tissue of the skin, which contributes to its structural and mechanical function 
protecting the body from injury. It is formed by different filamentous proteins 
such as collagen and elastic fibres surrounded by the extracellular matrix. 
Collagen fibres are able to bind water which gives tensile strength to the skin, 
however this property declines with age resulting in the appearance of wrinkles 
in aged skin (Waugh and Grant 2010). The most important cell found in the 
dermis is the fibroblast. In addition, nerves, vascular and lymphatic networks 
and skin appendages are supported in the dermal cellular matrix (Richmond 
and Harris 2014). 
The dermis is divided in two layers; close to the epidermis there is the 
papillary dermis where fibroblasts are more abundant (Geerligs 2009). A high 
percentage of the papillary dermal matrix is formed by ground substance, 
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whereas it has a small distribution of elastic and collagen fibrils. Furthermore 
the orientation of these fibres is vertical to allow them to connect with the 
dermal-epidermal junction. Bellow the papillary dermis, a thicker layer called the 
reticular dermis is found where fibres are already horizontally oriented. This 
layer can extend its capacity up or down protecting vessels and cells against 
mechanical insults (Geerligs 2009). Papillary and reticular fibroblasts in culture 
have a different gene expression pattern, which can be related to their different 
behaviour within the skin (Janson et al. 2012).  
Collagen is the most abundant extracellular protein in the dermis. Classic 
ultrastructurally recognizable cross-banded collagen fibrils in the dermis contain 
collagens I, III and V, but the microfibrillar collagen VI, as well as collagen XIV, 
which is part of the FACIT (Fibril Associated Collagens with Interrupted Triple 
helices) collagen subfamily, are also found in the dermis (Gelse et al. 2003). 
Furthermore, multiplexis collagens XV and XVI are produced by fibroblasts of 
the dermis (Gelse et al. 2003). Collagen I is the major component of the fibrils, 
and the amount of the other types of collagen varies.  
Dermal fibroblasts are the most abundant cell in the dermis. They are 
responsible for synthesizing the fibres and ground substance of the extracellular 
matrix, but they can also remove them by the secretion of several proteolytic 
enzymes. Dermal fibroblasts are also involved in the synthesis of some parts of 
the basement membrane.  
During the tissue repair processes dermal fibroblasts differentiate into 
myofibroblasts encouraging contraction of the wound (Rockey et al. 2013). 
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Furthermore, they are involved in the increase of the amount of collagen III 
content during wound healing (Bolognia et al. 2003). 
Immune cells are also found in the dermis such as macrophages, 
lymphocytes and mast cells; in particular mast cells are known to develop 
different functions; vasoactive and smooth muscle-contracting activities, 
secretion of chemotactic factors, proteolysis and anticoagulation (Richmond and 
Harris 2014). They are extremely important for inflammatory reactions and they 
release diverse important substances following degranulation. They are 
commonly found in close proximity to fibroblasts. Cell-to-cell communications 
between them enables mast cells to modulate collagen production by dermal 
fibroblasts (Abe et al. 2000).  
1.1.3 Skin appendages: the hair follicle and sebaceous gland 
The hair follicle is a unique organ found in the skin of mammals. Hair 
follicles are formed by a down-growth of epidermal cells into the dermis (Waugh 
and Grant 2010) and their main functions are physical protection and thermal 
insulation, although they are also responsible for camouflage in some 
mammals, and for the disposal of sweat and sebum (Stenn and Paus 2001). 
They also contribute to the sensory and tactile senses of the skin. However, in 
humans hair also has a very important social and psychological impact 
(Schneider et al. 2008). 
Therefore, there is a need for continuous hair renewal during life (Alonso 
and Fuchs 2006). In order to replace hairs, the hair follicle cycles continuously, 
going through periods of growth and rest (Stenn and Paus 2001). The hair 
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follicle has a permanent upper segment, which comprises the follicular 
infundibulum and isthmus and a non-permanent lower segment, where the 
lower follicle and bulb are found (Figure 1-4). The fibre of terminal hairs is made 
of keratin filaments surrounded by a sulfur-rich matrix (Whiting 2004). The bulb 
of the hair follicle (Figure 1-4) is closely associated with blood vessels, the 
source of nutrition; therefore cells from the bulb are highly proliferative. As they 
divide and then differentiate, they move upwards and loose their proximity to the 
blood vessels, ending in death and keratinisation (Waugh and Grant 2010). 
 
Figure 1-4: The hair follicle structure.  
(A) H&E staining of the human anagen hair follicle, showing the permanent structures 
(infundibulum and isthmus) and the anagen associated components (suprabulbar region and 
the bulb). (B) The isthmus at high magnification, which is formed by the connective tissue 
sheath (CTS), the basal membrane (BM), the outer root sheath (ORS), which is the most 
external one, the inner root sheath (IRS) and finally the hair shaft (HS). The square dashes 
show the approximate location of the bulge, the stem cell niche of the hair follicle, SG indicates 
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sebaceous gland, a structure attached to the hair follicle and APM indicates arrector pili muscle. 
(C) The bulb region at high magnification composed by the dermal papilla (DP), the connective 
tissue sheath (CTS) and the matrix (M). Adapted from Schneider et al., (2008).  
Hair follicles contain the most important stem cell niche in the skin 
regarding the number of quiescent stem cells and they are essential for hair 
renewal processes (Hsu et al. 2014). They are found in the bulge region, which 
express the surface marker CD200 and have a quiescent state (Figure 1-4). A 
more proliferative population of SCs can be also found below the bulge, in the 
outer root sheath of the anagen hair follicle and it is characterised by the 
expression of CD34 (Garza et al. 2011).   
Ectodermal-mesodermal interactions are very important for hair 
development. All the epithelial compartments of the hair follicle, in addition to 
the sebaceous glands and the apocrine glands, are formed from ectodermal 
hair follicle stem cells (Schneider et al. 2008). However, the dermal papilla and 
the dermal sheath, also known as connective tissue sheath are derived from the 
mesoderm. The dermal papilla is responsible for the induction of hair growth. It 
is formed by a cluster of mesenchyme-derived cells enclosed within the 
epidermal matrix producing the necessary signals to regulate hair growth 
(Kishimoto et al. 2000).  
Other structures can be found attached to the hair follicle. The small 
bundles of smooth muscle fibres of the arrector pili attached to the hair follicle 
can contract to erect the hair in situations of stress, fear, or cold, because they 
are connected and stimulated by sympathetic nerve fibres (Waugh and Grant 
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2010). Furthermore, the sebaceous duct unit is also continuous and empties 
into the hair canal (Figure 1-4) (Schneider et al. 2008).  
1.2 Wound repair 
When the skin barrier is disrupted, the wound healing process is essential 
for skin recovery and repair, but it is a very complex process. It involves 
different cells, signals and molecular pathways taking place in a regulated and 
co-ordinated manner.  
This process has been typically described by the initiation of immediate 
events such as coagulation and hemostasis followed by three important phases; 
the inflammatory phase, the proliferative phase and the remodelling phase 
(Diegelmann and Evans 2004). However, during these phases many cellular 
and molecular processes take place at the same time, which means that the 
difference between phases is not clearly separated, and that some processes 
from two different phases can overlap (Figure 1-5). 
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Figure 1-5: The four stages of normal wound healing in time.  
Overlap between the four stages, hemostasis, inflammation, proliferation and remodelling. 
Cells involved in each of the wound healing stage are indicated.  Adapted from (Diegelmann 
and Evans 2004). 
1.2.1 The wound healing stages 
1.2.1.1 The immediate events 
Immediately after injury two processes take place in order to stop bleeding 
and avoid blood leaking; coagulation is the formation of a clot over the wound 
providing a matrix over which keratinocytes can migrate. This clot consists of 
platelets embedded in a mesh of cross linked fibrin fibres where they can 
release cytokines and growth factors and activate the complement cascade. 
The amount of fibrin and size of the clot will be determined not just by 
coagulation, but also by its balance with endothelial cells, thrombocytes and 
fibrinolysis (Velnar et al. 2009). These first signals are responsible for triggering 
the whole wound healing sequence of events (Martin 1997). At the same time, 
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hemostasis occurs, consisting of an intense vasoconstriction for the first 5 to 10 
minutes followed by active vasodilatation 20 minutes after injury to ensure blood 
supply once the clot is formed (Stadelmann et al. 1998). 
1.2.1.2 The inflammatory phase 
While the fibrin clot is being formed and platelets migrate to the wound the 
inflammatory phase is also initiated. During this phase, inflammatory cells are 
recruited to the wound site and initiate a healing cascade mediated primarily by 
cytokines including platelet-derived factors and macrophage-derived factors.  
First of all, a vasomotor-vasopermeability response is essential to 
permeabilise the site of trauma, leading to an influx of a variety of leukocytes, 
which migrate to the wound site by chemotactic migration. They kill bacteria and 
remove devascularised tissue fragments and debris. Furthermore, the first three 
hours are critical to avoid infection because it is when the wound is least 
protected. Adequate tissue oxygen tension is important for leukocytes to kill 
bacteria via oxidative intracellular mechanisms (Eming et al. 2007). 
Neutrophils are one of the first leukocytes to infiltrate to the wound site. 
Neutrophils are attracted to the wound by chemoattractive agents such as TGF-
β, complement components (mostly C3a and C5a) and formylmethionyl 
peptides secreted by either bacteria or platelets 24 to 36 hours after injury,  
(Velnar et al. 2009). Diapedesis is the process by which neutrophils and other 
inflammatory cells migrate from the blood vessels through the endothelium to 
the wound site. Once in the wound site, neutrophils release reactive oxygen 
species (ROS) and lysosomal enzymes such as proteases and matrix 
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metalloproteinase (MMP) including collagenases, gelatinases and elastases to 
destroy foreign bacteria and material after phagocytosis (Shaw and Martin 
2016).  
Monocytes are attracted to the wound site by clotting factors, complement 
components, cytokines, and collagen or elastin breakdown products. Once in 
the wound they mature into macrophages 48 to 72 hours after wounding, during 
the late inflammatory phase (Velnar et al. 2009). Furthermore, they are able to 
act at low pH so their lifespan is longer than that of the neutrophils, thus 
providing an abundant reservoir of growth factors and other chemoattractive 
mediators to the wound site to activate skin cells around the wound margin. 
Mast cells are another type of resident leukocytes in the skin and they 
have a key role during different stages of wound healing (Koh and DiPietro 
2011). 
Although inflammation during normal wound healing lasts for 2 to 5 days, 
the immune response continues for the whole wound healing process. 
Lymphocytes, B and T cells, are the responsible for this adaptive immune 
response, which is a delayed but more specific immune response. Lymphocytes 
are the last type of immune cells to enter into action. They are attracted by 
interleukin-1 (IL-1), complement components and immunoglobulin G (IgG) 
breakdown products 72 hours after wounding (Velnar et al. 2009). B cells, which 
are antibody secreting cells, are also able to produce cytokines and growth 
factors, present antigens on its cell membrane and regulate T cell activation and 
differentiation (Landen et al. 2016). On the other hand, T cells also produce 
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growth factors while functioning as immunological effector cells.  In particular, 
regulatory T cells are involved in the attenuation of the interferon-γ production 
and accumulation of macrophages to regulate tissue inflammation (Sorg et al. 
2017). This is mediated through the activation of the epidermal growth factor 
receptor pathway in order to enable the regeneration process of the wound.  
1.2.1.3 The proliferative phase 
The formation of granulation tissue is essential for the wound healing 
process. Dermal fibroblasts at the wound edges start the production and 
deposition of fibronectin which binds fibrin creating scaffolding on which 
fibroblasts can migrate into the wound (Stadelmann et al. 1998). The 
proliferation of dermal fibroblasts to this scaffold leads to the development of 
granulation tissue, which will therefore enable re-epithelialization. After increase 
of DNA replication, migration and metabolic activity of fibroblasts during the first 
two days after wounding, dermal fibroblasts start proliferating (Stadelmann et al. 
1998). Resting fibrocytes of regional connective tissue and perivascular 
adventitia, and in haired skin, dermal sheath cells from the hair follicles are the 
source of fibroblasts (Jahoda and Reynolds; Jahoda and Reynolds 2001). 
Changes in expression of certain receptors, such as integrins allow 
fibroblasts to migrate into the clot. Integrins from part of specialized cell surface 
structures called focal adhesions (FAs) which mediate the adhesion between 
the extracellular matrix (ECM) and the actin cytoskeleton of fibroblasts (Zaidel-
Bar et al. 2007). They are regulated by different signals from the surrounding 
matrix and growth factor milieu. Specifically, integrins binding collagen 
receptors are down-regulated, while integrins which bind fibrin, fibronectin and 
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vitronectin are all up-regulated (Martin 1997) to allow migration of fibroblasts to 
the wound site.  
After migration, fibroblasts are responsible for glycosaminoglycans (GAGs) 
and collagen production (Shaw and Martin 2016). GAGs form an amorphous gel 
called “ground substance” useful for collagen fibres to be deposited and 
aggregated.  Collagen type I and III start to be produced at high levels, 
increasing the wound tensile strength, reaching at maximum levels at the end of 
the first week. It has been shown that type III collagen accumulation precedes 
that of type I in wound repair, and the final type I/III collagen ratio in the skin is 
of vital importance for the healing process (Dale et al. 1996). For example, 
when comparing the normal skin ratio, which is 4:1, with hypertrophic and 
immature scars, there is a dramatic change. Hypertrophic and immature scars 
show a 2:1 proportion of type I/III collagen (Stadelmann et al. 1998). 
Due to the higher metabolic need of cells during the proliferative phase, 
and the lack of vascularisation in the wound site, angiogenesis is critical during 
this phase of wound healing; therefore new capillary growth also takes place 
(Velnar et al. 2009).  
Re-epithelialization is required to close the wound with a layer of 
keratinocytes. In the basal layer, this process involves mobilization, migration, 
mitosis and cellular differentiation of keratinocytes from the surrounding 
epidermis.  
After wounding, cell contact inhibition is lost, which induces the 
keratinocytes that are immediately adjacent to the wound margin to migrate. 
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This process is called epithelial-mesenchymal transition (EMT), where epithelial 
cells that are in contact with a basement membrane, change to a mesenchymal 
cell phenotype by activating different biochemical changes related to an 
enhanced migratory capacity, invasiveness, resistance to apoptosis and 
production of ECM proteins (Kalluri and Neilson 2003). During wound healing, 
keratinocytes undergoes type 3 EMT as part of the repair process which has 
already been started by fibroblasts and immune cells. Unlike EMT in fibrosis, 
EMT in wound healing is associated with inflammation; once inflammation has 
been resolved and the wound site is covered by keratinocytes again, the 
reverse MET occurs (Kalluri and Weinberg 2009). During EMT, downregulation 
of hemidesmosomes occurs to enable keratinocyte migration and new 
fibronectin-recognising integrins (e.g. α5β1, αvβ1 and αvβ6) are expressed 
(Koivisto et al. 2014).  
In addition, fibroblasts in the dermis relocalise their collagen receptors to 
grasp hold of the provisional wound matrix and the underlying wound dermis.  
Proteases are also expressed at this stage in order to cut a path through the 
fibrin clot to allow keratinocytes to migrate and plasminogen (Plg) urokinase-
type (uPA) and the tissue-type (tPA) are upregulated to activate plasmin. This 
scenario makes it possible for keratinocytes to advance through the border as 
the rate of mitosis increases in cells distant from the wound site (Haensel and 
Dai 2017).  
The phenotype of repairing epidermis shows a very particular pattern of 
expression of KRTs. Activation of both KRT16 and KRT17 happens immediately 
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after wounding and is required for re-epithelialisation (Patel et al. 2006), while 
they are almost absent in normal human skin. Furthermore, KRT14, normally 
expressed in the basal layer of the epidermis, is unregulated in the new 
epithelial tissue.  
Once both edges of the wound meet, the keratinocytes stop migrating due 
to cell contact inhibition signalling. Then, they undergo mesenchymal-epithelial 
transition (MET) and the protein expression profile of basal keratinocytes 
returns to normal and allows them to be able to differentiate again and restore 
the barrier function of the epidermis (Stadelmann et al. 1998). 
Once homeostasis has been achieved and the barrier has been restored, 
the maturation phase takes places, which consists of collagen reorganization 
and GAG degradation. This period of remodelling can last for up to 2 years  
(Stadelmann et al. 1998). 
1.2.1.4 The remodelling phase 
The remodelling phase normally starts four days after wounding when 
some fibroblasts start to differentiate into myofibroblasts expressing high levels 
of α-smooth muscle actin (α-SMA) after stimulation by transforming growth 
factor beta 1 (TGF-β1) and the mechanical stimuli generated from resisting 
wound contraction forces (Sorg et al. 2017). Myofibroblasts ensure attachments 
via adherent molecules that attach them to each other as well as to the wound 
margins leading to wound closure (Velnar et al. 2009).  
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Once the wound contraction forces are relaxed again, cell surface 
fibronectin is released and the myofibroblast cell surface receptors become 
desensitized, which means they cannot respond to growth factors in the 
surrounding tissue. However, the exact molecular mechanism of this process 
remains unknown (Stadelmann et al. 1998). Finally, myofibroblasts undergo 
apoptosis, even when growth factors are added to the wound of a rat model 
(Burgess et al. 1990).  
An increase in the expression of α-SMA in mechanically scratched 
monolayers of human dermal fibroblasts has been described (Pomari et al. 
2015), and also in other mesenchymal cells from different body locations such 
as rat hepatic stellate cells (Rockey et al. 2013). 
1.2.2 Metabolic activity in wound healing 
Wound healing is a highly energy demanding process. During wound 
healing there is a need of high proliferation rate, production of extracellular 
matrix as well as the prevention of infection. Furthermore, different metabolites 
play an essential role during cell signalling (André-Lévigne et al. 2017). 
Metabolism refers to the pathways required for the production or consumption 
of energy from different sources, from carbohydrates and lipids, as well as 
proteins during starvation periods. Catabolism is the set of pathways used for 
the production of energy by the living cells. Aerobic respiration metabolise 
carbohydrates through glycolysis and the pentose phosphate pathway in the 
cytosol which produce pyruvate which are then used by the citric acid cycle in 
the mitochondria creating reducing species such as NADH and NADPH. Fatty 
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acids can be the source of energy by the production of acyl CoA derivatives, 
which go through beta oxidation in the mitochondria generating short carbon 
chain regulatory intermediates such as succinate. Finally, the reducing species 
create an electron gradient which is used by oxidative phosphorylation in the 
electron transport chain of the mitochondria to generate the energy molecule, 
ATP. All these processes, glycolysis in the cytosol and citric acid cycle and 
electron transport in the mitochondria, are able to produce ATP (Griffiths et al. 
2017). 
The adenine nucleotides ADP and ATP are used by skin cells to promote 
those biological processes needed for regeneration. Specifically, ATP was 
found to induce epithelial cell migration in vitro (Dignass et al. 1998). 
Furthermore, the reducing species, NADPH, created during catabolic processes 
such as glycolisis, are not only used by the oxidative phosphorylation process 
but they can also act as cofactors of ROS-generating NADPH oxidase enzymes 
as well as several antioxidant enzymes which control the redox state of the cell. 
Metabolically active cells show an irrefutable relationship between metabolism 
and cellular redox state (Griffiths et al. 2017). Finally, metabolic activity has a 
huge impact in the immune response immediately after wounding. The first 
responder cells of the innate immune response, neutrophils, are largely 
dependent on glycolysis while in immune cells in the absence of any demand 
rely mainly on oxidative phosphorylation (Griffiths et al. 2017). 
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1.2.3 Acute vs. chronic wound healing in the skin 
Although the normal process of wound healing is well documented, it is 
not clear why a normal wound may develop into a chronic non-healing wound 
where complete healing does not take place, and what the cellular and 
molecular differences between them are. A number of different types of chronic 
wounds may arise and a significant proportion of the population may suffer from 
them resulting in a highly cost condition to manage by the healthcare providers  
(Guest et al. 2017).Therefore, a deeper understanding of chronic wounds is 
essential in order to find an effective and patient friendly treatment, such as 
home-used light based devices, which have been shown to have the potential to 
improve wound healing due to stimulatory effects on proliferation and migration 
of different skin cell populations, including keratinocytes, fibroblasts and 
immune cells (Chabert et al., 2015) 
There are a number of features which characterize chronic wounds and 
differentiate them from normal wounds and their healing process. The epidermis 
of tissue surrounding chronic wound was shown to be very different from intact 
epidermis (Figure 1-6).  
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Figure 1-6: Histology of epidermis of healthy human skin and ulcers.  
(A) Healthy human skin, (B) preassure ulcer skin, (C) venous ulcer skin and (D) diabetic 
foot ulcer skin. Adapted from Pastar et al., (2014). 
Proliferative keratinocytes are found in the basal layer of the epidermis 
which ensure skin homeostasis in normal skin (Figure 1-6, A), however, a 
hyperproliferative epidermis is found in many different chronic wounds such as 
pressure ulcers (Figure 1-6, B), venous ulcers (Figure 1-6, C) and diabetic foot 
ulcers (Figure 1-6, D) where keratinocytes undergo mitosis not only in the basal 
layer but also in the suprabasal (Pastar et al., 2014). Activation of c-myc was 
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proposed to be involved in this response characteristic of chronic wounds 
(Stojadinovic et al., 2005) as a downstream target of β-catenin.  
Furthermore, another difference between both types of wounds is found in 
the volume of granulation tissue present, which is bigger in chronic than acute 
wounds but more important is the poor quality of this granulation tissue 
(Stadelmann et al., 1998). In order for normal wound healing to proceed, this 
granulation tissue must contain capillaries that vascularise the tissue, and it 
must be rich in different types of cells, such as fibroblasts and myofibroblasts, 
inflammatory cells, endothelial cells and pericytes. As the healing process 
advances, cells are removed from this tissue by undergoing apoptosis, and the 
granulation tissue is converted to an acellular and a vascular matrix of collagen 
(Stadelmann et al., 1998). A low quality granulation tissue at the beginning of 
the process may result in the development of chronic wounds. On a more 
frequent basis, failure of the development of granulation tissue during wound 
healing in a timely manner can lead to a high degree of cellularity in the 
granulation tissue at the later stages of wound healing, such as myofbroblasts, 
neutrophils or lymphocytes, which may result in chronic wounds. These wounds 
may eventually heal with abundant scar tissue (Stadelmann et al., 1998).   
Finally, wound contraction is required to reduce the size of the wound and 
close the defect; however in chronic wounds this process takes place 
indiscriminately and leads to a disorganized structural integrity, loss of function 
and cosmetic deformity in the wound site (Pastar et al., 2014). 
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1.3 Photobiomodulation: a deep understanding of the role of 
light in the skin 
Photobiomodulation is emerging as a clinical application for skin disorders, 
including wound healing but the lack of understanding of the molecular targets 
impedes identification of effective therapeutic parameters (Mignon et al. 2016). 
Before addressing the question of how skin cells are able to interact with low 
levels of light, it is essential to understand the properties of light and its 
propagation within different biological structures in human skin.  
1.3.1 Can the skin interact with light? 
Since the skin acts as a barrier between the human body and the 
environment it is continuously exposed to any kind of environmental factor, 
including light.  
Light is commonly used to refer to the visible part of the electromagnetic 
spectrum. It covers a wavelength range from 400 (violet) to 780 (red) nm. 
Furthermore, the neighbouring parts of this spectrum of electromagnetic 
radiation can also be seen with the help of some optical devices, and the skin is 
also exposed to them. Ultraviolet (UV) light which is close to blue light, ranges 
from wavelengths of 100 to 400 nm and infrared (IR) light (0.78-2000 µm) is 
found at the opposite end of the light spectrum, just after red light (Table 1-1) 
(Altshuler and Tuchin 2009).  
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Type of radiation Wavelength (λ) 
 
Ultraviolet (UV) 
UVC 100-280 nm 
UVB 280-315 nm 
UVA 315-400 nm 
 
 
Visible light 
Violet 400-450 nm 
Blue 450-490 nm 
Cyan 490-520 nm 
Green 520-560 nm 
Yellow 560-590 nm 
Orange 590-620 nm 
Red 620-780 nm 
 
Infrared (IR) 
Near IR 0.8-2.5 µm 
Middle IR 1.5-50 µm 
Far IR 50-2000 µm 
Table 1-1: Electromagnetic radiation from UV to IR including visible light spectra.  
When light interacts with human skin, part of the radiation is reflected back 
due to the different refractive index in comparison to the atmosphere (Lister et 
al. 2012). The rest is able to penetrate the skin. The effects that this penetration 
may cause depend on wavelength, intensity and exposure of the light. High 
irradiance and low exposure times leads to photomechanical or ablative 
mechanisms, while medium irradiance and medium exposure times produce 
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photothermal responses. Both mechanisms are able to stop skin functionality. 
However, when the energy is low enough not to cause these negative 
consequences (low irradiance and long exposure times), scattering and 
photoabsorption take place inside the skin (Boulnois 1986). Different molecules 
called chromospheres (Young 1996; Altshuler and Tuchin 2009) are responsible 
for absorbing light in the skin; these include protoporphyrin IX, melanin, 
riboflavin, oxyhemoglobin, bilirubin and β-carotene (Figure 1-7). Heme groups 
of blood cells and water (Mahmoud et al. 2008) strongly absorb IR light at 
wavelengths greater than 1100 nm (Huang et al. 2009). 
 
Figure 1-7: Absorption spectra of different skin chromophores.  
Adapted from Mahmoud et al., (2008). 
 In addition, some molecules called photoreceptors or photoacceptors are 
known to absorb light undergoing any kind of photochemical reaction (Lister et 
al. 2012). In the world of photobiology this is the most interesting and useful 
phenomenon as it is the one which can be used to produce molecular controlled 
effects in cells. Photoreceptors are especially important for plants as most of 
their functions are regulated by light. In humans, two members of the G protein 
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coupled receptor (GPCR) family, opsin 1 (OPN1) and opsin 2 (OPN2) or 
rhodopsin (RHO), are the main photoreceptors as they are present in the eye 
and are involved in vision (Terakita 2005). Since the skin is the human organ in 
which more surface area is exposed to light, it makes sense to hypothesise that 
photoreceptors (either known or unknown ones) are also present in skin cells. 
An understanding of the correct light parameters that modulate such receptors 
will be a step forward towards understanding the skin’s response to light, and 
whether its effects can be harnessed for therapeutic benefits. 
The use of light for medical applications has previously mainly focused on 
the use of low-level laser therapy (LLLT). This treatment uses light in the red or 
near-IR region of the electromagnetic spectrum and a power of up to 500 mW. It 
can be either continuous or pulsed light with a low energy density, normally 
between 0.04 and 50 J/cm2 which means no heat, sound or vibrations are 
produced (Huang et al. 2009). However, a new term has arisen to include a 
wider range of wavelength in the visible light spectra; photobiomodulation 
(Mignon et al. 2016).    
Human cell models have been used to analyse cell biology, protein 
expression and percentage of closure after a scratch in primary fibroblasts and 
keratinocytes, showing beneficial effects when using red light (Chabert et al. 
2015). Interestingly, hypertrophic scar derived fibroblasts from human donors 
were irradiated with red light at 660 nm and IR (880 nm) (Webb et al. 1998; 
Webb and Dyson 2003). These studies demonstrated that red light induced an 
increase in number of cell count for both normal dermal and hypertrophic scar 
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derived fibroblasts during the first five days following irradiation at both 2.4 and 
4 J/cm2 (Webb et al. 1998). However the NIR exposure reported the opposite 
effect, showing a significant decrease in cell number on day five for normal 
fibroblasts, and on day 4 for hypertrophic fibroblasts with the same radiant 
exposure (Webb and Dyson 2003). In parallel to this observation, the beneficial 
outcomes of red light was also reported for human diabetic fibroblasts, showing 
a higher degree of migration in comparison with both NIR irradiated and non-
irradiated fibroblasts (Houreld and Abrahamse 2010). 
Animal studies have also been used to test the effect of light on wound 
healing in vivo. One of the most interesting studies was done on epidermal 
barrier recovery in mice, where red light increased the rate of epidermal barrier 
recovery in comparison with both white light and dark conditions (Denda and 
Fuziwara 2008). They further suggested that phosphodiesterase 6 may be 
involved in this effect (Goto et al. 2011). 
Clinical studies on the effect of light on wound healing have also been 
reported. A double-blind randomized placebo controlled trial (14 patients and 23 
leg ulcers) was performed to assess the outcome of combined 660 and 890 nm 
light-emitting diode (LED) therapy (Minatel et al. 2009). The LED treated group 
demonstrated faster healing and more granulation tissue production at day 30 
than the placebo group. Furthermore, 58.3% of the treated wounds were healed 
at day 90 in comparison to only one placebo ulcer which was healing by this 
time (which corresponds approximately to 9%) (Minatel et al. 2009). 
Nevertheless, these clinical trials have obvious limitations as wounds can differ 
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quite a lot one from each other; they normally have different causes, time of 
healing and outcomes. Therefore, well-designed clinical trials are a requirement 
to comprehensively validate light-based therapies for wound healing (Beckmann 
et al. 2014).  
Notwithstanding studies using blue and violet light in photobiomoulation are 
growing, and they seem to be very promising as OPNs mainly absorbing light at 
these wavelengths, but the effects appear to be different to the use of red light. 
Irradiation with blue light has reported a reduction in the proliferation of primary 
epidermal keratinocytes at doses above 33 J/cm2, with an increase in apoptosis 
only at extremely high doses 100 J/cm2 (Liebmann et al. 2010). On the other 
hand, low doses of blue light, below 4 J/cm2, increased proliferation of outer root 
sheath hair follicle keratinocytes (Buscone et al. 2017) and metabolic activity in 
primary fibroblasts (Mignon et al. 2017) after one light treatment; however, 
multiple light treatments resulted in a decrease of metabolic activity of dermal 
fibroblasts even at very low doses (Mignon et al. 2017). Blue light (5 J/cm2) 
stimulated markers of early differentiation in epidermal keratinocytes, such as 
KRT1 and KRT10, but only high doses of blue light (66 and 100 J/cm2) induced 
the involucrin (INV) marker of late differentiation (Liebmann et al. 2010). Blue 
light has also been reported to delay the epidermal barrier recovery in mice 
(Denda and Fuziwara 2008). Reduction in proliferation and metabolic activity at 
non-toxic doses has also been observed in primary dermal fibroblasts 
(Oplander et al. 2011; Taflinski et al. 2014). In a scratch-wound assay, although 
low doses of blue light (2, 5 and 10 J/cm2) did not modulate migration of human 
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primary dermal fibroblasts, higher doses (55 J/cm2) inhibited migration 
(Masson-Meyers et al. 2016).  
A reduced of proliferation and enhanced differentiation of epidermal 
keratinocytes after blue light irradiation (Liebmann et al. 2010) makes this 
wavelength very promising for the treatment of psoriasis. Furthermore, it has 
been proposed that blue light reduce cytokine and interleukin release (Masson-
Meyers et al. 2016). All these characteristics also makes blue light appealing for 
the treatment of other conditions such as fibrotic skin conditions and the 
prevention of keloids and hypertrophic scars. However, very low doses of blue 
light might follow another mechanism, which is still to be uncovered. 
As previously discussed, the efficacy of light treatment for skin disorders and 
wound healing has been assessed in the laboratory using cell and animal 
models, as well as in human clinical trials. However there are still challenges to 
overcome regarding the relevance of the models used, and the selection of light 
parameters (Liebmann et al. 2010; Mignon et al. 2017). Although it is clear that 
light has an effect on biological organisms, not all types of light will have a 
beneficial outcome. Therefore, it is very important to select the correct light 
parameters for wound healing regarding wavelength, irradiance (W/cm2) and 
radiant exposure (J/cm2). Secondly, it is very important to use a relevant model 
for the study of light treatments. The closer the model is to the real clinical 
situation, the better. New in vitro wound healing models are becoming more 
popular as 3D culture technology advances. Reconstructive skin and full 
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thickness human skin ex vivo models are already in used by different research 
laboratories (Stephens et al. 2013). 
All these facts have to be taken into account when choosing a model to 
perform experiments; primary human fibroblasts or keratinocytes, 3D skin 
models and ex vivo wound healing models may be the most convenient to use, 
but avoiding cell lines as their characteristics can differ significantly with respect 
to the in vivo situation (Katayama et al. 2015). 
1.3.2 Possible mechanisms of action of light in human skin: an overview 
of skin photoreceptors 
Direct targets for photobiomodulation include cytochrome c oxidase 
(Karu 1999), photolysis of nitrozated proteins to generate nitric oxide (Liebmann 
et al. 2010; Oplander et al. 2013), ROS production (Opländer et al. 2011; Khan 
and Arany 2015; Nakashima et al. 2017) and light activation of calcium ion 
channels (Wang et al. 2016). Emerging photoreceptors in humans are opsins 
(OPNs) (Tsutsumi et al. 2009; Haltaufderhyde et al. 2015) and cryptochromes 
(CRYs) (Hoang et al. 2008) (Figure 1-8). 
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Figure 1-8: Photoreceptors present in epidermal keratinocytes.  
OPN: opsin, CRY: cryptochrome, CCO: cytochrome c oxidase, ROS: reactive oxygen 
spices, NO: nitric oxide and IC: ion channels. Image self-drawn.  
1.3.2.1 Cytochrome c oxidase 
Nowadays, the most commonly accepted mechanism of action of 
photobiomodulation or low-level-light therapy (LLLT) is through cell metabolism 
(Hamblin et al. 2006; Huang et al. 2009; Chung et al. 2012; Prindeze et al. 
2012) with cytochrome c oxidase (CCO) the proposed photoreceptor (Karu 
1999; Karu and Kolyakov 2005).  
Following this theory, it has been established that LLLT is able to excite 
an electron within the cytochrome c oxidase structure, stimulating the transfer of 
electrons through the respiratory chain. This leads to an increase of the proton 
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electrochemical potential, increasing adenosine triphosphate (ATP) synthase 
activity and increasing cell metabolism (Prindeze et al. 2012). As a 
consequence, cell proliferation, migration and adhesion are also enhanced and 
cell apoptosis is prevented  (Karu 1999). It has been reported that an overall 
shift in the cell redox potential may in turn induce transcriptional changes 
(activation of NF-β and other transcription factors) explaining the effects on 
growth factor production, extracellular matrix deposition, cell proliferation and 
cell motility, which are all important during wound healing (Hamblin and 
Demidova 2006). Finally, NO is able to bind to CCO via the heme center. 
Photoactivation of CCO is able to dissociate NO, allowing increase in 
respiration and ATP formation again (Huang et al. 2009).  
In order to study the direct interaction of light with cytochrome c oxydase, 
some work has been done related to action and absorption spectra. An action 
spectrum is the rate of a physiological activity plotted against wavelength of light 
and an absorption spectrum is a spectrum of radiant energy whose intensity at 
each wavelength is a measure of the amount of energy at that wavelength that 
has passed through a selectively absorbing substance. Karu and Kolyakov 
(2005) showed a relationship between the action spectra of proliferation and 
DNA content in HeLa cells (epithelial cervix cancer cell line) regarding its 
interaction with light and the absorption spectra of the most important structures 
of cytochrome c oxidase.  
This study was the starting point to consider this molecule as the main 
photoreceptor for photobiomodulation. Cytochrome c oxidase is a 
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transmembrane protein of the inner mitochondrial membrane involved in the 
electron transfer within the respiratory chain. It accepts electrons from 
cytochrome c and gives them to oxygen, the last electron acceptor to form a 
water molecule (Figure 1-9). The most important intermediates involved in 
electron transfer within this protein are copper A (CuA), heme a, heme a3 and 
CuB, and its redox state determines the redox state of cytochrome c oxidase 
which can be either oxidized or reduced (Karu and Kolyakov 2005). 
 
Figure 1-9: Structure and biochemical reactions of cytochrome c oxidase.  
Adapted from Hamblin and Demidova (2006). 
Limitations are also present especially when trying to match both action 
and absorption spectra because the biological effect measured may just be an 
indirect consequence of the application of light. Four peaks were found within 
the visible to IR wavelength light, which were identified with the absorption 
spectra of CuA, heme a, heme a3 and CuB separately, but not with the 
absorption spectra of cytochrome c oxidase. In fact when analyzing both its 
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oxidised and reduced form, the two biggest peaks are found in other regions; 
the first one in the blue region and another one around 600 nm (Karu and 
Kolyakov 2005). Both forms are able to absorb radiation through other regions 
of the electromagnetic radiation meaning that cytochrome c oxidase could be 
excited with any kind of light within the visible or IR spectrum. However, apart 
from Karu and colleagues (2005) little has been reported in this field, so it has 
not yet been demonstrated whether CCO is the photoacceptor for visible/IR 
radiation. To overcome the limitations of action spectra studies, testing directly 
the activity of the putative photoreceptor comparing both light exposed and non-
exposed conditions is required. Only one study reported by Wong-Riley and 
colleagues (2005) showed the role of CCO in response to light in neutrophils. 
They showed how pretreatment with red light completely reverted the effect of 
tetrodotoxin (TTX), a voltage-dependent sodium channel blocker, which blocks 
neuronal impulse activity, decreasing ATP demand and down-regulating 
cytochrome c oxidase activity. Furthermore, this pretreatment with red light also 
increased the efficacy of cytochrome c oxidase when using potassium cyanide 
(KNC) an irreversible inhibitor of cytochrome c oxidase (Wong-Riley et al. 
2005). These discoveries, together with the comparison of absorption and 
action spectra already explained, give more solid evidences supporting the role 
of cytochrome c oxidase as a photoreceptor. 
1.3.2.2 The opsins  
Cell signalling is an important event which enables cells to communicate 
with each other and with the environment. This way, they are prepared to 
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respond to environmental changes or perturbations.  Membrane receptors have 
the role of transmitting the signal to intracellular signal transduction cascades, 
altering cell behaviour. Fundamentally, the components of a signalling 
transduction pathway are first, the signal and the receptor and subsequently, 
the transduction, the effector and the final response (Alberts et al. 2007) 
There are three main cell surface receptors: ion-channels, GPCRs and 
enzyme-linked receptors (Alberts et al. 2007). G-protein-coupled receptors or 
seven transmembrane receptors (7TMs) are the biggest cell surface receptor 
family comprising a 3-4% of the whole human genome (May et al. 2007). OPNs 
are GPCRs which can be stimulated by light through a covalent binding to a 
vitamin A derived chromophore which is normally 11-cis-retinaldehyde (Ebrey 
and Koutalos 2001). 
When the receptor protein is activated, it can join a G protein complex 
which includes three subunits α, β and γ. One of these three subunits of the G 
protein complex, the α subunit hydrolyses GTP to GDP; and in doing so the βγ 
complex is activated as well (Alberts et al. 2007). Downstream enzymes 
activated by G proteins catalyse the production of molecules which act as 
secondary messengers. Many downstream signalling pathways can be 
activated by GPCRs. The phosphatidylinositol pathway through phospholipase 
C is considered to be one of the most important GPCR pathways (Pierce et al. 
2002), being mediated by Gq proteins. Another G protein, G13 is also activated 
by GPCRs and transmit the signal through Rho downstream signalling pathway.  
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Although GPCRs can bind a broad variety of different ligands, their 
primary structure, as well as their tertiary structure is are highly conserved 
(Strader et al. 1995). All these proteins share a structure of seven hydrophobic 
segments that are the transmembrane-spanning α-helices, most commonly 
known as TM domains. These seven domains are separated by extra- and 
intracellular hydrophilic loops, with an extracellular N-terminus and an 
intracellular C-terminus. Due to the variety of GPCRs, they divide into three 
distinct subfamilies based on sequence differences, which are principally found 
beyond the TM domains (Pierce et al. 2002).  
The class A subfamily includes OPN2 or RHO and β2 adrenergic 
receptor-like receptors. It is the largest of the three GPCRs subfamilies (Gether 
2000). The class B subfamily includes glucagon/calcitonin receptor like 
receptors. Finally, metabotropic glutamate-like receptors represent the class C 
subfamily (Figure 1-10) (Vauquelin and Van Liefde 2005).  
 
Figure 1-10: Families A of GPCRs.  
Adapted from Gether, (2000).  
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Mammalian OPN2 or RHO, one of the better studied GPCRs, is present 
in rod cells within the retina and plays a remarkable role in vision in dim and 
dark light (Bourne and Meng 2000). OPNs in general and OPN2 in particular, 
bind covalently to the photochromophore retinal both in the dark (inactive) state 
and after photoactivation (Bourne and Meng 2000). The absorption of a photon 
by the 11-cis retinal isomeric form causes a conformational change and 
produces the all-trans retinal which enables the visual pigment rhodopsin to 
undergo a conformational change to become active (R*). This signal leads to a 
depolarization of the cell membrane and in the context of vision, it will reach the 
cell membrane of retinal neurons (Dell'Orco 2013). 11-cis-retinal acts as an 
inverse agonist, blocking the constitutive activity of the receptor which can be 
activated only by light (Gether 2000).  
However, other OPNs are also expressed in mammals. OPN1-short 
wavelength (OPN1-SW) has its maximum absorption spectra in the violet-blue 
range, but the peak for OPN1-middle/long wavelength (OPN1-M/LW) is at 
higher wavelengths, in the green part of the spectra. OPN2 can be excited by 
blue-green light. In humans, OPN1 and OPN2 (rhodopsin) are the main 
photoreceptors in the eye. They transduce the light signal through the G protein 
transducin or Gt. Transducin, in turn, activates the cGMP-dependent 
phosphodiesterase, which hydrolyzes cGMP, thus reducing its concentration 
and leading to the closure of sodium channels in the outer segment membrane 
(F). Following isomerization and release from the opsin proteins, all-trans retinal 
is reduced to all-trans retinol and travels back to the retinal pigment epithelium 
to be ‘recharged’. Finally, peropsin was found in the retinal pigment epithelium 
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(RPE) of the mammalian eye where it can act as a retinal photoisomerase 
(Terakita 2005). 
Non-visual OPNs have also been identified; OPN3 or encephalopsin 
activates the Gi/Go pathway and has its absorption peak at 460 nm of the light 
spectra, OPN4 or melanopsin transduces the light signal through Gq protein 
and OPN5 or neuropsin, a UV-R sensitive photoreceptor, activates Gi proteins 
(Poletini et al. 2015). Each of them has its maximum absorption spectra at a 
different wavelength, being able to respond to different light parameters and 
activating a different G protein related downstream pathway, which will induce 
different biological responses.  
Following the work of Miyashita, Moriya et. al. (2001) describing the 
presence of OPN2 and cone opsins in murine melanocytes, Tsutsumi et al. 
(2009) confirmed the presence of rhodopsin-like proteins and opsin-like proteins 
throughout the human epidermis from the face, and a reconstructed skin model 
using both reverse transcription polymerase chain reaction (RT-PCR) and 
immunohistochemistry (IHC). OPN2 was observed throughout most of the 
epidermis except the basal layer. Furthermore, the presence of two different 
types of OPNs was confirmed. The first one, stimulated by a shorter wavelegth, 
OPN1-SW was found in the upper layer of the epidermis, and OPN1-M/LW 
opsin-like protein, stimulated by a longer wavelength, was localized to the basal 
layer of the epidermis. Furthermore, while they confirmed this finding in total 
RNA from facial human skin by RT-PCR, any of these photoreceptors were not 
found in primary human keratinocytes derived from neonatal foreskin in culture.  
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Subsequently, a recent study on the role of violet light in primary cultures of 
human epidermal keratinocytes derived from neonatal foreskin found 
expression of OPN2 by immunocytochemistry (ICC) and western blot (Kim et al. 
2013). Finally, a detailed study by Haltaufderhyde, K. et al. (2015) using primary 
human epidermal melanocytes derived from neonatal foreskin, and purchased 
primary human keratinocytes (Lifeline Cell Technology; they do not give details 
from the origin of these keratinocytes) demostrated the presence of OPN1-SW, 
OPN2, OPN3 and OPN5 mRNA in both cell types as well as OPN4 in 
melanocytes while OPN1-M/LW was not detected in either.  
Strong evidence for the photosensitivity of OPNs to light in tissues other 
than the eye is now emerging (Kojima et al. 2011; Wicks et al. 2011; Kim et al. 
2013; Koyanagi et al. 2013; Sikka et al. 2014; Toh et al. 2016; Buscone et al. 
2017; Regazzetti et al. 2017). It has been shown that OPN-like receptors have 
an important role in light reception and signal transduction through a G protein 
and the polycation liposome (PCL)-mediated pathway, which mobilizes calcium 
(Ca2+) following UVA exposure which induced dose-dependent melanin 
production by human melanocytes (Wicks et al. 2011). More specifically, OPN2 
played a role in the effect of UV in mediating differentiation of human epidermal 
keratinocytes derived from neonatal foreskin (Kim et al. 2013).  
Focusing on non-visual OPNs, OPN3 has been shown to be a 
photoreceptor in lower animals such as pufferfish and mosquito.  It has been 
shown the role of OPN3 to interact with light in vertebrates (Koyanagi et al. 
2013). In line with this, Buscone et al., (2017) have recently reported that OPN3 
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downregulates proliferation of human hair follicle outer root sheath cells in 
culture; furthermore, blue light was inducing proliferation of outer root sheath 
cells, effect which was abrogated after silencing of OPN3.  Melanopsin or OPN4 
has been highly studied in the context of circadian clock. It has been identified 
as a circadian clock photoreceptor in mammals, which means it is able to 
entrain the circadian clock in several mammal tissues (Panda et al. 2002; 
Hankins et al. 2008). Apart from its circadian function, OPN4 was shown to 
specifically respond to blue light in mice mediating the blue-light vasorelaxation 
response of blood vessels in mice (Sikka et al. 2014). Human and mice OPN5 
were able to respond to UV (380nm) light through Gi mice signalling pathway. 
This was leading to the formation of a new OPN5 photoproduct absorbing blue 
light (Kojima et al. 2011). Finally, peropsin was also studied in human skin and 
it contributed to the UV light-induced Ca2+ release in a retinal-dependent way in 
N/TERT-1 keratinocyte cell line (Toh et al. 2016). These findings reveal a role 
for OPNs in a very important function of the skin, melanin production, as well as 
hair follicle cell proliferation. 
Even though there is new evidence for the role of OPNs in non-
photoreceptive tissues, their specific function still needs to be explored in more 
detail. Further explanation about the circadian clock will be made in the next 
section, however, the idea of non-visual OPNs mediating circadian clock 
photoentrainment by their interaction with light in peripheral tissues is gaining 
momentum (Poletini et al. 2015; de Assis et al. 2016), and highlights the 
importance of the circadian clock in skin physiology and wound healing (Plikus 
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et al. 2015). Therefore, non-visual OPNs are emerging as interesting targets for 
wound healing light-based therapies. 
1.3.2.3 Cryptochrome 
Cryptochromes are one of the three groups of proteins that belong to the 
family of photolyases/cryptochromes. This diverse gene family shares the 
presence of two photoactive molecules within their structure throughout all the 
biological kingdoms (Chaves et al. 2011), the chromophores flavin adenine 
dinucleotide (FAD) and pterin (Hsu et al. 1996). These chromophores are able 
to absorb blue light which give the role of blue light receptors to the 
photolyase/cryptochrome family.  
Furthermore, photolyases act as light-dependent DNA repair enzymes; 
while on the other hand, cryptochromes (first identified in A. thaliana (Ahmad 
and Cashmore 1993)) are signalling molecules involved in circadian clock 
regulation in both plants and animals (Chaves et al. 2011). They are also 
regulated by external light signals, which can lead to circadian 
photoentrainment in plants and some animals such as Drosophila (Chaves et al. 
2011). Despite the presence of FAD and pterin in mammalian CRY, their role as 
blue light receptors in mammals has not yet been established (Lucas and 
Foster 1999) (Figure 1-11).  
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Figure 1-11: Molecular clock of drosophila and mouse.  
C or Cry: Cryptochrome; P or Per: Period; T or Tim: Timeless; Cl, Clock; B or Bmal1: 
Brain and muscle ARNT (arylhydrocarbon receptor nuclear translocator)-like protein 1; R or 
Reb-erbα; Cy, Cycle. Adapted from (Chaves et al. 2011). 
Nowadays, the role of CRYs in the circadian clock molecular machinery 
in different animals including humans has been accepted (Zhao et al. 2014). As 
a consequence of exposure to daily cyclic variation of light and dark, circadian 
rhythms have been observed through all biological kingdoms, as a highly 
conserved system. These circadian rhythms produce oscillations at the 
molecular, physiological and behavioural level of organisms and it confers on 
them a selective advantage (Sancar 2000). In humans, its molecular pathway is 
based on two main feedback loops cryptochrome/period (CRY/PER) and REV-
ERBs/retinoic acid receptor-related orphan receptor (ROR) which are 
connected by aryl hydrocarbon receptor nuclear translocator like  (ARNTL) or 
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BMAL1 and clock circadian regulator (CLOCK) (Figure 1-12) (Geyfman and 
Andersen 2009). 
 
Figure 1-12: The peripheral circadian clock in human skin.  
Possible implication of OPNs in the modulation of circadian clock is suggested with a 
red question mark. Pointed arrow means activation and stopped arrow means inhibition.  
The importance of the circadian clock in the cell cycle regulation has 
been already established (Plikus et al. 2015). Although the mechanism of action 
is not completely understood, it has been established that the circadian clock 
regulates several cell cycle check point genes such as wee1 and Cyclin 
Dependent Kinase Inhibitor 1A (CDKN1A) (Plikus et al. 2015). Furthermore, 
molecules such as the mammalian TIM and non-POU domain-containing 
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octamer-binding protein (NONO) interact with both circadian proteins and cell 
cycle proteins (Kowalska et al. 2013). The connection between both circadian 
clock and cell cycle processes is of interest in wound healing research, 
especially when the focus is on chronic wounds where cell regulation is 
completely lost. Kowalska et al., (2013) have shown that Nono knockout mice 
display an impaired wound healing response; these animals were characterised 
by delayed epidermal regeneration, loss of dermal organization and decreased 
collagen deposition in the wound site.  
Regarding the photoreceptor function of cryptochromes, the two human 
Cryptochrome proteins CRY1 and CRY2 were first identified as Drosophila (6-4) 
photolyase homologues, but they lacked both the ability to bind to damaged 
DNA and to repair thymidine photoproducts, which led to the conclusion that 
these two genes may act as blue-light receptors (Hsu et al. 1996). 
Subsequently, numbers of studies have been done to elucidate both the 
expression and function of these two proteins. The dual function of mammalian 
CRYs as circadian clock regulators and photoreceptors was also suggested  
due to their structural similarity with non-mammalian CRYs (Vitaterna et al. 
1999), however no strong evidence has yet been shown and arguments have 
been proposed against human CRY ability to respond to blue light (Foster and 
Helfrich-Förster 2001). The different role of CRYs within the circadian clock of 
mammals in comparison to plants or other animals is clear. While, for example 
in Drosophila, cry is not part of the core molecular mechanism of the circadian 
clock, but acts more like a gate that interacts with timeless (tim) and gives an 
input to the molecular loops to function, while in mammals CRY is part of one of 
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the two feedback loops that maintain cellular rhythmicity (Figure 1-11). This 
difference can be more important than the highly similar protein structure when 
addressing the question of mammalian CRY as the circadian clock photo 
entrainment molecule (Foster and Helfrich-Förster 2001). However, it is still a 
fact that CRY contains two chromophores inside its protein structure that may 
not transduce in a change of protein conformation, but may be involved in the 
production of ROS as a stress signalling mechanism (Hoang et al. 2008).  
There are only limited studies that demonstrate that the human CRY1 
and CRY2 proteins are able to interact with light.  Hoang, Schleicher et al. 
(2008) used the action spectra approach to measure the level of oxidized flavin 
in insect living cells transfected with human CRY1; showing that human CRY1 
undergoes light-dependent proteolysis after blue light exposure when 
expressed in living flies (Hoang et al. 2008). This is the most promising finding 
supporting the role for cryptochromes as photoreceptors in humans. However, 
whether this degradation is the result of a direct effect of the light on hCRY 
molecule or wheather other mechanisms are involved is not clear. Furthermore, 
non-irradiated controls at every time point were not included for comparison, 
and the light-dependent function of hCRY within human cells was not 
addressed.    
Peripheral clocks are found in all organs in the human body. Specifically, 
PER1 and CLOCK mRNA were found in human skin (Zanello et al. 2000). 
These data were confirmed and consolidated by showing the mRNA expression 
of BMAL1 and TIM in human skin (Bjarnason et al. 2001). Furthermore, PER1 
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and BMAL1 followed a circadian behaviour (Bjarnason et al. 2001). Human 
primary skin cells were shown to express CRYs and to maintain circadian 
oscillations in culture; primary keratinocytes from neonatal foreskin showed 
mRNA oscillations for most of the clock genes after synchronisation with 
chelated FBS, including BMAL1, REB-ERBAα, , REB-ERBAβ, PER1, PER2, 
PER3, CRY1 and CRY2 (Janich et al. 2013). Primary dermal fibroblasts from 
the anterior pubic region also showed oscillations in culture of BMAL1, PER1, 
PER2, CRY1 and CRY2 after synchronisation with dexamethasone (Lippert et 
al. 2014). Furthermore, gene silencing of CRY1 in epidermal keratinocytes 
resulted into increase on late differentiation and reduced in colony formation, 
while PER2 was significantly unregulated (Janich et al. 2013). This shows the 
relevance of CRY1 in epidermal keratinocytes proliferation and differentiation in 
vitro.  
In order to study the role of CRYs and OPNs in the context of the circadian 
clock, it is important to understand how this molecular pathway can be 
modulated. Several pharmacological tools have been identified to regulate the 
CRY/PER feedback loop; KL001 was found to block one of the enzymes 
required for CRYs degradation, stabilising the protein while longdaysin (LD) 
dowregulates the degradation of PERs (Hirota et al. 2012) (Figure 1-12). KL001 
was used to study corneal wound healing and was shown to slow down the re-
epithelialisation process in mice (Xue et al. 2017), suggesting the use of 
interventional strategies to regulate biological rhythms to improve corneal 
healing. 
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1.4 Aim and objectives 
Expression of the photoreceptors OPNs in human skin and latest findings 
about their implication in diverse functions of the skin such as melanin 
production and hair follicle cell proliferation open a new field to explore a range 
of opportunities for the development of new light-based therapies specifically 
targeting OPNs with differennt light parameters. Furthermore, photosensitivity of 
human CRY to blue light has also opened the possibility of regulating the 
peripheral circadian clock of human skin using photobiomodulation.  
The first aim of this study was to investigate the expression of OPNs and 
CRYs in human skin from different anatomical regions and to establish whether 
primary epidermal keratinocytes and dermal fibroblasts retain expression in 
culture. Then, to investigate the effect of different light parameters on epidermal 
keratinocytes in terms of their metabolism and migration in a scratch wound 
assay by using gene silencing of OPNs and CRYs , establishing their role in 
normal conditions and after blue light exposure. Finally, to develop an ex vivo 
human skin wound healing model to determine whether light inrradiation can 
improve re-epithelialisation. 
Objectives: 
• Localisation of visual OPNs, OPN1-SW and non-visual OPNs, OPN3 and 
OPN5 photoreceptors as well as the circadian clock CRY1 and CRY2 in 
human skin in situ.  
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• Confirmation of mRNA and protein expression of OPNs and CRYs in 
primary epidermal keratinocytes and dermal fibroblasts in vitro to validate 
further use as a model to investigate the effect of light on cellular 
responses.  
• Determine the optimal light parameters to modulate epidermal 
keratinocyte metabolism, migration, DNA synthesis and differentiation.  
• Establishing a role for photoreceptors in epidermal keratinocyte DNA 
synthesis, migration and differentiation with low levels of blue light 
irradiation following gene knock down by siRNA transfection (targeting 
OPN3 and CRY1) in combination with KL001 treatment.  
• Investigate the effect of light on wound healing using an ex vivo human 
wound healing model to evaluate the efficiency of selected light 
parameters in re-epithelialisation, and the expression of photoreceptors 
in the new epithelial tissue formed.  
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2 MATERIALS AND METHODS 
Ethical approval to carry out this study was granted by the Chair of the 
Biomedical, Natural and Physical Sciences Research Ethics Panel at the 
University of Bradford on the 24th of October 2014.  
2.1 Human skin samples 
Skin samples from healthy patients undergoing facelift plastic surgery or 
abdominoplasties were obtained with informed consent. The skin tissue was 
immediately placed in transporting media until it was processed no longer than 
12 h later.  
Transporting media was made as follows: Minimum Essential Medium 
(MEM), GlutaMAX supplement  (GIBCO, UK) was supplemented with 10% 
foetal calf serum (FCS) (GIBCO), 250 Units/ml penicillin and 250 µg/ml 
streptomycin (Pen/Strep) (GIBCO), 7.5 µg/ml of amphotericin B and 6.15 µg/ml 
of sodium deoxycholate, both contained in fungizone antimycotic (GIBCO) and 
2 mM of L-alanyl-L-glutamine dipeptide in 0.0085% of NaCl or glutaMAX 
(GIBCO) and stored at 4˚C. 
After reception, skin tissue was placed in a 60 mm tissue culture dish 
(Starstedt) with PBS (Figure 2-1, 1) and fat tissue was removed using scissors. 
Then, the skin was cut into small squares (≈1cm2); some of the pieces were 
embedded in OCT for further histological analysis of in vivo skin (section 2.2.5) 
and the rest was used for primary epidermal keratinocyte and dermal fibroblast 
cell extraction (section 2.2.2).  
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2.2 Establishment of primary cells 
2.2.1 Cell culture solutions 
2.2.1.1 Primary epidermal keratinocyte growth media  
Primary keratinocyte growth media was made up using keratinocyte 
growth media 2 (PromoCell, UK) supplemented with 0.004 ml/ml of bovine 
pituitary extract, 0.125 ng/ml of epidermal growth factor (recombinant human), 5 
µg/ml of insulin (recombinant human), 0.33 µg/ml of hydrocortisone, 0.39 µg/ml 
of epinephrine, 10 µg/ml of tranferrine holo (human), 0.06 mM of CaCl2 100 
Units/ml penicillin and 100 µg/ml streptomycin (Pen/Strep) (GIBCO) and 2.48 
µg/ml fungizone (GIBCO). Keratinocyte growth media 2 was kept at 4 ˚C and all 
supplements at -20 ˚C. Once media was supplemented, it was stored at 4 ˚C for 
no longer than one month.  
2.2.1.2 Primary dermal fibroblast growth media  
Primary fibroblast growth media was made up using Dulbecco’s modified 
Eagle’s medium (DMEM) with L-glutamine (Sigma-Aldrich) supplemented with 
10% foetal bovine serum (FBS) (GIBCO), 100 Units/ml penicillin and 100 µg/ml 
streptomycin (Pen/Strep) (GIBCO), 2.5 µg/ml of amphotericin B and 2.05 µg/ml 
of sodium deoxycholate, both contained in fungizone antimycotic (GIBCO). 
DMEM was kept at 4 ˚C and FBS, Pen/Strep and fungizone at -20 ˚C. Once 
fibroblast medium was prepared, it was kept at 4 ˚C for no longer thatn one 
month. 
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2.2.1.3 Primary cells freezing media 
Cryo-SFM (Promocell) was used to freeze primary human keratinocytes. 
Fibroblasts were frozen in media prepared using 80% of fibroblasts growth 
media (2.2.1.2), 10% FBS (GIBCO) and 10% dimethyl sulfoxide (DMSO) 
(Sigma-Aldrich). 
2.2.2 Cell extraction 
After cleaning and cutting the skin tissue as described above (Figure 2-1, 
1), into small pieces, they were placed in 5.2 U/ml of dispase (GIBCO) in PBS 
with 100 Units/ml penicillin and 100 µg/ml streptomycin (Pen/Strep) (GIBCO) 
and 2.5 µg/ml of amphotericin B and 2.05 µg/ml of sodium deoxycholate, both 
contained in fungizone antimycotic (GIBCO) and kept at 4 ˚C overnight.  
Working under the dissecting microscope (Leica), the epidermis was 
peeled using forceps and kept in primary keratinocyte growth media (2.2.1.1) in 
ice. The remaining dermis was placed in fibroblast growth media (2.2.1.2), 
which was also kept in ice (Figure 2-1, 2). Once all the skin tissue was 
processed, the epidermis was trypsinised with 3 ml of 0.05% Trypsin/EDTA 
(GIBCO, Netherlands) for 5 to 10 minutes at 37 ˚C and vortexed (Figure 2-1, 4). 
After removing the excess epidermis, trypsin neutralising solution (TNS) (Lonza, 
UK) was added (equal volume as trypsin) and the suspension was centrifuged 
for 5 min at 600 g. The pellet was dissolved in keratinocyte growth media 
(2.2.1.1) and cultured in T75 flasks (Corning, UK) at approximately 25,000 
cells/ml (Figure 2-1, 5).  
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Between 6 and 12 pieces of dermis were placed in a T75 flask (Corning) 
with the papillary dermis facing down (Figure 2-1, 6) and once it had stuck to 
the flask, 5 ml of fibroblast growth media (2.2.1.2) was added. Both primary 
keratinocytes and fibroblasts were incubated at 37 ˚C and 5% CO2 and 
maintained by changing the media every other day until they reached 80-90% 
confluence (Figure 2-1, 7) when they were either passaged or frozen in liquid 
nitrogen.  
 
Figure 2-1: Workflow of primary fibroblasts and keratinocytes extraction from 
human skin.  
1 - Reception of post-surgery skin; clean, remove fat and cut into small pieces. 2 - Incubate 
overnight in 5.2 U/ml of dispase. 3 - Peel the epidermis from the dermis. 4 – Trypsinise the 
epidermis (5 to 10 mins at 37 ˚C), vortex and remove pieces of epidermis. Add equal volume of 
TNS and centrifuge for 5 mins at 1000 rpm. 5 – Resuspend the pellet in keratinocyte growth 
media and culture cells in a T75 flask. 6 – Culture dermis explants in fibroblast growth media in 
a T75 flask . 7a – Incubate primary keratinocytes at 37 ˚C 5% CO2. 7b – Incubate primary 
keratinocytes at 37 ˚C 5% CO2.  
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2.2.3 Cell maintenance and passaging 
Cells were maintained at 37 ˚C and 5% CO2 in a humidified incubator. 
Both primary keratinocyte growth media (2.2.1.1) and fibroblast growth media 
(2.2.1.2) were changed every other day until cells reached confluence. Special 
care had to be taken with primary keratinocytes; they had to be passaged at 
80% confluent to avoid differentiation.  
2.2.3.1 Primary epidermal keratinocytes 
Once primary keratinocytes had reached 80% confluence, they were 
washed with PBS twice. Then, 0.5 mM of ethylenediaminetetraacetic acid 
(EDTA) (GIBCO) was added (Table 2-1) and cells were incubated for 4 min at 
37 ˚C to disrupt cell-cell interactions. After removing EDTA, 0.05% 
Trypsin/EDTA (GIBCO) was added for 2 mins at 37 ˚C (Table 2-1). Under the 
phase contrast microscope cells were checked for detachment from the flask 
and a double volume of TNS was added (Table 2-1).  
Volumes added of  T25 flask T75 flask 
0.05 mM EDTA 1.5 ml 2.5 ml 
0.05% Trypsin/EDTA 1 ml 2 ml 
TNS 2 ml 4 ml 
Fibroblasts growth media (for 
trypsin neutralisation) 
2 ml 4 ml 
Table 2-1: Keratinocyte and fibroblast passaging.  
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Cells were transferred to a 15 ml Falcon tube (Starstedt, UK) and cell 
number and viability quantitated using an improved Neubauer haemocytometer 
(Hawksley, UK). The cell suspension was mixed with trypan blue solution 0.4% 
(Sigma-Aldrich) (1:1) and 10 µl was added into the haemocytometer. The total 
number of cells and the non-viable cells (blue colour) in the 4 corners and the 
middle compartments were counted. Cells in the bottom and left grids were 
taken into account, discarding cells in the upper and right grids of the 
compartments. The average number of cells was calculated and multiplied by 2 
(dilution factor) and by 104 (0.1 mm depth) to calculate the cell concentration 
(number of cells per ml). This information was used to plate cells at the desired 
cell density. Cells were centrifuged at 400 g for 5 mins; the supernatant was 
removed and the pellet was re-suspended in keratinocyte growth media 
(2.2.1.1) and the cells were plated at the desired cell density. For routine 
passaging, cells were split at a ratio of 1:3.  
2.2.3.2 Primary dermal fibroblasts  
Similar to primary keratinocytes, monolayers of primary fibroblasts were 
washed twice with 1x PBS after reaching 80-90% confluence. Then, 0.05% 
Trypsin/EDTA (GIBCO) was added for 5 mins at 37 ˚C. Under the phase 
contrast microscope it was checked whether cells had detached from the flask. 
Tapping the bottom of the flask helped in the detachment process. A double 
volume of fibroblast growth media (2.2.1.2) which contained 10% FBS was 
added to neutralise the trypsin and the cell suspension was transferred to a 15 
ml Falcon tube. Cells were counted as previously described for primary 
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keratinocytes and centrifuged at 400 g for 5 mins. The supernatant was 
removed and the cell pellet was re-suspended in fibroblast growth media 
(2.2.1.2) and plated at the desired cell density. For routine passaging, cells 
were split at a ratio of 1:3. 
2.2.4 Freezing and thawing cells 
Correct freezing and defrosting processes are critical for cell viability. The 
freezing process has to be done slowly, while defrosting has to be done quickly. 
Once confluence was reached, cells were processed as previously described 
up to the point of centrifugation (see 2.2.2). After centrifugation, the supernatant 
was discarded and the cells were re-suspended in 1 ml of either fibroblasts 
freezing media or Cryo-SFM freezing media (see 2.2.1.3) or transfer to 
CryoPure tubes (Sarstedt) labelled with the sample tracking number, gender 
and age of the patient, passage number, date and size of flask. The CryoPure 
tubes were placed in liquid nitrogen vapour for 24 h before transferring into 
liquid nitrogen. 
When the cells were required, culture flasks were labelled and filled with 
either warmed fibroblast growth media (2.2.1.2) or keratinocyte growth media 
(2.2.1.1). Cells were taken from liquid nitrogen and immediately thawed under 
hot water. Then, the cell suspension was added to its flask and incubated at 37 
˚C and 5% CO2 for 24h to allow cells to attach before the medium was changed.   
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2.3 The expression of photoreceptors in human skin in situ by 
immunofluorescence 
 Human female skin samples from face and abdomen were obtained 
from facelift (n=1) or abdominoplasty surgeries respectively (n=5) from females 
after ethical approval was given (Table 2-2). Samples were snap frozen 
embedded in OCT medial and kept at -80 °C. 
 
 
 
 
 
 
 
Table 2-2: Human skin donor details used for immunofluorescence. 
Cryosections of 7 to 10 µm thickness were cut with a Cryostat 
(Cryotome™ FSE Cryostats, Thermo Scientific), mounted on Superfrost+ glass 
microscope slides (Thermo-scientific, Netherlands) and store at -80 °C. 
Cryosections were air-dried at room temperature for 10 minutes and then fixed 
in either 4% paraformaldehyde (PFA) (Sigma-Aldrich, Netherlands) or cold 
acetone (Sigma-Aldrich, Netherlands) for 10 minutes as indicated in table 2-3. 
Then, sections were washed 3 times with PBS and permeabilisation step was 
Body site Age 
Face (F) 63 
Abdomen (A) 
59 
Unknown (U) 
51 
44 
55 
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done for nuclear antibodies (CRY1 and CRY2) with 0.1% triton (Sigma-Aldrich, 
Netherlands) for 10 minutes. 100 µL of blocking solution (table 2-3) was added 
to the sections before incubating for 1h at room temperature. Double staining 
was done with desired antibody (table 2-3) and 1:200 KRT14 antibody (Abcam, 
ab51054 or ab7800). Sections were incubated with the primary antibody in 
blocking solution at 4 °C overnight. One section per slide was incubated with 
blocking solution only as negative control. Sections were washed with 0.05% 
tween in PBS three times for 10 minutes each before incubating with the 
secondary antibodies Alexa-488 (Abcam, ab150073) and Alexa-647 (Abcam, 
ab150115) at a 1:200 dilution for 1h at 37 °C. Sections were washed again with 
0.05% tween in PBS three times for 10 minutes each before mounting using 
VECTASHIELD® Mounting Media with 4',6-diamidino-2-phenylindole (DAPI) 
(VECTOR laboratories). The cell lines HeLa and MCF-7, kindly provided by 
Christa Dam (Philips Research) were used as positive controls.  
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 Fixation Blocking Primary antibody Primary 
antibody 
dilutions 
IHC and ICC IHC ICC IHC ICC IHC ICC 
OPN1-
SW 
Cold acetone:            
-20 °C for 10´ 
5% BSA 
+ 5% 
Donkey 
Serum 
5% BSA ab5407 (Millipore) 1:200 
 
OPN3 Cold acetone:            
-20 °C for 10´ 
5% BSA 
+ 5% 
Donkey 
Serum 
5% BSA ab66742 
(Abcam) 
ab75285 
(Abcam) 
1:100 
 
1:100 
 
OPN5 Cold acetone:            
-20°C for 10´ 
5% BSA 
+ 5% 
Donkey 
Serum 
5% BSA ab199668 (Abcam) 1:200 
 
1:500 
 
CRY1 4%PFA: RT for 
10´ 
          5% BSA ab54649 (Abcam) 1:200 1:400 
 
CRY2 4%PFA: RT for 
10´ 
5% BSA PA5-13125 (Thermo 
Fisher Scientific) 
1:100 
 
KRT 
10 
NA 4%PFA: 
RT for 10´ 
NA 3% BSA NA ab150075 
(Abcam) 
NA 1:200 
Table 2-3: Immunofluorescence protocol for immunohistochemistry (IHC) of skin 
and immunocytochemistry (ICC) of primary cell cultures.          
NA indicates not applicable. 
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2.4 Expression of photoreceptors in human primary skin cells 
in culture by RT-qPCR and immunofluoresence 
After cell expansion (section 2.2.3), primary keratinocytes and fibroblasts 
were plated in 6-well plates (Greiner bio-one, UK) at a density of 50,000 to 
100,000 cells per well for RNA extraction, or in Millicell EZ slide 8-well glass 
chamber slides (Merck, UK) at between 5,000 and 10,000 cells per well for 
immunocytochemistry (ICC) in the appropriate growth media. After reaching 80 
to 90% confluence, cells were washed with 1x PBS twice and the media was 
either changed to fibroblast media supplemented with 2% FBS or to 
keratinocyte media without EGF and fungizone. After 24h, the RNA from 6-well 
plates was harvested and pooled for qPCR of photoreceptor mRNA expression 
and cells in chamber slides were fixed in 4% PFA or in cold acetone for ICC of 
photoreceptor expression. 
2.4.1 Total RNA expression by RT-qPCR 
RNA was extracted from primary female human epidermal keratinocytes 
(n=4 donors) and primary female human dermal fibroblasts from facial skin 
(n=2), scalp (n=2), breast (n=3) and abdominal skin (n=1). A human 
immortalized keratinocyte cell line NCTC 2544 (gift from Dr. Thornton) was 
included as a control. The age of the patient, passage number and sample 
name is specified in table 2-4 and 2-5. RNA from human fetal normal eye tissue 
(Biochain, UK) was purchased to use as positive control. 
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Body site Age Passage Sample 
Cell line NCTC - NCTC 
Face (F) 61 4 EK-F61* 
53 3 EK-F53• 
53 3 EK-F53▲ 
49 5 EK-F49 
Table 2-4: Primary human epidermal keratinocyte samples used for 
photoreceptors RNA expression by qRT-PCR.  
EK denotes epidermal keratinocytes. *, • and ▲ denotes derived from the same donor in Table 
2-5. 
Body site Age Passage Sample 
Face (F) 61 4 DF-F61* 
53 3 DF-F53• 
53 3 DF-F53▲ 
57 4 DF-F57 
Scalp (S)     56 4 DF-S56 
51 4 DF-S51 
Breast (B) 
48 7 DF-B48 
44 4 DF-B44 
34 5 DF-B34 
Abdomen (A) 55 6 DF-A55 
Table 2-5: Primary human dermal fibroblast samples used for photoreceptors RNA 
expression by RT-qPCR.  
DF denotes dermal fibroblasts. * denotes derived from the same donor. *, • and ▲ denotes 
derived from the same donor in Table 2-4. 
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2.4.1.1 RNA extraction and quantification 
Primary cell total RNA extraction was performed with the RNeasy Mini Kit 
(QUIAGEN, UK) according to the RNeasy Mini Handbook protocol (QUIAGEN 
2012). All the processes were performed using TipOne filter tips (STARLAB, 
UK) which are sterile and certified RNase, DNase, DNA and pyrogen free were 
used to avoid again RNA degradation and/or DNA contamination. 10 µl/ml of β-
mercaptoethanol (Sigma-Aldrich) was added to Buffer RLT provided by the kit 
and added straight away to the cell monolayer pipetting up and down for not 
more than one minute. Then, the suspension was transferred to a 1.5 ml 
microcentrifuge tube where 350 µl of 70% ethanol was added to the lysate and 
mixed by pipetting. Up to 700 µl of the cell extract was transferred to the 
RNeasy spin column and centrifuge at 13000 rpm for 15 sec at 4 ˚C. This step 
was repeated if the total volume exceeded 700 µl. Subsequently, on-column 
DNase digestion was performed using the RNase-free DNase set (QUIAGEN 
2012) to remove possible DNA contamination of the sample. Following 
appendix D (QUIAGEN 2012), 350 µl of buffer RW1 was added to wash the 
RNeasy spin column and centrifuged at 13000 rpm for 15 s at 4 ˚C. 80 µl of 
0.34 U/µl of DNase I in buffer RDD was added to the RNeasy spin column to 
eliminate any DNA contamination. Samples were incubated for 15 min at room 
temperature. Then, the column was washed with 350 µl of buffer RW1 again 
and centrifuged at 13000 rpm for 15 s at 4 ˚C. Then, 500 µl of RPE buffer was 
added and centrifugation took place at 13,000 rpm, 15 s, 4 ˚C first. After 
discarding flow-through, this step was repeated changing the centrifugation 
conditions to 2 mins (same speed and temperature). RNeasy spin column was 
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placed in a new collection tube and it was centrifuged again for 1 min at 13,000 
rpm and 4 ˚C to eliminate any residual of buffer RPE in the column. Finally, the 
RNA was collected; the RNeasy spin column was placed in a new 1.5 ml 
collection tube (RNAse free) supplied in the kit and 25 to 30 µl of RNase-free 
water was added to the membrane of the spin column, which was centrifuged at 
13,000 rpm for 1 min at 4 ˚C. This step was repeated using the RNase-free 
water, where the RNA was eluted to increase the final RNA concentration. 
RNA quantification was analysed using a NanoPhotometer (IMPLEN). 
One microliter of nuclease-free water provided in the RNeasy Mini Kit was used 
as a blank. One microliter of RNA was added to the NanoDrop which gave the 
concentration in ng/µl and the RNA quality by the A260/280 and 260/230 ratios, 
which should be around 2 and 2.2 respectively.    
The human universal reference total RNA (Clontech) and total RNA human 
foetal normal tissue - whole eye (Biochain, UK) were used to verify quality and 
specificity of primers and they were also used as positive controls for 
photoreceptor expression. 
2.4.1.2 cDNA synthesis 
The high capacity cDNA reverse transcription kit with RNase inhibitor from 
Applied Biosystems (UK) was used for cDNA synthesis by reverse transcription 
following the manufacturer’s instructions. The amount of total RNA used was 
500 ng per 20 µl reaction. To perform the reverse transcription, the reactions 
were put in a thermal cycler where the conditions where set up as follows: pre-
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heating at 25 ˚C for 10 min, anneling at 37 ˚C for 120 min and strand synthesis 
at 85 ˚C for 5min and holding at 4 ˚C.  
2.4.1.3 qPCR 
SYBR Green (Applied Biosystems) was used for RT-qPCR experiments, 
with 10µl final volume reactions. The samples were kept on ice and TipOne filter 
tips were used throughout. Two master mixes were prepared; one for cDNA 
dilution into nuclease-free water (0.03 µl/µl final concentration) and the second 
one for SYBR Green reagent (1:2) and primer mix (1µM final concentration) 
(Sigma-Aldrich) (Table 2-7). Primers were either chosen from publication or 
self-designed using an on-line tool called GenScript real-time PCR (TaqMan) 
primer design (GenScript 2002). Self-complementarity of the primers was 
checked using another on-line tool, oligonucleotide properties calculator (Kibbe 
2007) and Primer-BLAST (Ye et al. 2012) to ensure primer specificity to the 
target RNA. Primers for amplification of photoreceptors are specified in Table 2-
7. While working with SYBR Green, lights were switched off to avoid light 
interaction with this reagent. Reactions were loaded in PCR plates (STARLAB) 
which were spun down for 20 sec at 4 ºC before they were introduced into the 
qPCR machine (Applied Biosystems).  
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Gene Primer sequence 
Ampli
con 
(bp) 
Design  T (⁰C) 
OPN1-
SW 
Forward: 
5’CGCCAGCTGTAACGGATACT3’ 
144 GeneScript (NM_001708.2) 63.1 Reverse: 
5’CCGAAGGGCTTACAGATGAC3’ 
OPN2 
Forward: 
5'AGGAACACGAGGATTCTTGC3’ 
166 GeneScript (NM_000539.3) 62.2  Reverse: 
5'GCGAGGGTCTGAGAGGATAG3’ 
OPN3 
Forward: 
5’CAATCCAGTGATTTATGTCTTCA
TGATCAGAAAG3’ 125 Haltaufderhyde et al., (2015) 63.1  Reverse: 
5’GCATTTCACTTCCAGCTGCTGGT
AGGT3’ 
OPN5 
Forward: 
5’CTAGACGAAAGAAGAAGAAGCT
GAGACC3’ 119 GeneScript (NM_181744.3) 63.1 Reverse: 
5’GCGGTGACAAAAGCAAGAGA3’ 
CRY1 
 
Forward: 
5'TAAGAGGCTTCCCTGCAAAA3’ 
230 Lin et al., (2014) 63.1 
Reverse: 
5'GCCTCCATTCCCATTAGGAT3’ 
CRY2 
Forward: 
5’AGGAGAACCACGACGAGA3’ 
288 Lin et al., (2014) 61.2 
Reverse: 
5'TCCGCTTCACCTTTTTATAC3’ 
GAPDH 
Forward: 
5’TATAAATTGAGCCCGCAGCC3’ 
143 GeneScript (NM_002046.5) 
61.2, 
62.2 
and 
63.1 
 
Reverse: 
5’CGACCAAATCCGTTGACTCC3’ 
Table 2-6: qPCR primers for photoreceptor amplification.  
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The Genex software (Biorad) was used for quantification, which was done 
using the Ct (CtΔΔ) equation method and normalised to the housekeeping gene 
GAPDH. The final relative expression results were plotted and analysed with 
Prism (GraphPad, San Diego, CA, USA).  
2.4.2 Protein expression by immunocytochemistry 
Primary keratinocytes and dermal fibroblasts used for 
immunocytochemistry of photoreceptors are listed in table 2-8. All samples 
come from female donors. Age of donor, passage number and sample name 
are specified in table 2-8.  
Cell type Body site Age Passage Sample 
Primary 
keratinocytes 
Face (F) 64 3 EK-F64 
61 4 EK-F61 
53 4 EK-F53 
Primary 
fibroblasts 
Face (F)     57 4 DF-F57 
Scalp (S) 53 4 DF-S53 
51 4 DF-S51 
Breast (B) 48 7 DF-B48 
Table 2-7: Primary human epidermal keratinocytes and dermal fibroblasts used for 
photoreception protein expression analysis by ICC.  
EK denotes epidermal keratinocytes. DF denotes dermal fibroblasts. 
Cells were grown as indicated in section 2.2.3. Once the desired 
confluence was reached, the media was changed to EGF and fungizone free for 
keratinocytes or 2% FBS for fibroblasts and the cells were fixed after 24 h. For 
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fixation, cells were washed with PBS twice and 4% PFA for 10 min at room 
temperature or acetone for 10 min at -20 ˚C was added to the Millicell EZ slide 
where cells were growing. Single staining only was done as described for 
immunohistochemistry (section 2.2.5). Little differences in the protocol were 
detailed in table 2-3. 
2.5 Ex vivo wound healing model 
An ex vivo wound healing assay was adapted from (Stojadinovic and 
Tomic-Canic 2013) but the round wounds described were substituted to straight 
wounds as described by (Rizzo et al. 2012). Skin samples from healthy patients 
undergoing abdominoplasty surgery were obtained with informed consent. 
Tissue was processed within the first 8h after surgery. Tissue was washed in 1x 
PBS twice, and the fat was removed using scissors. The tissue was again 
washed twice in 1x PBS and placed in the lid of a 60 mm tissue culture dish 
(Sarstedt). Using the dissecting microscope (Leica), a double blade scalpel (1 
mm gap) made in house (Philips Research) was used to make two incisions in 
the epidermis and the upper part of the papillary dermis (Figure 2-2, 2). Using 
forceps and scissor, the epidermis was cut so that a wound was created (Figure 
2-2, 3). With a scalpel, small rectangles were cut around the wound; a metal 
plate with marked lines was used to help make reproducible cuts. The final 
result was a 60 to 80 mm2 rectangular wound surrounded by epidermis at both 
sides (Figure 2-2, 4). Total area of the wounded skin samples were 
approximately 65 cm2 and they were placed on a Netwell insert (6 well Netwell 
mesh inserts, CORNING) in a 6-well plate with 2 ml of phenol red free complete 
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DMEM. Wounds were cultured at the air-liquid interface to recreate in vivo 
conditions for up to 124 hours (around 5 days).  
 
Figure 2-2: Ex vivo wound healing model using abdominal skin.  
1. Reception of post-surgery abdominal skin. Skin was cleaned and fat was removed. 2. Two 
incision were made with a scalpel of ≈1cm width. 3. The epidermis between the two incisions 
made was removed using forceps and scissors. 4. Wounds were cultured in the air-liquid 
interface and pictures were taken twice a day for 6 days. 5. The wound area of each picture was 
analysed using Image J.  
2.6 Light treatment of cells and wounds 
Two different light devices were used to irradiate cells and ex vivo wound 
cultures depending on the requirements of the experiment.  
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2.6.1 Sirius-24  
A custom light-based device was designed and developed in Philips 
Research (High Tech Campus, Eindhoven, The Netherlands) to study the effect 
of different wavelengths of light in cells in vitro; Sirius -24. It was designed as a 
two-box device where different LEDs were grouped in 6 different wavelengths, 
the first box was called blue box (Figure 2-3, A) and the second box was the red 
box (Figure 2-3, B). It was developed in house by Charles Mignon to work with 
24 well plates (Mignon et al. 2017). One LED is designed to be in place to 
homogenously irradiate each well of the plate (Figure 2-3).  
 
Figure 2-3: Light device Sirius-24 used for screening of parameters in epidermal 
keratinocytes.  
Adapted from Mignon et al.,(2017). 
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The blue box (Figure 2-2, A) holds three wavelengths; two rows are 
illuminated by blue light (447 nm) and the other two by cyan light (505 nm) and 
green light (530 nm) respectively. The red box (Figure 2-2, B) holds longer 
wavelengths; one row is illuminated by yellow light (591 nm), another two with 
red light (655 nm) and the last row is illuminated with near infrared (NIR) light 
(850 nm). Each row can be controlled separately with a software program so 
that one row can always be the non-irradiated control.  
2.6.2 Blue and red light panels  
Two other devices were used once a certain light parameter was selected 
for further experiment after the screening of wavelength and irradiance effects. 
Identical LEDs were in place to deliver a flat and homogenous illumination over 
the area of a multiple well plate for cell culture (104 cm2). This device was 
designed to illuminate the cell culture from the top, therefore, to avoid reflection 
plates were placed on a transparent stage which was on top of a black surface 
(Figure 2-4). One device emitted blue light (453 nm ± 16 nm). This device has 
previously been used for in vivo and in vitro and experiments (Velnar et al. 
2009; Kleinpenning et al. 2010; Liebmann et al. 2010; Mignon et al. 2017). A 
very similar light-based device was used to study the effect of red light. This 
time the wavelength peak was 656 nm. Both wavelengths were almost the 
same as the ones used by Sirius-24.  
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Figure 2-4: Light panel device to homogenously irradiate a multiple well plate. 
2.7 Metabolic activity of epidermal keratinocytes assessed by 
Alamar Blue® assay. Screening of light parameters.  
Metabolic activity of epidermal keratinocytes was assessed to screen a 
wide range of visible to infrared light parameters (Table 2.9). Black frame 24 
well-plates (Porvair, Netherlands) were used to avoid light propagation between 
different light treated groups.  Epidermal keratinocytes at 80% confluence were 
treated in EGF free, fungizone-free keratinocyte media to prevent an excessive 
proliferation which is triggered by EGF and avoid any interferences of fungizone 
in the behaviour of the keratinocytes. Media was refreshed after irradiation. 
Irradiation was used using Sirius-24 (Section 2.2.8.1). Details of light 
parameters used are shown in Table 2-9.  Alamar Blue® assay (Thermo Fisher 
Scientific) was used to assess metabolic activity of keratinocytes. It is based on 
the redox state of its active ingredient, resazurin which is a blue non-fluorescent 
dye. After reduction of resazurin by the living cell, it becomes resorufin, a highly 
fluorescent pink-colored molecule (Rampersad 2012). Alamar Blue® was added 
to the cell culture 22 h after irradiation and fluorescence intensity was measured 
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after 2 h in a plate reader at 37 ⁰C (FLUOstar Omega II, BMG Labtech) 
(excitation: 544 nm, emission: 590 nm).  
Group 
Wavelength 
(nm) 
Irradiance 
(mW/cm2) 
Radiant 
exposure 
(J/cm2) 
Time (sec) 
Control None None None 
Same as 
treated 
Blue light 447 50 
2 40 
30 600 
Cyan light 505 
30 2 67 
30 30 1000 
Green light 530 
30 2 67 
30 30 1000 
Red light 655 
16 3.2 200 
40 30 750 
65 200 3077 
Infrared light 850 
40 60 1500 
80 250 3125 
Table 2-8: Light parameters used to investigate an effect on the metabolic activity 
of epidermal keratinocytes.  
Absorbance values were exported into Microsoft Excel (2010) and relative 
metabolic activity of light treated epidermal keratinocytes to non-irradiated 
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keratinocytes from each respective plate was calculated. Mean values from four 
different patients were used for two-way ANOVA statistical analysis (Section 
2.2.12). 
2.8 Scratch-wound assay to analyse migration of human 
primary epidermal keratinocytes after blue and red light 
irradiation 
After cell expansion (section 2.2.3) (Figure 2.5 – 1), epidermal 
keratinocytes were plated in 12-well plates at 100,000 cells per well (Figure 2.5 
– 2). After two days cells had reached 80% confluence and the media was 
changed to EGF free, funguizone free media (Figure 2.5 – 3). After 24 h, a 
scratch assay was performed (Figure 2.5 – 4). Four 10 µL tips were inserted 
into a scratch device built in house (Philips research) to scratch cell monolayers 
in 12-well plates. Two parallel scratches were also done to increase the area of 
cells affected by this perturbation. Afterwards, cells were washed twice with 
PBS and 1 ml of fresh media was added to each well. Four to eight replicates 
were carried out in for each of the conditions studied (non-irradiated, 2 J/cm2 of 
blue light, 30 J/cm2 of blue light and 30 J/cm2 of red light). Only selected light 
parameters were studied, therefore, the panel light-based devices (section 
2.2.7.2) were used for this experiment.   
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Figure 2-5: Scratch-wound assay. 
1. Primary cell culture for cell expansion. 2. Cells were seeded into 6 or 12-well plates. 3. Cells 
were grown to confluence and pretreated for 24h. 4. Scratch was made with a 2-10 µl pipette tip 
using scratch device (Philips Research) in 12-well plates 5. Pictures of the scratch were taken at 
specific time points after cells were scratched.  
After the scratch-wound was made and before the light treatment was 
applied four pictures per scratch were taken at the center of the well. A 
stereoscopic microscope at 10x magnification with a Nikon Coolpix digital 
camera was used to take the images. This was repeated at 12h and 21h after 
the initial scratch-wound/light treatment.  
The scratch-wound area was analysed using Image J software. The speed 
of closure in the scratch-wound was analysed in Microsoft Excel; i.e. area at 
12h (A12h) or 21h (A21h) minus the starting area (A0h) was divided by the number 
of hours after scratching (12 or 21 respectively). The relative speed of closure 
was calculated by dividing the light-treated groups by the mean of the control 
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non-treated groups.  Results from three donors (three independent 
experiments) were plotted in GraphPad (GraphPad, San Diego, CA, USA) and 
two-way ANOVA statistical analysis was performed (Section 2.2.12).   
2.9 Physiological significance of OPN3 and CRY1 in primary 
epidermal keratinocytes and dermal fibroblasts 
2.9.1 Synchronisation of dermal fibroblasts 
Primary fibroblasts were cultured in 6-well plates (Greiner bio-one) until 
they reached 80% confluence and then washed twice with 1x PBS before the 
media was changed to either primary fibroblast media supplemented with 10% 
FBS, serum free medium or serum free medium supplemented with 250 nM of 
dexamethasone in 0.0025% ethanol (vehicle control) for 24h. The RNA was 
extracted at 4 and 24 h after synchronisation, converted into cDNA and clock 
gene expression was analysed by qPCR as described in section 2.2.6.1. 
Primers used are listed in table 2-10. 
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Gene Primer sequence 
Amplicon 
size (bp) 
Design/ref. 
Annealing T 
(⁰C) 
CRY1 
(NM_00
4075.4) 
 
Forward: 
5'TAAGAGGCTTCC
CTGCAAAA3’ 
230 
Lin et al., 
(2014) 
58.6 
Reverse: 
5'GCCTCCATTCCC
ATTAGGAT3’ 
CRY2 
(NM_02
1117.3) 
Forward: 
5’AGGAGAACCAC
GACGAGA3’ 
288 
Lin et al., 
(2014) 
58.6 
Reverse: 
5'TCCGCTTCACCT
TTTTATAC3’ 
PER1 
(NM_00
2616.2) 
Forward: 
5’TGGCTATCCACA
AGAAGATTC3’ 
48 
James et 
al., (2007) 
58.6 
Reverse: 
5’GGTCAAAGGGC
TGGCCCG3’ 
PER2 
(NM_02
2817.2) 
Forward: 
5’TCCAGATACCTT
TAGCCTGATGA3’ 
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Shih et al., 
(2005) 
62.2 
Reverse: 
5’TTTGTGTGTGTC
CACTTTCGA3’ 
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PER3 
(NM_00
128986
2.1) 
Forward: 
5’CCCCTCTCTGTC
CTCTGTTG3’ 
326 GeneScript  62.2 
Reverse: 
5’ACTGCCATTGTT
GCCTGTAA3’ 
BMAL1 
(NM_00
1178.5) 
Forward: 
AAACCAACTTTTC
TATCAGACGATGA
A 87 
Archer et 
al., (2008) 
58.6 
Reverse: 
5’TCGGTCACATCC
TACGACAAAC3’ 
CLOCK 
(NM_00
126784
3.1) 
Forward: 
5’TTGTAAGCTGCC
TGGGTTTC3’ 
109 GeneScript  58.6 
Reverse: 
5’CTCAGTGTTTGC
TGGTGGTG3’ 
GAPDH 
(NM_00
2046.5) 
Forward: 
5’TATAAATTGAGC
CCGCAGCC3’ 
143 GeneScript  
58.6, 61 and 
62.2 
 
Reverse: 
5’CGACCAAATCC
GTTGACTCC3’ 
80 
U6 
(NR_00
4394.1) 
Forward: 
5’CTCGCTTCGGC
AGCACA3’ 
94 GeneScript  
58.6, 61 and 
62.2 Reverse: 
5’AACGCTTCACGA
ATTTGC3’ 
Table 2-9: RT-qPCR primers and conditions for clock genes. 
2.9.2 Effect of modulating the circadian clock with KL001 and 
longdaysin in scratched dermal fibroblasts: changes in 
expression of circadian clock genes  
Primary fibroblasts were cultured in 6-well plates (Greiner bio-one) until 
they reached 85-90% confluence before washing twice with 1x PBS and 
synchronising by incubating in serum-free fibroblasts media for 24h. Then, cells 
were washed twice with 1x PBS and monolayers of cells were scratched as 
described in section 2.2.9. Cells were either incubated with 0.016 % DMSO 
(vehicle control), 8 µM of KL001 or 8 µM of longdaysin (LD) in triplicate wells for 
24h before RNA was extracted, converted into cDNA and analysed by qPCR as 
described in section 2.2.6.1. Primers used for different circadian clock genes 
are listed in Table 2-9. 
2.9.3 Scratch assay of synchronised and transfected primary 
keratinocytes 
Primary epidermal keratinocytes at 80% confluency were synchronised 
with 12% FBS in EGF-free funguizone-free keratinocyte growth media (2.2.1.1) 
for 2h (Janich et al. 2013) and then washed twice with PBS. 50 nM of smartpool 
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siRNAs directed against OPN3 or CRY1 (ON-Targetplus, Dharmacon) using 
Lipofectamine RNAiMax (Invitrogen) according to the manufacturer’s 
specifications were used to transfect epidermal keratinocytes. Eight µM of 
KL001 in EGF-free funguizone-free keratinocyte growth media (2.2.1.1) was 
used to treat epidermal keratinocytes. Non-targeting siRNA control 
(Dharmacon) and 0.016% of dimethyl sulfoxide (DMSO) was used as control. 
After a 24h incubation, a scratch-wound assay was performed as described 
previously (section 2.2.10) and the media was replaced with, or without, 8µM of 
KL001. The RNA was collected 24h after the initial scratch using 350 µl of RLT 
buffer (Qiagen) with β-mercaptoethanol (Sigma-Aldrich). RNA extraction, cDNA 
synthesis and qPCR to amplified OPN3, CRY1 and CRY2 were carried out as 
described in section 2.2.6.1. Keratins (KRTs) primers were also used for qPCR 
(Table 2-11).  
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Gene Primer sequence 
Amplic
on size 
(bp) 
Design/ref. 
Annealing 
temperatu
re (˚C) 
KRT17 
(NM_00
0422.2) 
Forward: 
5’AGGGAGAGGATGCCCACCTG3’ 
107 GeneScript  
61.2 or 
62.4 Reverse: 
5’GCGGGAGGAGATGACCTTGC3’ 
KRT14 
(NM_00
0526.4) 
Forward: 
5’GCCTGTCTGTCTCATCCTC3’ 
76 GeneScript  62.4 
Reverse: 
5’CTGAAGCCACCGCCATAG3’ 
KRT1 
(NM_00
6121.3) 
Forward: 
5’ACTTGACAACTTGCAGCAGG3’ 
143 GeneScript  61.2 
Reverse: 
5’CAATGATGCTGTCCAGGTCG3’ 
KRT10 
(NM_00
0421.3) 
Forward: 
5’AGCATGGCAACTCACATCAG3’ 
126 GeneScript  62.4 
Reverse: 
5’TGTCGATCTGAAGCAGGATG3’ 
GAPDH 
(NM_00
2046.5) 
Forward: 
5’TATAAATTGAGCCCGCAGCC3’ 
143 GeneScript  
61.2 or 
62.4 Reverse: 
5’CGACCAAATCCGTTGACTCC3’ 
Table 2-10: KRTs and GAPDH primers for RT-qPCR and amplification conditions.  
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2.9.4 Analysis of proliferation and differentiation of epidermal 
keraitnocytes by the EdU assay and KRT10 staining 
Round glass coverslips of 20 mm2 area (Fisherbrand, The Netherlands) 
were cleaned in 100% isopropanol and added to 12-well plates. They were 
washed three times with PBS and coated with 0.5% gelatin (Sigma-Aldrich) in 
distilled water at 37 ºC for 2h. Coverslips were washed a further 3 times with 
PBS and sterilised under UV light for 20 minutes before seeding epidermal 
keratinocytes. Cells were seeded at 200,000 cells per well, so they would be at 
approximately 80% confluence after 24h.  Cells were synchronised with 12% 
FBS in as described previously and washed twice with PBS. 50 nM of smartpool 
siRNAs directed against OPN3 or CRY1 (ON-Targetplus, Dharmacon) using 
lipofectamine RNAiMax (Invitrogen, Netherlands) according to the 
manufacturer’s specifications were used to transfect primary epidermal 
keratinocytes. 8 µM of KL001 was used to treat parallel cultures of 
keratinocytes. Non-targeting siRNA control (Dharmacon) and 0.016% of DMSO 
was used as control and added where necessary. After a 24h incubation, light 
treatment was performed in two out of four plates using the blue light panel 
(section 2.6.2). Light parameters were 50 mW/cm2 for 40 seconds (2 J/cm2) and 
the media was replaced with, or without, 8 µM of KL001. The 5-ethynyl-2’-
deoxyuridine (EdU) reagent in the Click-iT EdU Alexa Fluor 488 imaging kit 
(Thermo Fisher Scientific) was also added to the culture media. EdU is a 
nucleoside analog of thymidine, therefore it is easily incorporated into the DNA 
of cells in culture during DNA synthesis, showing a very specific staining of the 
S phase of the cell cycle. Cells were incubated for 10h before fixing with 4% 
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PFA. EdU staining was done following manufacturer instructions after which 
ICC of KRT10 was performed. Blocking was done with 3% BSA for 1h at room 
temperatura. Fixed cells on coverslips were washed three times with PBS and 
rabbit anti-cytokeratin 10 antibody (ab76318, Abcam) was added at 1:200 
dilution overnight. Coverslips were washes three times with PBS and 0.05% 
tween 20 (Sigma-Aldrich) and Alexa-647 (ab150075) secondary antibody was 
used at 1:200 dilution for 1h at 37 ºC. After washing three times with 0.05% 
tween 20 – PBS, two coverslips were mounted (no light vs blue light treated) in 
one glass slide using VECTASHIELD® Mounting Media with 4',6-diamidino-2-
phenylindole (DAPI) (VECTOR laboratories).   
Fluorescence imaging was done using a fluorescent microscope/scanner, 
the 3D HISTECH Panoramic MIDI (3D HISTECH) with a Nikon Eclipse 501 
camera. Same acquisition settings were used throughout the imaging process. 
The software Panoramic viewer was used to take 16 pictures per well. Analysis 
of positive green (EdU) and red (KRT10) cells related to total (blue) number of 
cells (DAPI) was done using Image J. This was done by applying the same 
threshold to different pictures, converting the picture to binary and using the 
watershed option to differentiate between closed cells. Finally, the option 
analyse particles was chosen, and analysis was done excluding cells on the 
edges of the picture. A minimum size of 100 was used to avoid measuring 
unspecific staining as positive. This was repeated for every channel (blue, red 
and green). Summation of cells from the 16 pictures was done for each well in 
Microsoft Excel. % of EdU positive cells and KRT10 positive cells was divided 
by non-targeting non irradiated control to get relative % numbers. Two way 
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ANOVA analysis was performed in each cell donor with replicates value of n=4. 
EdU staining was done in two different donors and KRT10 staining in three 
donors.  
2.10 Effect of blue and red light in an ex vivo wound healing 
model 
2.10.1 Ex vivo culture, wound size analysis and KRT17 
expression 
Ex vivo wounds cultured at the air liquid interphase (section 2.2.7) were 
treated with either blue (2 and 30 J/cm2 at 50 mW/cm2), or red (30 J/cm2 at 40 
mW/cm2) light immediately after wounds were created and every 24h after that. 
Phenol red-free complete DMEM was used for the ex vivo culture to avoid 
interaction of light with phenol red. The blue and red light panels were used for 
irradiation (Section 2.2.8.2). Images were taken at 0h, 48h and 120h just before 
light treatment using the microdissecting microscope (Leica), and the media 
was changed immediately after every light treatment. This is to be sure that the 
effect induced by light is a direct effect of this light on tissue and not an indirect 
effect mediated by the chemicals in the culture media. Wound area was 
measured using Image J from pictures taken by the microdissection microscope 
at 0.68 magnification.   
Samples were harvested immediately after the wounds were made, and 
then 4 h after the third (day 2) light treatment. They were snap frozen and 
embedded in OCT media, and stored at -80⁰C. An anti cytokeratin 17 (made in 
rabbit) primary antibody (ab109725, Abcam, The Netherlands) and an anti 
86 
cytokeratin 14 primary (made in mouse) antibody (ab7800, Abcam) were used 
at a 1:200 dilution. Double immunofluorescence protocol was done as 
previously described (section 2.2.5). 
2.10.2 Laser microdissection, RNA extraction and qPCR of 
photoreceptors 
A cryostat, Microm HM550 (ThermoFisher Scientific), was cleaned with 
RNase away spray (ThermoFisher Scientific). Cryosections of 7µm thickness 
were collected at -28⁰C and placed onto mmi MembraneSlides, RNAse free 
(Molecular Machines and Industries, USA). Sections were kept in the original 
container where membrane slides were before use at -80⁰C to ensure an 
RNase free environment. Sections were stained with haematoxylin using the 
mmi H&E staining kit (Molecular Machines and Industries) which is also RNase 
free, prior to microdissection. The epithelial tongue from ex vivo wounds was 
collected into mmi isolation caps, 0.5 ml diffuser caps (Molecular Machines and 
Industries). This is a collection tube whose cap contains a membrane. This was 
done by using a Nikon T2000 laser capture microscope. Images were taken 
before and after microdissection was performed (Figure 3-17). Laser capture for 
each sample (up to 10 sections) was performed for a maximum time of one 
hour to minimise RNA degradation. 350µL of RLT buffer from RNeasy Micro Kit 
(QIAGEN) was added to the samples, which were kept at -80⁰C. RNA isolation 
was performed following the manufacturer’s instructions. RNA was finally eluted 
in 12µL of RNase free water. ArcturusTM RiboAmp® PLUS Kit (ThermoFisher 
Scientific) was used to amplify RNA. Final RNA concentration was assessed 
using a NanoPhotometer (IMPLEN).and quality was assessed with Agilent 2100 
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bioanalyzer (Agilent). The cDNA synthesis was performed as detailed 
previously (section 2.2.6.1.2). Quantitative PCR was carried out using 0.5 µL of 
cDNA. OPN1-SW, OPN3, OPN5, CRY1, CRY2 and KRT17 mRNA was 
amplified with previously described primers using the same conditions (Table 2-
6 and 2-8). The relative gene expression was calculated as previously 
described with n=3 wounds from the same donor.  
2.11 Statistical analysis 
Statistical analysis of the results obtained experimentally is needed to 
establish differences in the observed data and therefore, reach conclusions. 
Statistical analysis was done using Prism (GraphPad, San Diego, CA, USA), 
which allows the performance of different tests based on the data provided. 
 When comparison is made between two groups, there are two main tests 
which could be performed; t-test (parametric) is able to compare means while 
the Mann-Whitney U-test (non-parametric) compares medians (Fowler et al. 
1998). Both tests results in a level of significance which is known as p-value. 
Significant results are those p-values equal of bellow 0.05; * represents p-value 
≤ 0.05, ** represents p-value ≤ 0.01 and *** represents p-value ≤ 0.001  
In this work, statistical analysis of the means for more than two groups 
was often needed. The analysis of variance (ANOVA) allows comparison of any 
number of sample means in one single test so that it is a highly advantageous 
statistical test to use in biology. One-way ANOVA was used to analyse the 
effect of one variable over the sample mean of different treatment groups while 
two-way ANOVA was used to analyse the effects of two independent variables 
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on a dependent variable (Fowler et al. 1998). Similarly to t-test and Mann-
Whitney U-test, p-values indicate level of significance of ANOVA. * represents 
p-value ≤ 0.05, ** represents p-value ≤ 0.01 and *** represents p-value ≤ 0.001.  
The type of statistical test selected for each analysis is clearly specified in 
each one of the figure’s legend within the results section.   
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3 RESULTS 
3.1 Photoreceptors are expressed in human skin  
The expression and localisation of different classes of photoreceptors 
OPNs and CRYs was compared using immunohistochemistry in cryosections of 
female facial and abdominal skin and in primary cell cultures of epidermal 
keratinocytes and dermal fibroblasts by quantitative RT-PCR and 
immunocytochemistry (ICC).  
3.1.1 Expression of OPN1-sw, OPN3 and OPN5 in facial and 
abdominal skin in situ 
Localisation of OPNs in human skin was both specific and consistent 
when female skin from facial (n=1) and abdominal (n=3) regions were 
compared. Double staining was performed with keratin 14 (KRT14) in order to 
identify the basal layer of the epidermis. KRT14 was visualised with red staining 
(Figure 3.1).  
OPN1SW was expressed throughout the epidermis and dermis of human 
skin. While expression was more prominent in the suprabasal layer of the 
epidermis, the epidermal basal layer and the dermal fibroblasts in the dermis 
also expressed OPN1SW as indicated by the white arrows in figure 3.1, (A and 
B). In contrast, OPN3 was mainly expressed in the basal layer of the epidermis, 
although a very low expression could be seen also in the suprabasal layer 
(Figure 3.1, C and D). In contrast, OPN5 was exclusively localised to the basal 
layer of the epidermis and was not detected in the dermis (Figure 3.1, E and F).   
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Figure 3-1: Localisation of OPN1-SW, OPN3 and OPN5 in human skin. 
Representative images of the localisation of OPN1-SW, OPN3 and OPN5 in facial and 
abdominal female skin by immunohistochemistry. (A) Localisation of OPN1-SW (green) and 
KRT14 (red) in facial skin (FS). (B) Localisation of OPN1-SW (green) and KRT14 (red) in 
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abdominal skin (AS). (C) Localisation of OPN3 (green) and KRT14 (red) in FS. (D) Localisation 
of OPN3 (green) and KRT14 (red) in AS. (E) Localisation of OPN5 (green) and KRT14 (red) in 
FS. (F) Localisation of OPN3 (green) and KRT14 (red) in AS. (G-H) Negative control (no 
primary antibody). Nuclei are counterstained with DAPI (blue). Magnification = 40x. Scale bar = 
75 µm. 
3.1.2 Expression of CRY1 and CRY2 in facial and abdominal skin in 
situ 
Both CRYs were expressed in human female facial and abdominal skin 
(Figure 3.2). Double staining was performed with KRT14 in order to identify the 
basal layer of the epidermis. KRT14 was identified by either green staining (A 
and B) or by red staining (C and D). 
Localisation of CRY1 was confined to the nuclei of epidermal 
keratinocytes in facial skin (Figure 3.2, A); however, expression of CRY1 in 
abdominal skin did not follow the same pattern. Expression of CRY1 was more 
prominent in the cytoplasm of epidermal keratinocytes (Figure 3.2, B), and was 
only seen in two of the three donors. In contrast, CRY2 was localised to the 
nucleus and cytoplasm of epidermal keratinocytes in both facial and abdominal 
skin (Figure 3.2, C and D respectively). The dermal compartment of abdominal 
skin also showed CRY1 and CRY2 expression, but results were inconclusive in 
facial skin. In addition, the staining did not appear to be very specific in this 
compartment, due to auto fluorescence of the extracellular matrix of the dermal 
compartment.  
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Figure 3-2: Localisation of CRY1 and CRY2 in human skin.  
Representative images of the localisation of CRY1 and CRY2 in human female facial skin (FS) 
and abdominal skin (AS) by immunohistochemistry. (A) Localisation of CRY1 (red) and KRT14 
(green) in FS. (B) Localisation of CRY2 (green) and KRT14 (red) in AS. (C) Localisation of 
CRY1 (red) and KRT14 (green) in FS. (D) Localisation of CRY2 (green) and KRT14 (red) in AS. 
(E-F) Negative control (no primary antibody). Nuclei are counterstained with DAPI (blue). Scale 
bar = 75 µM. 
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3.1.3 Expression of photoreceptors in human primary skin cells in 
culture 
3.1.3.1 OPN1-SW, OPN3, CRY1 and CRY2 were expressed in 
cultured primary human epidermal keratinocytes and 
dermal fibroblasts; while OPN2 was only found in dermal 
fibroblasts and OPN5 in epidermal keratinocytes. 
The expression of OPN1-SW was verified in primary cultures of human 
epidermal keratinocytes, and detected for the first time in primary cultures of 
human dermal fibroblasts. Analysis by RT-qPCR confirmed the expression of 
OPN1-SW mRNA in all the cells analysed; the human keratinocyte cell line 
NCTC, primary cultures of epidermal keratinocytes derived from facial skin 
(n=4) and primary cultures of dermal fibroblasts derived from female facial skin 
(n=3) scalp (n=2), breast skin (n=3) and abdominal skin (n=1) (Figure 3-3, A 
and B respectively). Human eye RNA was included as a positive control.  
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Figure 3-3: The expression of OPNs mRNA in primary cultures of human 
epidermal keratinocytes (EKs) and dermal fibroblasts (DFs).  
Relative expression of mRNA in the NCTC cell line (indicated by a triangle) and EKs (indicated 
by a circle); for OPN1-SW (n=4) (A), OPN3  (n=4) (C), OPN5  (n=4) (E) ±SEM quantitated by 
RT-qPCR; Relative expression of mRNA in DFs (indicated by a diamond) for OPN1-SW (n=9) 
(B), OPN2  (n=8) (D), OPN3  (n=9) (F), ±SEM quantitated by RT-qPCR; human eye RNA 
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(indicated by a square) and human reference (ref.) RNA (indicated by an inverted triangle) were 
the positive controls.  
The protein expression of OPN1-SW was confirmed by 
immunocytochemistry in primary cultures of both keratinocytes (n=3) and 
fibroblasts (n=3) (Figure 3-4). A negative control where the primary antibody 
was omitted verified the specificity of the staining (Figure 3-4, G). The 
localisation of this protein was cytoplasmic in both cell types; in dermal 
fibroblasts OPN1-SW was polarised in a specific region close to the nucleus 
(Figure 3-4, B).  
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Figure 3-4: The localisation of OPNs in primary cultures of human epidermal 
keratinocytes (EKs) and dermal fibroblasts (DFs).  
Representative images of OPN1-SW (green) (A), OPN3 (green) (C), OPN5 (green) (E), 
localisation in EKs (n=3) by immunofluorescence. Representative images of OPN1-SW (green) 
(B), OPN2 (red) (D), OPN3 (green) (F), localisation in DFs (n=3) by immunofluorescence; nuclei 
are counterstained with DAPO (blue). Scale bar = 75 µm. 
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The expression of mRNA for OPN2 in primary keratinocytes (n=2) and 
fibroblasts (n=8) was analysed by RT-qPCR. Human eye RNA was used as a 
positive control. OPN2 was not detected in the primary keratinocytes analysed, 
but it was present in 6/8 cultures of primary human dermal fibroblasts (n=6/8) 
(Figure 3-3, D). The exceptions included fibroblasts derived from facial skin 
(DF-F61) which were derived from the same donor as one of the epidermal 
keratinocyte cultures (EK-F61) and a second one derived from scalp skin (DF-
S56). Immunocytochemistry confirmed that OPN2 was specifically localised in 
the cytoplasm and in the plasma membrane of dermal fibroblasts (n=3) (Figure 
3-4, D).   
The expression of mRNA for the non-visual opsin, OPN3 in primary 
keratinocytes (n=4) and fibroblasts (n=9) was analysed by RT-qPCR. OPN3 
was expressed in all cell cultures analysed, including the NCTC human 
keratinocyte cell line NCTC (Figure 3-3, C and F). Human reference RNA was 
included as a positive control. Immunocytochemistry confirmed that OPN3 was 
specifically localised in the cytoplasm and plasma membrane of keratinocytes 
(n=3) and fibroblasts (n=3). (Figure 3-4, C and F respectively).  
The expression of mRNA for the non-visual opsin, OPN5 in primary 
keratinocytes (n=4) and fibroblasts (n=9) was analysed by RT-qPCR. OPN5 
was expressed in the NCTC cell line and all the primary keratinocytes analysed 
(n=4) (Figure 3-3, E), however it was not expressed in any of the cultures of 
dermal fibroblasts n=9 (Table 3-1). Human reference RNA was used as a 
positive control. Immunocytochemistry confirmed that localisation of OPN5 was 
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similar to OPN3 in keratinocytes (n=3), and was predominately expressed in the 
cytoplasm and plasma membrane (Figure 3-4, E). 
Talking about the expression of both CRY1 and CRY2, their mRNA 
expression was confirmed by qPCR in non-synchronised cell cultures of primary 
epidermal keratinocytes and dermal fibroblasts. All cells analysed i.e. the NCTC 
cell line, primary keratinocytes (n=6) and primary dermal fibroblasts (n=8) 
expressed CRY1 and CRY2 (Figures 3-5). Positive controls included human 
reference mRNA and human eye mRNA. The protein expression of both CRYs 
in cultured cells was confirmed by immunocytochemistry. CRY1 was mainly 
localised to the nucleus of keratinocytes (n=3) and fibroblasts (n=3) (Figure 3-5, 
B and D), although one of the keratinocyte cultures (61-year-old female donor) 
only expressed CRY1 in the cytoplasm. In contrast, CRY2 was mainly localised 
to the cytoplasm of both cell types (Figure 3-5, F and H respectively). 
99 
 
Figure 3-5: The expression of CRYs in primary cultures of human epidermal keratinocytes (EKs) and dermal fibroblasts (DFs).   
Relative expression of mRNA in the NCTC cell line (indicated by a triangle) and EKs (indicated by a circle); for CRY1 (n=6) (A) and CRY2 (n=6) (C)  and in 
DFs (indicated by a diamond) for CRY1 (n=8) (E) and CRY2 (n=8) (G) ±SEM quantitated by RT-qPCR; human eye RNA (indicated by a square) and 
human reference (ref.) RNA (indicated by an inverted triangle) were the positive controls. Representative images of CRY1 (red) and CRY2 (green) 
localisation in EKs (n=3) (B and D respectively) and DFs (n=3) (F and H respectively) by immunofluorescence; nuclei are counterstained with DAPi (blue).   
Scale bar is 75 µm. 
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Table 3-1: Summary of the mRNA expression of different photoreceptors.  
*, •, ▲ indicate cells derived from the same donor. ND denotes not detected. ✓ denotes detected. NA denotes not analysed.  
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Table 3-2: Summary of the protein expression of different photoreceptors in human skin ¨in situ¨ and in cells in culture.  
ND denotes not detected. ✓ denotes detected. NA denotes not analysed.  
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3.2 The effect of visible to infrared (IR) light on the metabolic 
activity of cultured epidermal keratinocytes: a screening of 
parameters 
The metabolic activity of primary cultures of epidermal keratinocytes in 
response to a range of different light parameters after 24h was assessed with 
the Alamar Blue assay.  
3.2.1 Short wavelength- and dose- dependent effect of light on the 
metabolic activity of primary human epidermal keratinocytes 
Two different radiant exposures were used for each short-wavelength light 
tested (blue, cyan and green light). Low doses of blue and cyan light (2 J/cm2) 
increased metabolic activity of keratinocytes while high doses (30 J/cm2) did not 
have any significant effect (n=4 donors) (Figure 3-6).  
 
Figure 3-6: Blue and cyan, but not green light modulates the metabolic activity of 
cultured keratinocytes after 24h.  
The relative metabolic activity of epidermal keratinocytes to metabolic activity of non-irradiated 
keratinocytes (no light, grey bar) 24h after exposure to blue (blue bar), cyan (turquoise bar) or 
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green (green bar) light at either 2 J/cm2 or 30 J/cm2. Data is presented as the mean of the 
relative metabolic activity ± SEM (n=4 donors, 6 replicates). * Denotes p<0.05 using a one-way 
ANOVA test.  
3.2.2 Long wavelength- and dose- dependent effect of light on the 
metabolic activity of primary human epidermal keratinocytes 
Two different radiant exposures were used for each long wavelength light 
tested (red and near infrared (NIR)). Low doses of red light (3.2 J/cm2 and 30 
J/cm2) increased the metabolic activity of primary epidermal keratinocytes, while 
higher doses (200 J/cm2) had no effect (Figure 3-7, A). Similarly, low doses of 
NIR light (60 J/cm2) stimulated the metabolic activity of keratinocytes, but in 
contrast higher doses (250J/cm2) supressed it (Figure 3-7, B).   
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Figure 3-7: The effect of long wavelength (red and NIR) light on the metabolic 
activity of cultured keratinocytes.  
(A) Relative metabolic activity of cultured epidermal keratinocytes 24h after exposure to no light 
(grey bar), or one exposure to red light at 3.2 J/cm2, 30 J/cm2 and 200 J/cm2 (red bars). (B) 
Relative metabolic activity of cultured keratinocytes 24h after exposure to no light (grey bar), or 
one exposure to NIR light (dark red bars) at 60 J/cm2 or 250 J/cm2. Data is presented as the 
mean of the relative metabolic activity ± SEM (n=4 donors, 6 replicates). * Denotes p<0.05 
using a one-way ANOVA test; NIR denotes near infrared.    
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3.3 Blue light modulates migration of human primary epidermal 
keratinocytes 
The blue and red light parameters shown to modulate the metabolic 
activity of cultured keratinocytes (section 3.2) were selected to determine 
whether they could also modulate keratinocyte migration in a scratch-wound 
assay.  
3.3.1 High doses of blue light modulate epidermal keratinocyte 
migration, but lower doses of blue light or red light had no 
effect 
The speed of closure of epidermal keratinocytes was measured at 12h 
and 21h after scratching by analysing the area of the scratch-wound in 
comparison with the same scratch-wound at time 0h (Figure 3-8, A). No 
changes in keratinocyte migration were seen following exposure to lower doses 
of blue light (2J/cm2). Only higher doses of blue light (30J/cm2) modulated 
keratinocyte migration by reducing the speed of closure of the scratch wound by 
20% when compared to the no light control (Figure 3-8, B). Furthermore, 30 
J/cm2 of red light did not have any significant effect on the rate of migration of 
epidermal keratinocytes (Figure 3-8, B).   
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Figure 3-8: Low level blue light has no effect on epidermal keratinocyte speed of 
closure, higher doses delay migration, but higher doses of red light have no effect.  
(A) Representative images of epidermal keratinocytes exposed to no light, 2 J/cm2 of blue light, 
30 J/cm2 of blue light and 30 J/cm2 of red light at 0h, 12h and 21h after scratch-wound.  (B) 
Normalised speed of closure of epidermal kerationcytes after 2 J/cm2 and 30 J/cm2 of blue light 
exposure and 30 J/cm2 of red light with respect to no light control. Analysis was done after 12 
and 21 hours after scratch-wound/light treatment were performed. Data is presented as the 
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mean of the normalised speed of closure (n=3 donors, 4 replicates) ± SEM. ** denotes p<0.01 
and *** denotes p<0.001 using two-way ANOVA test. 
3.4 Blue light at low doses modulates DNA synthesis and 
KRT10 expression of human primary epidermal keratinocytes 
Since OPNs have an absorption peak in the blue light wavelength, to 
further understand their potential role on epidermal keratinocytes, the effect of 2 
J/cm2 of 453nm (blue) light on DNA synthesis and cell differentiation was 
investigated. DNA synthesis of keratinocytes was reduced following exposure to 
low levels of blue light, as it was shown by the EdU incorporation assay in green 
(Figure 3-9). However, differentiation, as shown by expression of KRT10, a 
marker of early differentiation, was induced (Figure 3-9). 
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Figure 3-9: Low level blue light reduced DNA synthesis while induced 
differentiation of epidermal keratinocytes.  
(A-B) Representative image of non-irradiated (A) and blue light (2 J/cm2) irradiated epidermal 
keratinocytes, where DNA synthesis is indicated by incorporated EdU (green) and differentiation 
is indicated by KRT10 positive cells (red). Nuclei are counterstained with DAPI (blue). Scale bar 
Is 100 µm. (C) Quantification of DNA synthesis by EdU incorporation of epidermal keratinocytes 
after irradiation with 453 nm (blue) light at 2 J/cm2. Data presented as relative mean of EdU 
positive cells/DAPI (n=2 donors) ± SEM. ** indicates p > 0.01 using unpaired t-test.  (D) 
Quantification of differentiation by KRT10 expression after irradiation with 453 nm (blue) light at 
2 J/cm2. Data presented as relative mean of KRT10 positive cells/DAPI (n=3 donors) ± SEM. * 
indicates p > 0.05 using unpaired t-test. 
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3.5 Physiological significance of OPN3 and CRY1 in primary 
epidermal keratinocytes and dermal fibroblasts 
OPN3 and CRY1 were highly expressed in both primary epidermal 
keratinocytes and dermal fibroblasts cultures (Figure 3-3). A more in depth 
study of OPN3 and CRY1 function in both epidermal keratinocytes and dermal 
fibroblasts is addressed in this section.     
3.5.1 The synchronisation and transfection conditions of 
cultured cells 
Circadian clock synchronisation is controlled by the suprachiasmatic 
nucleus (SCN) pacemaker in vivo, but since this synchrony can be lost in vitro, 
cell cultures require synchronisation when studying CRYs and other proteins 
involved in the molecular clock.  
Silencing using siRNA is an efficient way to stop the production of target 
proteins. Transfection of the siRNA is a critical point in primary cell cultures. 
Therefore, both the optimisation of synchronisation, and the successful 
transfection of primary cell cultures are crucial steps in studying the role of 
OPNs and CRYs in primary epidermal keratinocytes and dermal fibroblasts in 
vitro.   
3.5.1.1 Synchronisation of cultured human primary dermal 
fibroblasts 
In culture, cells may lose the synchrony normally maintained in vivo and 
may cycle in a cell-autonomous manner. The circadian rhythm can be 
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synchronised in cultured cells by either serum starvation/serum shock or 
dexamethasone treatment (Balsalobre et al., 2000). 
Primary fibroblasts from facial skin were preincubated under different 
culture conditions and mRNA was analysed to determine changes in expression 
of circadian clock genes. Circadian clock gene expression was analysed at 4 h 
and 24 h after synchronisation following different culture conditions for 24h; i.e. 
normal fibroblast growth media (2.2.1.2) with 10% FBS (S+), serum starvation 
(SS) or 250 nM of dexamethasone (Dex). Expression of CRY1, CRY2 and 
PER1 was induced after SS and Dex incubation in comparison to non-
synchronised cells (S+) indicating an induction of the circadian clock machinery 
at 4h after synchronisation (Figure 3-10). Furthermore, mRNA expression of 
CRY1, PER1 and BMAL1 was downregulated between 4 and 24h under all 
three culture conditions (Figure 3-10). In contrast, downregulation of CRY2 was 
seen only after serum starvation (SS) (Figure 3-10).  
. 
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Figure 3-10: Dermal fibroblasts maintain circadian oscillations in culture.  
(A) CRY1 expression, (B) CRY2 expression, (C) PER1 expression and (D) BMAL1 expression 
quantitated by RT-qPCR in cultured dermal fibroblasts after 4h and 24h following incubation 
with 10%FBS (S+), after synchronisation with serum starvation (SS) or synchronisation with 250 
nM dexamethasone (Dex). Data presented as the mean relative expression to GAPDH of three 
technical replicates ± SD; ** denotes p<0.001 and *** denotes p<0.0001 in a two-way ANOVA.  
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3.5.1.2 KL001 and longdaysin modulate the circadian clock in 
cultured dermal fibroblasts: changes in expression of 
circadian clock genes 
Dermal fibroblasts were synchronised by serum-starving and then 
scratching to study differences in circadian clock gene expression during 
fibroblasts migration. Interestingly, both CRY2 and PER2 were upregulated in 
scratch-wounded monolayers 36h after scratching while no changes were seen 
for the rest of clock genes, including the core circadian clock BMAL1 and 
CLOCK (Figure 11-A). 
Furthermore, the synchronised serum-starving and then scratching 
scratched fibroblasts were incubated with 8 µM of KL001 or longdaysin (LD) for 
36h. Both molecules modulated the mRNA expression of most of the 
investigated circadian clock genes in cultured dermal fibroblasts; CRY1, CRY2, 
PER1, PER2, PER3, BMAL1 and CLOCK (Figure 3-11, B). The same 
concentration of KL001 and LD modulated circadian clock gene expression in a 
differential manner; on one hand, 8 µM of KL001 significantly down regulated 
CRY1, CRY2, PER1, PER2, PER3 and BMAL1 mRNA expression, but there 
was no change in the expression of CLOCK mRNA after 36h. In contrast, 8 µM 
of LD significantly upregulated mRNA expression of CRY1, PER1, PER2 and 
PER3, but had no effect on CLOCK mRNA expression. BMAL1 was the only 
gene down regulated after 36h following incubation with LD, however its 
expression remained higher than corresponding dermal fibroblasts that had 
been treated with KL001 (Figure 3-11).  
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Figure 3-11: Expression and modulation with KL001 and longdaysin of clock genes 
in dermal fibroblasts.  
(A) CRY1, CRY2, PER1, PER2, PER3, BMAL1 and CLOCK mRNA expression in non-wounded 
and wounded dermal fibroblasts quantitated by RT-qPCR in serum-starved synchronised cells 
at passage 5,  36h after scratching. Data presented as the mean relative to the expression of 
GAPDH of three technical replicates ± SD. *** Denotes p<0.001 in a multiple t-test using the 
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Holm-Sidak method. (B) CRY1, CRY2, PER1, PER2, PER3, BMAL1 and CLOCK mRNA 
expression quantitated by RT-qPCR in serum-starved synchronised dermal fibroblasts at 
passage 5, 36h after scratching and treatment with either 8 µM KL001 or 8 µM LD. Data 
presented as the mean relative to the expression of GAPDH of three technical replicates ± SD. * 
Denotes p<0.05, ** denotes p<0.01 in a two-way ANOVA. LD indicates longdaysin; W denotes 
wounded. 
3.5.1.3 Viability of transfected epidermal keratinoctyes with 
lipofectamine-siRNA complexes 
In order to optimise the conditions for silencing experiments, the viability of 
epidermal keratinocytes after treatment with 3µL/mL of lipofectamine alone, or 
as a complex with non-target siRNA (NTR), or OPN3 siRNA was assessed with 
trypan blue staining. All three conditions downregulated viability in comparison 
to the negative control, but viability always remained above 60% (Figure 3-12). 
There was no difference in cell viability between the three different treatment 
conditions tested.  
 
Figure 3-12: Lipofectamine (3uL/mL) reduced viability of epidermal keratinocytes 
by 20%.  
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The lipofectamine control (3uL/mL), lipofectamine with the non-target siRNA (NTR) control and 
lipofectamine with the siRNA targeting OPN3, all similarly reduced epidermal keratinocyte 
viability in comparison to the negative control. Data presented as the mean % of viable cells 
(n=1 donor, 6 replicates) ± SD. * Denotes p<0.05 using Mann Whitney non parametric t-test. 
3.5.2 OPN3 and CRYs regulation in synchronised epidermal 
keratinocytes 
It was previously shown that KL001 modulates circadian clock gene 
expression in dermal fibroblasts (Figure 3-8) previously by stabilising CRYs 
protein (Hirota et al. 2012), which was reflected in the downregulation of CRY1 
and CRY2 mRNA expression (Figure 3-8). Furthermore, use of lipofectamine for 
siRNA transfection in epidermal keratinocytes maintained cell viability above 
60% (Figure 3-9).  
Synchronisation of epidermal keratinocytes was performed with 12% FBS 
for 2h as described by Janich et al., (2015) and transfection with either 50 nM of 
siRNA against OPN3 (siOPN3), or CRY1 (siCRY1), or incubation with 8 µM of 
KL001 for 24h. A scratch-wound assay in epidermal keratinocytes was done 
after silencing or KL001 incubation to study the function of OPN3 and CRY1 in 
keratinocyte migration. Images of the scratch-wound were taken immediately 
after scratching and after 12 h and 21 h. The mRNA was collected 24h after 
scratching and the efficiency of silencing and effect of KL001 treatment was 
assessed.  
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3.5.2.1 Silencing efficiency of OPN3 and CRY1 was above 65% 
while KL001 downregulated both CRYs 
Firstly, modulation of OPN3, CRY1 and CRY2 by either silencing or the 
CRY stabiliser molecule, KL001 was confirmed by RT-qPCR. Silencing OPN3 
(siOPN3) reduced OPN3 expression by 87% (n=3 donors) (Figure 3-13, A), 
while silencing CRY1 (siCRY1) reduced CRY1 expression by 66% (Figure 3-13, 
B). In addition, pharmacological treatment with 8 µM of KL001 reduced the 
expression of both CRY1 and CRY2 by 71% and 41% respectively (Figure 3-13, 
C).  
 
Figure 3-13: Transfection efficiency of OPN3 and CRY1 was above 65% while 
KL001 reduced mRNA of both CRYs in synchronised and scratched epidermal 
keratinocyte cultures.  
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(A) Silencing OPN3 with 50 nM of siRNA against OPN3 (siOPN3) reduced OPN3 mRNA 
expression by 87% in comparison to 50 nM of non-target siRNA control (NTRC). (B) Silencing 
CRY1 with 50nM of siRNA against CRY1 (siCRY1) reduced CRY1 mRNA expression by 66% in 
comparison to 50 nM of non-target siRNA control (NTRC). (C) 8 µM of KL001 treatment for 48 h 
reduced CRY1 and CRY2 mRNA expression by 71% and 40% respectively in comparison to 
vehicle control (VC). Data is presented as the mean relative expression to control (n=3 donors, 
triplicates) ± SEM. GAPDH was used as a housekeeping gene. Unpaired t-test was used to test 
silencing of OPN3 (A) and silencing of CRY1 (B) reduction while two-way ANOVA for KL001 
treatment (C). *** denotes p<0.001. 
3.5.2.2 Knockdown of OPN3 upregulated CRY1 expression while 
KL001 upregulated OPN3  
In order to investigate the molecular mechanisms where OPN3 and 
circadian clock play a role and whether there is any relationship between them, 
changes in mRNA expression of different photoreceptors was analysed after 
silencing OPN3 and KL001 treatment. 
Silencing of OPN3 downregulated OPN3 expression in synchronised and 
scratched epidermal keratinocytes, both in the presence and absence of KL001 
(Figure 3-13, A). However when epidermal keratinocytes were incubated with 
KL001 only, which stabilised CRY1 and CRY2 proteins (Hirota et al. 2012), 
there was a significant upregulation of OPN3 mRNA (Figure 3-13, A). On the 
other hand, knockdown of CRY1 had no effect on OPN3 mRNA expression 
(Figure 3-13, A).  
In contrast, KL001 downregulated both CRY1 and CRY2 (Figure 3-14, B 
and C). Interestingly, knockdown of OPN3 significantly upregulated CRY1 
(Figure 3-14, B), but incubation of OPN3 knockdown cells with KL001 
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downregulated CRY1 expression to similar levels seen with KL001 incubation 
only. However, knockdown of OPN3 did not modulate expression of CRY2 but 
knockdown of CRY1 upregulated CRY2 expression (Figure 3-14, C). Incubation 
with KL001 downregulated CRY2 expression and the combination of 
knockdown of OPN3 with KL001 did not attenuate the downregulation in 
response to KL001 (Figure 3.14, C) similar to the effects seen on the 
expression of CRY1.  
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Figure 3-14: Silencing of OPN3, CRY1 or KL001 treatment of synchronised, 
scratched epidermal keratinocytes modulates OPN3, CRY1 and CRY2 mRNA expression. 
OPN3 (A) CRY1 (B) and CRY2 (C) mRNA expression after treatment with 50 nM of non-target 
siRNA control (NTRC), 50 nM of siOPN3, 50 nM of siCRY1, 8 µM of KL001, or 50 nM of 
siOPN3 in combination with 8 µM of KL001. Data is presented as relative expression to control 
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(n=3 donors) mean ± SEM. GAPDH was used as a housekeeping gene. NS Denotes not 
significant, * denotes p<0.05, ** denotes p<0.01 and *** denotes p<0.001 (two-way ANOVA). 
3.5.2.3 Effect of siOPN3, siCRY1 and KL001 treatment on the 
migration of epidermal keratinocytes 
After confirmation of the successful downregulation of OPN3 and CRY1 in 
transfected epidermal keratinocytes and modulation of CRY1 and CRY2 with 
KL001 in scratched cultures of epidermal keratinocytes (Figure 3-13), scratch-
wound images were analysed to determine whether OPN3 or CRYs have any 
role in the regulation of epidermal keratinocyte migration. A scratch assay was 
done 24h after silencing as previously described (section 3.4.2) and images 
were taken at 12h and 21h following the scratch-wound. Silencing OPN3 or 
CRY1 did not influence epidermal keratinocyte migration (Figure 3-15). 
However a delay in migration was seen after 21 h when epidermal keratinocytes 
were incubated with 8 µM of KL001 (n=3 donors). Silencing OPN3 in KL001 
treated epidermal keratinocytes abrogated the delay in migration seen in cells 
treated with KL001 only (Figure 3-15). However, the combination of siOPN3 and 
siCRY1 had no effect on cell migration.  
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Figure 3-15: KL001 inhibits epidermal keratinocyte migration at 21h, which is 
attenuated by knockdown of OPN3.  
Normalised speed of closure of synchronised epidermal keratinocytes to non-target siRNA 
control non treated cells (NTRC). Epidermal keratinocytes were treated with 50 nM of non-target 
siRNA control (NTRC), 50 nM of siOPN3, 50 nM of siCRY1, 8 µM of KL001 and 50 nM of 
siOPN3 in combination with 8 µM of KL001. Data presented as the speed of closure relative to 
NTRC (n=3 donors, passages 2-3) mean ± SEM. * Denotes p<0.05, ** denotes p<0.01 and *** 
denotes p<0.001 (two-way ANOVA).  
3.5.2.1 Effect of siOPN3 and KL001 treatment on DNA synthesis 
of epidermal keratinocytes 
The effect of silencing OPN3 and KL001 treatment on DNA synthesis of 
synchronised epidermal keratinocytes was investigated by the EdU 
incorporation assay. Silencing of OPN3 in non-irradiated cultures had no effect 
on DNA synthesis; however, KL001 downregulated DNA synthesis by 
approximately 50% as measured by EdU uptake (Figure 3-16). Knockdown of 
OPN3 in combination with KL001 treatment partially reversed this effect (Figure 
3-16).  
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Figure 3-16: Effect of siOPN3 and KL001 on epidermal keratinocyte DNA synthesis. 
EdU positive cells / DAPI for siOPN3, KL001 treatment and siOPN3+KL001 relative to non-
target siRNA control (NTRC) control. Data was presented as the mean of relative EdU positive 
cells/DAPI ± SD (n=4) in donor 1 (A) and 2 (B). * Denotes p<0.05, ** denotes p<0.01 and *** 
denotes p<1x10-3 in a one-way ANOVA. 
3.5.2.2 Effect of siOPN3, siCRY1 and KL001 treatment on the early 
differentiation of epidermal keratinocytes 
To understand further the role of OPN3 and CRY1 in epidermal 
keratinocyte differentiation, KRT1 and KRT10 expression was analysed by RT-
qPCR as an indication of early differentiation in scratched cultures of epidermal 
keratinocytes. Silencing of OPN3 did not have any significant effect on either 
KRT1 or KRT10 mRNA expression. On the other hand, silencing of CRY1 
stimulated early differentiation of keratinocytes by inducing a statistically 
significant increase in the expression of KRT10. Treatment with KL001 induced 
a two-fold significant upregulation in both KRT1 and KRT10 (Figure 3-17, A and 
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B respectively). Interestingly, knockdown of OPN3 in combination with KL001 
abrogated the upregulation of differentiation induced by KL001.  
Furthermore, the protein expression of KRT10 was also investigated by 
immunocytochemistry after silencing of OPN3 and KL001 treatment. Non-light 
irradiated keratinocytes showed a similar pattern of KRT10 protein expression 
to the mRNA expression demonstrated by RT-qPCR in the three donors studied 
(Figure 3-17). Incubation of epidermal keratinocytes with KL001 increased the 
number of KRT10 positive cells (Figure 3-17, C-E), and this effect which was 
supressed when combined with knockdown of OPN3 in two out of the three 
donors investigated (Figure 3-17, D and E).  
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Figure 3-17: Silencing of CRY1 or incubation with KL001 upregulates differentiation in 
synchronised and scratched epidermal keratinocytes.  
KRT1 (A) and KRT10 (B) mRNA expression after incubation of epidermal keratinocytes with 
50nM of non-target siRNA control (NTRC), 50nM of siRNA against OPN3 (siOPN3), 50nM of 
siRNA against CRY1 (siCRY1), 8µM of KL001, or a combination of 8µM of KL001 and 50nM of 
siRNA against OPN3 (KL001 + siOPN3) was normalised against GAPDH. Data is presented as 
relative expression to control (n=3 donors) mean ± SEM. * denotes p<0.05, ** denotes p<0.01 
and *** denotes p<0.001 (one-way ANOVA). (C-E) KRT10 positive cells / DAPI for siOPN3, 
KL001 treatment or siOPN3+KL001 relative to non-target siRNA control (NTRC) in donor 1 (C), 
2 (D) and 3 (E). 
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3.5.3 The role of OPN3, CRY1 and CRY2 in the blue light 
response of epidermal keratinocytes 
It has previously been shown that KL001 downregulates CRY1 and CRY2 
and upregulates OPN3 (Figure 3-14). In terms of functionality it inhibits 
migration (Figure 3-15), proliferation (Figure3-16) while stimulated early 
differentiation of keratinocytes (Figure 3-17) both of which were abrogated by 
OPN3 knockdown. Non-scratched and synchronised cultures of epidermal 
keratinocytes were treated with non-target siRNA control (NTRC), siOPN3, 
incubation with 8 µM of KL001 or siOPN3 in combination with 8 µM of KL001. 
Parallel cultures of keratinocytes were irradiated with low level blue light (2 
J/cm2) to investigate if modulation of differentiation could be mediated by OPN3 
or the circadian clock at 10 h after irradiation by ICC for KRT10. Changes in 
DNA synthesis was analysed in response to knockdown of OPN3 or KL001 
treatment the presence or absence of 2 J/cm2 of blue light irradiation, which 
was studied by EdU uptake. 
3.5.3.1 Effect of siOPN3, siCRY1 and KL001 treatment on DNA 
synthesis in epidermal keratinocytes in the absence or 
presence of blue light irradiation 
Low levels of blue light (2 J/cm2) reduced DNA synthesis but induced 
differentiation of primary epidermal keratinocytes (Figure 3-9). In order to 
investigate the role of OPN3 and circadian clock to mediate this effect, the 
combination of siOPN3 and KL001 treatment was performed in non-irradiated 
and blue light irradiated cultures of epidermal keratinocytes in parallel. 
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When keratinocytes were irradiated with low level blue light, a decrease 
in DNA synthesis was seen in non-target siRNA control (NTRC) keratinocytes. 
This effect was also seen following OPN3 knockdown (Figure 3-18). However, 
in the presence of KL001 either alone or in combination with OPN3 knockdown, 
blue light did not modulate DNA synthesis (Figure 3-18).  
 
Figure 3-18: Effect of siOPN3 and KL001 on epidermal keratinocyte DNA synthesis after 
low level blue light irradiation.  
EdU positive cells / DAPI for siOPN3, KL001 treatment and siOPN3+KL001 non irradiated and 
irradiated with 2 J/cm2 of blue light relative to NTRC no light in donor 1 (A), donor 2 (B) and 
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donor 3 (C). Data was presented as the mean of relative EdU positive cells/DAPI ± SD (n=4 
replicates). * Denotes p<0.05, ** denotes p<0.01 and *** denotes p<0.001 (two-way ANOVA). 
3.5.3.2 Effect of siOPN3, siCRY1 and KL001 treatment on 
epidermal keratinocyte differentiation in response to blue 
light irradiation 
When analysing the effect of blue light in silenced and/or KL001 treated 
cells, there was an increase in the number of differentiating keratinocytes 
treated with the non-target siRNA (NTRC) in response to low level blue light 
(Figure 3-19). However, blue light had no effect on KRT10 expression after 
OPN3 silencing, KL001 treatment or KL001 treatment in combination with 
siOPN3 (Figure 3-19).  
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Figure 3-19: Effect of siOPN3 and KL001 on epidermal keratinocytes differentiation after 
low levels of blue light irradiation.  
(A) Representative experiment of KRT10 positive cells / DAPI for siOPN3, KL001 treatment and 
siOPN3+KL001 non irradiated and irradiated with 2 J/cm2 of blue light relative to NTRC no light. 
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Data was presented as the mean of relative KRT10 positive cells/DAPI ± SD (n=4 replicates). * 
Denotes p<0.05, ** denotes p<0.01 and *** denotes p0.001 (two-way ANOVA). Experiment was 
repeated in two extra donors.  
3.6 Effect of blue and red light on an ex vivo human skin wound 
healing model 
While published data has confirmed the effect of red light in wound healing 
(Posten et al. 2005), there is no data on the effect of blue light. Therefore, the 
development of efficient and knowledge-based light devices to improve wound 
healing is required. In order to test the effect of red light and blue light on wound 
healing, an ex vivo human skin wound healing model was developed to 
investigate the response to light in conditions that resemble human skin wound 
healing in vivo.  
3.6.1 Expression of KRT17 in ex vivo wounds after two days in 
culture 
Ex vivo wounds from female abdominal skin were frozen in OCT 
immediately after wounding (day 0) or after two days in culture (day 2). KRT17 
and 14 were detected by immunofluorescence on day 0 and day 2 (Figure 3-20, 
shown in green and red respectively). While at day zero wounds showed 
expression of these two proteins in the basal layer of the epidermis (Figure 3-
20, A and B), they both were also expressed throughout the epidermis and 
epithelial tongue of ex vivo wounds after 2 days in culture, showing an increase 
in the level of expression (Figure 3-20, C and D). 
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Figure 3-20: KRT14 and KRT17 upregulation during human wound healing.  
First panel shows H&E staining, second panel shows merged KRT17 (green) and KRT14 (red) 
immunofluorescence in one of the wound edges, third panel shows merged KRT17 (green) and 
KRT14 (red) immunofluorescence in the opposite wound edge. (A) H&E staining of ex vivo 
wound, KRT17 (green) and KRT14 (red) are expressed in the basal layer of human ex vivo 
wounds at day 0. (B and C) An epithelial tongue (within dashes) was formed after two days in 
culture (H&E staining); KRT17 (green) and KRT14 (red) are upregulated in the epithelial tongue 
and surrounding epidermis of day 2 wounds. Scale bar = 75 µm. 
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3.6.2 Expression of photoreceptors in the epithelial tongue of human 
ex vivo wounds  
The protein expression of photoreceptors has already been 
demonstrated in facial and abdominal skin (Figure 3-1 and 3-2) as well as in 
cultures of primary keratinocytes and fibroblasts (Figure 3-3, 3-4 and 3-5) in this 
study. Re-epithelialisation is one of the most important phases of wound healing 
in order to close the wound and avoid infection, and epidermal keratinocytes are 
main players in this phase. In order to understand the role of photoreceptors in 
this process, the expression at both mRNA and protein levels in the epithelial 
tongue of the ex vivo wounds was investigated.  
Wound cryosections were stained with haematoxylin and the desired 
area selected and cut by the laser microdissection technique. Images were 
taken before and after the cut (Figure 3-21). The collected material was used for 
RNA extraction and amplification.  
 
Figure 3-21: Laser microdissection of epithelial tongue as part of ex vivo human wounds 
after two days in culture.  
(A) Haematoxylin staining of an ex vivo wound before performance of laser microdissection. (B) 
Haematoxylin staining of an ex vivo wound after performance of laser microdissection. 
Abdominal skin from a 55-year-old female. Arrows indicate epithelial tongue.  
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Samples with good RNA quality were selected for analysis of photoreceptors by 
RT-qPCR. Human reference RNA was used as a positive control. There was no 
amplification of OPN1-SW, OPN5 and CRY2 during the RT-qPCR process (Figure 3-
22, A, C and E respectively). However, OPN3 and CRY1 showed very similar melt 
curve peaks to the positive control (Figure 3-22, B and D). This indicates positive 
expression of OPN3 and CRY1 in the epithelial tongue of human wounds ex vivo.    
 
Figure 3-22: OPN3 and CRY1 mRNA expression in the epithelial tongue of human 
wounds ex vivo.  
Melt curves obtained after qPCR amplification of epithelial tongue RNA (n=9 wounds from 55-
year-old female abdominal skin) and human reference RNA for OPN1-SW (A), OPN3 (B), OPN5 
(C), CRY1 (D) and CRY2 (E).  
133 
In order to verify the mRNA expression data of newly formed epithelium during 
re-epithelialisation, protein expression was also investigated using 
immunofluorescence staining for OPN1-SW, OPN3 and OPN5. 
 Although, OPN1SW mRNA was not detected in the RT-qPCR analysis (Figure 3-
22), positive staining for the protein was seen in the new epithelium formed. This 
expression was more prominent in the more differentiated keratinocytes of the 
epithelial tongue (Figure 3-23, A).  
OPN3 protein expression was in agreement with mRNA expression. OPN3 was 
highly expressed in the most basal layer of the new epithelium formed during wound 
healing showing co-localisation with KRT14 (Figure 3-23, B).  
Finally, OPN5 was expressed in the edges of epithelial tongue of the wound only 
(Figure 3-23, C). This expression was less prominent than in the normal, intact 
epidermis, where a clear signal was seen in the basal layer of the epidermis (Figure 3-
1). This low expression could be one reason why OPN5 was not detectable by RT-qRT 
(Figure 3-23, C). 
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Figure 3-23: Localisation of OPNs in ex vivo wounds.  
Co-localisation of OPN1SW (A), OPN3 (B) and OPN5 (C) (green) with KRT14 (red) in ex vivo 
wounds. Nuclei are counterstained with DAPi (blue). First panel indicates merged, second panel 
indicates photoreceptors staining (green), third panel indicates KRT14 staining (red) and fourth 
paned indicates DAPi (blue) .Representative images of wounds from two different donors.  
3.6.3 Blue and red light modulate wound healing ex vivo  
Reproducible ex vivo wounds were performed as previously explained 
(section 2.10 ). Speed of closure was highly variable between donors. Donor 1 
had the highest speed of closure followed by donor 3 and finally donor 2 (Table 
3-3).  
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 Donor 1 Donor 2 Donor 3 
Age 51 44 55 
Area 4 - 12 mm2 
Speed 
of 
closure 
at day 2 
(mm2/h) 
0.132 ± 0.017 0.048 ± 0.016 0.071 ± 0.016 
Speed 
of 
closure 
at day 5 
(mm2/h) 
0.065 ± 0.016 0.032 ± 0.010 0.053 ± 0.003 
Table 3-3: Rate of closure in an ex vivo human skin wound healing model in three 
different donors.  
Information about age of donors, the wound area at day 0 of all each donor and the mean 
speed of closure ± SD of control wounds at day 2 and 5 for each donor. 
The speed of closure for each wound was analysed at 2 days and 5 days 
after wounding. Two different doses of blue light 2 J/cm2 (n=3 donors) and 
30J/cm2 (n=2 donors) were used, while 30J/cm2 (n=3 donors) was used for red 
light. Wounds were exposed to the relevant doses of light once a day.  
Low doses of blue light (2J/cm2) increased the rate of re-epithelialisation 
after two days in culture in both donor 2 and 3 (Figure 3-24, A) following a 
similar trend at day 5 (Figure 3-24, B). Donor 1 did not show a statistically 
significant response in wound closure after treatment with light. In contrast, high 
doses of blue light (30 J/cm2) inhibited wound closure in donor 1 at day 2 
(Figure 3-24, A) and day 5 (Figure 3-24, B), while donor 3 did not respond to 
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this level of blue light. Red light (30 J/cm2) increased wound closure only in 
donor 2 at day 2 (Figure 3-24, A) and in donor 1 at day 5 (Figure 3-24, B).  
 
Figure 3-24: Effect of blue and red light on wound closure in an ex vivo human skin 
wound healing model.  
137 
(A) Representative pictures of wounds at 0 h and 2 days in culture and the mean of speed of 
closure after light exposures ±SD (n=5-7 wounds per donor). (B) Representative pictures of 
wounds at 0 h and 5 days in culture and the mean of speed of closure after light exposures ±SD 
(n=3-5 wounds per donor). Wounds were treated with light every 24h starting at 0h. * Denotes 
p<0.05, ** denotes p<0.01 in a two-way ANOVA.      
3.6.4 KRT17, OPN3 and CRY1 expression after light treatment of 
ex vivo wounds 
In order to further understand the effect of blue and red light on wound 
closure, KRT17 mRNA expression in the isolated epithelial tongue was 
analysed. There was no significant difference (Figure 3-25), probably as a result 
of the low number of wounds analysed (n=2 or 3 wounds per group), and the 
high variability between them.  
 
Figure 3-25: Effect of blue and red light on the expression of KRT17.  
Effect of blue (2 J/cm2 or 30 J/cm2) and red (30 J/cm2) light on KRT17 expression. Data was 
calculated relative to GAPDH and presented as the mean of the normalised (no light) relative 
expression of n=2-3 wounds ± SD. NS indicates not significant (one-way ANOVA).  
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The expression of OPN3 and CRY1 in the RNA isolated from the epithelial 
tongue was also analysed. Again, no significant differences were found, 
although low doses of blue light upregulated mRNA expression of these two 
photoreceptors in most of the wounds analysed (Figure 3-26).  
 
Figure 3-26: Expression of OPN3 and CRY1 in the epithelial tongue of ex vivo 
wounds treated with blue and red light.  
Relative mRNA expression of OPN3 (A) and CRY1 (B) after irradiation with blue light (2 or 30 
J/cm2) or red light (30 J/cm2). Human reference RNA was used as a positive control. Data was 
calculated relative to GAPDH and presented as the mean of the normalised (no light) relative 
expression of n=2-3 wounds ± SD. There were not significant differences (one-way ANOVA).  
139 
4 Discussion 
There is growing evidence that light may have an important role in 
different processes within human skin. For example, melanin production is a 
skin defence response to UV light (Slominski et al. 2004), while vitamin D 
synthesis, an essential hormone is synthesised in keratinocytes following 
exposure to UV light (Webb 2006). However, there is a growing amount of 
literature reporting a considerable range of effects in different types of skin cells, 
including cultured human keratinocytes and fibroblasts, as well as in in vivo 
mouse models after exposure to different light parameters (Hawkins et al. 
2005). Light-based devices for skin disorders are already commercially 
available and claim to produce beneficial effects in conditions such as psoriasis 
(Kleinpenning et al. 2012; Pfaff et al. 2015), and hair loss (Jimenez et al. 2014). 
However, it is not clear which molecular mechanisms are involved in these 
responses to light, yet this knowledge is required for the development of reliable 
light-based therapeutic devices.  
4.1 Photoreceptors are expressed in human skin  
The OPN family are GPCRs involved in functions related to vision within 
the eye of humans and other animals, and the molecular mechanisms are well 
established in this organ (Ebrey and Koutalos 2001). Recently, the visual opsins 
OPN1-SW, OPN1-MLW and OPN2 have been identified in human epidermis 
(Tsutsumi et al. 2009). In addition, expression of the non-visual OPN, OPN3 
has been reported in human scalp skin and the terminal hair follicles (Buscone 
et al. 2017).   
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In agreement with Tsutsumi et al., (2009), OPN1-SW was highly 
expressed in the stratum granulosum of the epidermis of facial skin (Figure 3-1). 
The OPN1-SW receptor is activated by violet light (420-440 nm) (Terakita 
2005), and violet light is a powerful wavelength but it does not penetrate very 
deep into the skin (Lister et al. 2012). This phenomenon may be the reason for 
OPN1-SW to be highly expressed in the more superficial layers of the epidermis 
(Figure 3-1). 
In contrast, the expression of OPN3 in facial skin was mainly confined to 
the stratum basal of the epidermis, although a low expression was also seen in 
the suprabasal layer (Figure 3-1). This is partially in agreement with the 
localization of OPN3 in human scalp epidermis (Buscone et al. 2017), although 
human scalp shows a higher expression of OPN3 in differentiated layers of the 
epidermis compared to facial skin (Figure 3-1). One explanation could be the 
different antibody used against OPN3; while Buscone et al., (2017) did not 
specify to which part of the OPN3 receptor their antibody binds to, this study 
used an antibody specifically directed against the C terminus of OPN3 (Table 2-
3), which is the part of the GPCR in charge of transmitting the signal 
intracellularly. Therefore, while Buscone et al., (2017) reported expression of 
OPN3 throughout all the epidermal layers of the scalp, an OPN3 capable of 
activating intracellular signalling pathways is mainly expressed in the basal 
layer of facial skin (Figure 3-1). Further studies of OPN3 expression in both 
facial and scalp skin using both antibodies will help to determine whether these 
differences between anatomical sites are only due to the different functionality 
of the face in comparison to the scalp, or whether it is related to the functionality 
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of the OPN3 receptor itself. Focusing on facial skin, OPN3 is expressed deeper 
in the skin than OPN1-SW. This could be related to the absorption spectra of 
this protein, which has its peak of absorption at a slightly longer wavelength 
(465 nm, blue spectrum) (Koyanagi et al. 2013) compared to OPN1-SW at 420-
440 nm (Terakita 2005).  
This is the first time that localization of OPN5, a UV-absorbing receptor 
(Yamashita et al. 2010), in human skin in situ has been described (Figure 3-1). 
In contrast to the other OPNs, OPN5 was restricted exclusively to the basal 
layer of the epidermis as illustrated by its perfect co-localization with KRT14, a 
specific marker of basal keratinocytes (Figure 3-1). This layer is composed of 
stem cells and highly proliferating keratinocytes, but also melanocytes which 
are responsible for the production of melanin required for protection of the skin 
from UV radiation (Singh et al. 2010). The peak of absorption for OPN5 is within 
the UV-A spectra (nm) (Yamashita et al. 2010). The penetration of UV light in 
the skin is more superficial than visible light, including violet light. However, 
OPN5 is expressed in the layer of the skin where protection against UV light is 
more critical, as it contains proliferative keratinocytes (Seery and Watt 2000; 
Blanpain and Fuchs 2009). Interestingly, OPN5 was also expressed in primary 
melanocytes from neonatal foreskin in culture (Haltaufderhyde et al. 2015). This 
could indicate a role of OPN5 in the UV response of basal keratinocytes, and 
there may be cross-talk with melanocytes to regulate skin protection against UV 
radiation which can induce DNA damage (Besaratinia et al. 2011).  
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Since it is possible that OPNs may be more predominately expressed in 
light-exposed areas of human skin such as facial skin, the localisation of OPNs 
in female abdominal skin from donors of a similar age was studied for 
comparison. The expression of OPN1SW, OPN3 and OPN5 was similar in facial 
and abdominal skin (Figure 3-1) suggesting there is no difference in expression 
with anatomical localisation. This could mean that abdominal skin may not the 
best anatomical region to study as a non-sun exposed area. Although normally 
covered, it may still be exposed to sun light during the summer period in many 
women. Alternatively, the biological function of OPNs may go beyond light 
reception in non-photoreceptive tissue, so that we still find these proteins in 
non-sun exposed areas. This is a relevant hypothesis especially for non-visual 
OPNs; for example, OPN3 has been found in a range of non-photoreceptive 
tissues such as brain, testis, liver, placenta, heart, lung, skeletal muscle, kidney 
and pancreas (Terakita 2005). 
CRYs are transcription factors that form part of the human molecular 
circadian clock machinery (Bjarnason et al. 2001; Buhr and Takahashi 2013). 
Although CRY1 mRNA oscillations in human oral mucosa have been reported 
(Bjarnason et al. 2001), CRY1 and CRY2 localisation in human skin has never 
been addressed. Localisation of CRY1 was restricted to the nuclei of epidermal 
keratincoytes in facial skin (Figure 3-2). However, abdominal skin had very low 
expression of CRY1, and cellular localisation was cytoplasmic (Figure 3-2). The 
localisation of CRY1 in non-skin cells has previously been reported to be 
confined mainly to the cell nucleus, but expression has also been reported to be 
localised in the cytoplasm of some of the  human kidney cell line 293A (Yoo et 
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al. 2013). Therefore, while expression of CRY can occur in both the nucleus 
and cytoplasm of cells, the fact that there were differences between facial and 
abdominal skin could have different explanations. First of all, the abdominal skin 
was obtained from patients going through abdominoplastia surgery where 
circadian clock might be disrupted (Shi et al. 2013). This could also explain the 
low expression of CRY1 in the abdominal skin of some of the donors. Secondly, 
CRYs are transcription factors which are able to travel from the cytoplasm to the 
nucleus in a circadian-dependent manner, and it is known that different tissues 
have their own rhythmicity (Hughey and Butte 2016). Therefore, it could also be 
the case that because the skin is the largest organ in the human body, different 
anatomical regions may keep their own circadian rhythmicity. 
On the other hand, CRY2 was mainly located in the cytoplasm, although 
positive staining was also seen in the nucleus.  Unlike CRY1, the expression of 
CRY2 in facial and abdominal skin was similar, indicating a more consistent role 
and therefore, probably function of CRY2. 
The important role of both keratinocytes and fibroblasts in wound healing 
and the ability of light to go through the epidermis and reach the dermis, makes 
them both important targets for the action of light on the skin during tissue 
repair. In order to confirm the relevance of primary cell cultures for studies of 
responses to light, expression of photoreceptors was also analysed in primary 
epidermal keratinocytes (n=4) and primary dermal fibroblasts (n=8-9) from 
different anatomical regions, all at early passage numbers. A keratinocyte 
human epidermal cell line (NCTC) was also included for comparison (Table 3-
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1). The mRNA expression of OPN1SW, OPN2, OPN3 and OPN5 in cultured 
normal human epidermal keratinocytes purchased from Lifeline Cell Technology 
has previously been reported (Haltaufderhyde et al. 2015), who did not specify 
the anatomical site that these keratinocytes were isolated from but whether this 
expression is retained at the protein level has only been reported for OPN2 
(Kim et al. 2013). Furthermore, the expression of OPNs in primary cultures of 
human dermal fibroblasts has not yet been explored. 
Primary human epidermal keratinocytes derived from female facial skin 
express OPN1-SW, OPN3 and OPN5 at the mRNA level (Figure 3-3 and Table 
3-1), confirming the results of a previous study by Haltaufderhyde and 
colleagues (2015). However, this study has also confirmed that OPN1-SW, 
OPN3 and OPN5 are expressed at the protein level (Figure 3-3). Interestingly, 
OPN2 was not detectable in the primary cultures of keratinocytes analysed, 
while an immortalized keratinocyte cell line NCTC 2544, did express mRNA for 
OPN2 (Table 3-1). These results are not in line with published data, as OPN2 
mRNA has been found in primary keratinocytes from neonatal foreskin (Kim et 
al. 2013) as well as in primary adult keratinocytes from an unknown anatomical 
site (Haltaufderhyde et al. 2015). It is not surprising to find differences between 
primary keratinocytes in culture and cell lines due to their different 
characteristics. Specifically, NCTC 2544 cells were derived from human skin 
after continuous growth in culture by spontaneous transformation (Bakken et al. 
1961). This process requires the overexpression of cell cycle genes and 
downregulation of cell differentiation genes (Katayama et al. 2015). OPN2 has 
been shown to reduce differentiation after activation with violet light in neonatal 
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foreskin keratinocytes (Kim et al. 2013), therefore, its positive expression in the 
NCTC 2544 cell line (Table 3-1) as well as in the highly proliferative neonatal 
foreskin keratinocytes (Kim et al. 2013) may be related to the maintenance of a 
reduced differentiation status in these two models. More information regarding 
the isolation of the keratinocytes used by Haltaufderhyde and co-workers (2015) 
would be required in order to further understand differences in OPN2 
expression in primary keratinocytes.   
In cultured keratinocytes, the protein expression of OPN1-SW was 
confined to the peri-nuclear region (Figure 3-4). This suggests localization to the 
Golgi apparatus, since GPCRs are present in the Golgi following protein 
synthesis, when they undergo post-translational modifications before locating to 
the plasma membrane. However, this would imply that OPN1SW is not a 
completely functional protein in keratinocytes. An alternative is that this 
compartment may be an endosome or a lysosome, since GPCRs are subjected 
to receptor trafficking (Drake et al. 2006).  Co-localization of OPN1SW with 
specific organelle markers such as GM130, a Golgi apparatus marker, will help 
to define their role in human keratinocytes. In contrast, OPN3 and OPN5 were 
both localized to the plasma membrane and cytoplasm in cultured keratinocytes 
in a similar manner to the expression of OPN2 in neonatal foreskin 
keratinocytes reported by Kim and co-workers (2014). Furthermore, this is the 
most common localisation for GPCRs, which are transmembrane receptors 
(Magalhaes et al. 2012).  
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Regarding dermal fibroblasts, this is the first report that shows the 
expression of OPN1SW, OPN2 and OPN3 mRNA in cultured human dermal 
fibroblasts. They were studied from fibroblasts isolated from different anatomical 
regions (breast, face, abdomen and scalp) (Table 3-1). However, OPN5 was not 
detected in any of the primary dermal fibroblast cultures (Table 3-1), in 
agreement with data previously shown in skin immunohistochemistry in situ, 
where the dermis of both facial and abdominal skin did not show expression of 
OPN5 (Figure 3-4). Although OPN2 was expressed in some dermal fibroblast 
cultures, it was absent in two out of the eight donors analysed (Table 3-1). 
Interestingly, the matching keratinocytes for one of these donors also did not 
express OPN2. This could mean that expression of OPN2 is donor-dependent; 
however, there were no more donor-matched keratinocytes and fibroblasts to 
be able to confirm this (Table 3-1). Another possible explanation is that cells in 
culture tend to loose OPN2 expression as differentiation of epidermal 
keratinocytes increases with passaging. In contrast, papillary fibroblasts only 
start to differentiate at later passages in culture, where expression of markers 
for fibroblast differentiation, such as α-SMA, only increased after at least 16 
passages in culture, reaching the levels found in reticular fibroblast (Janson et 
al. 2013). Since the cultures of primary fibroblasts used to determine OPN2 
expression were less than passage 10 (Table 3-1), any loss of OPN2 
expression due to differentiation in these fibroblasts is less likely.  
The protein expression for OPN1-SW was localised to the perinuclear 
region of primary dermal fibroblasts in culture, while OPN3 was found in both 
the cytoplasm and cell membrane. This expression was similar to that seen in 
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keratinocyte cultures, suggesting a similar function of these two proteins in both 
cells types. 
Non-synchronised primary human keratinocytes and fibroblasts derived 
from neonatal foreskin demonstrate oscillations in the expression of CLOCK 
and PER1 mRNA with protein localised to the cell nucleus of both cell types 
(Zanello et al. 2000). Furthermore, PER1 was also found in the cytoplasm of 
those cells (Zanello et al. 2000). A more extensive study of circadian clock 
cycling of the main circadian clock genes was reported by Sandu et al., (2012). 
They showed cycling of both CRY1 and CRY2 mRNAs in human primary 
abdominal keratinocytes and fibroblasts synchronised with dexamethasone 
(Sandu et al. 2012). Cycling of CRY1 and CRY2 in epidermal keratinocytes has 
also been reported after synchronisation with 12% serum shock (Janich et al. 
2013). However, localisation of CRY1 and CRY2 proteins in primary 
keratinocytes and fibroblasts in culture has never been reported. This study has 
confirmed the gene expression of both CRYs in non-synchronised primary 
keratinocytes from facial skin and fibroblasts from different anatomical regions 
(Figure 3-3 and Table 3-1). Furthermore, protein localisation of CRY1 was 
mainly confined to the cell nucleus, although cytoplasmic localisation was also 
seen in one of the three primary epidermal keratinocyte cultures. On the other 
hand, CRY2 was consistently localised to the cytoplasm (Figure 3-5). CRYs are 
transcription factors of the circadian clock, and they translocate from the 
nucleus to the cytoplasm in order to maintain circadian rhythmicity (Matsui et al. 
2016). The inconsistency shown by CRY localisation in primary keratinocytes 
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could be due to the lack of synchronisation, as rhythmicity has been shown to 
be lost in culture in rat-1 fibroblasts (Balsalobre et al. 2000).  
Since primary keratinocytes and fibroblasts retain the same expression of 
OPN1-SW, OPN3 and OPN5, as well as CRY1 and CRY2 in vitro as they do in 
vivo at both the mRNA and protein levels, they provide a physiologically 
relevant culture model to explore the effect of light on the function the two main 
human skin cells, keratinocytes and fibroblasts and to understand the role of 
these photoreceptors in cell migration and wound healing.  
4.2 The effect of visible to infrared (IR) light on the metabolic 
activity of cultured epidermal keratinocytes: a screening of 
parameters 
Photobiomodulation is known to follow a dose-dependent response for 
long-wavelengths (Huang et al. 2009; Chung et al. 2012), which has been 
reported to be beneficial in the treatment of pressure ulcers in vivo (Lanzafame 
et al. 2007) and the stimulation of human dermal fibroblast metabolism in 
culture (Mignon et al. 2017). In contrast, short wavelength light has been mainly 
reported to supress metabolism of primary human keratinocytes in culture in a 
dose-dependent manner (Liebmann et al. 2010), although blue light also 
stimulates the metabolic activity of cultured human dermal fibroblasts (Mignon 
et al. 2017) and outer root sheath keratinocytes (Buscone et al. 2017), following 
one exposure at 2 J/cm2 or 3.2 J/cm2 respectively. Since the expression of the 
photoreceptors OPN2 and OPN5 was seen to be cell type specific (Figure 3-1 
and 3-3), this could have an impact on the response of epidermal keratinocytes 
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and dermal fibroblasts to the same light parameters. A comprehensive 
screening of the effect of light of different wavelengths and radiant exposures 
on metabolic activity has been reported recently for dermal fibroblasts by 
Mignon and co-workers (2017), however, it has never been studied in primary 
human epidermal keratinocyte cultures.  
Since the metabolic activity of human dermal fibroblasts has already 
shown to be impacted by photobiomodulation (Mignon et al. 2017), this was the 
first response chosen to assess the effect of different wavelengths and radiant 
exposure on primary human epidermal keratinocytes.  
Interestingly, a dose-dependent response in terms of metabolic activity of 
keratinocytes following exposure to different wavelengths of light was seen 
(Figure 3-6 and 3-7). For blue (447nm) and cyan (505nm) light similar results 
were found; 2 J/cm2 induced metabolic activity of epidermal keratinocytes while 
30 J/cm2 had no effect (Figure 3-6). This effect would be due to different 
molecular mechanisms, since there are a large number of photoreceptors which 
absorb short-wavelength light. For example, CCO has different peaks of 
absorption throughout the visible spectrum, one of them is at 400 nm in the blue 
light region (Karu 1999). However, this starts decreasing at longer wavelengths, 
so that its ability to absorb green light is less than blue and cyan light. CCO is 
part of the respiratory chain of mammalian cells and blue light can increase its 
activity leading to an increase in ATP synthesis (Hamblin and Demidova 2006), 
ROS production  and NO bioavailability (Poyton and Ball 2011), leading 
eventually to the increase in metabolic activity at low doses of blue and cyan 
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light seen in this study (Figure 3-6). However, CCO is not the only 
photoreceptor present in primary human epidermal keratinocytes. The current 
study has demonstrated that the expression of OPN1-SW, OPN3 and OPN5 is 
retained in cultured epidermal keratinocytes in culture (Figure 3-3 and 3-4). 
Since an increase in metabolic activity was stimulated with light at 447 nm, 505 
nm, but not at 530 nm, this may be mediated partially by OPN1-SW or OPN3 as 
they have their peaks of absorption at 430 and 465 nm respectively, which is 
close to the wavelength of light which stimulated the metabolic activity of 
keratinocytes (Figure 3-6). Furthermore, OPN5 may also be involved since it 
has been shown to be capable of absorbing light at 447 nm after 
photoconversion following UV stimulation (Kojima et al. 2011). OPNs have been 
shown to respond to short wavelength light in different skin cells including 
melanocytes (Wicks et al. 2011; Regazzetti et al. 2017), epidermal 
keratinocytes (Kim et al. 2013) and outer hair follicle root sheath keratinocytes 
(Buscone et al. 2017). They induce Ca2+ signalling (Wicks et al. 2011) and 
regulate circadian clock photoentrainment (Do and Yau 2010). Circadian clock 
is a central regulator of metabolic activity in all different type of cells including 
keratinocytes (Spörl et al. 2011) which could explain the changes in metabolic 
activity of keratinocytes seen in this study (Table 3-6). Furthermore, short 
wavelength light can induce ROS production, for example by the FAD group of 
CRYs (Hoang et al. 2008) which could therefore, affect expression of circadian 
clock genes (CCGs) (Gauger and Sancar 2005). Finally, the activation of ion 
channels were found to be mediated by both blue and green light (Wang et al. 
2016) in human adipose-derived stem cells. However, since green light did not 
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modulate the metabolic activity of keratinocytes (Figure 3-6), activation of ion 
channels is not likely to be involved in this effect. 
With exposure to long wavelength light, a biphasic dose-dependent 
response in metabolic activity was also found. However, in this case, the 
stimulation of metabolic activity was also seen at the higher doses. For red 
(655nm) light, stimulation of metabolic activity was found at doses of both 3.2 
and 30J/cm2, while there was no effect with the higher dose of 200 J/cm2 
(Figure 3-7). NIR (850nm) light stimulated epidermal keratinocyte metabolism at 
60J/cm2, but suppression of metabolism was seen at extremely high doses, 250 
J/cm2 (Figure 3-7). This effect can probably be explained by the already 
established mechanism suggested by Karu and co-workers (2005), CCO which 
can also absorb red and NIR light. This protein is part of the respiratory chain of 
mammalian cells, which can increase its activity leading to an increase in ATP 
synthesis (Hamblin and Demidova 2006), ROS production  and NO 
bioavailability (Poyton and Ball 2011), which eventually, will induce gene 
expression through the NF-κB  and AP-1 transcription factors, which leads to 
production of growth factors, extracellular matrix deposition, cell motility and cell 
metabolism and the reduction of cell apoptosis (Hamblin and Demidova 2006). 
All these beneficial effect of red and NIR light are able to improve wound 
healing; for example, red light has been shown to induce interleukin-1 (IL-1) and 
8 (IL-8) production by adult foreskin keratinocytes, two essential interleukins 
during the initiation of the inflammatory phase of wound healing (Yu et al. 1996), 
while clinical studies have proposed the use of red and NIR light as an 
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adjunctive therapy for split-thickness skin grafting in burn patients with diabetic 
ulcers (Dahmardehei et al. 2016). 
However, increasing radiant exposure to higher levels, ATP and ROS 
increase above the necessary levels (Huang et al. 2009; Chen et al. 2011), 
producing a negative effect on metabolic activity of epidermal keratinocytes.  
4.3 Effect of blue and red light on migration of human primary 
epidermal keratinocytes 
Since OPNs have their absorption peak at wavelengths between 360-465 
nm (UV and blue light) and blue light increased the metabolic activity of primary 
keratinocytes (Figure 3-6), this makes blue light a promising wavelength at low 
and high doses to further investigate the effect of light on keratinocyte 
migration. While OPNs are not able to absorb red light, since red light also 
stimulated metabolic activity (Figure 3-7), and there is a large amount of 
literature supporting the use of red light to improve wound healing (Mignon et al. 
2016; Yadav and Gupta 2017), its effect on migration was also studied.   
Previous studies have reported that low doses of blue light (up to 10 
J/cm2) does not modulate migration of  primary human dermal fibroblasts in 
culture (Masson-Meyers et al. 2016; Oh et al. 2017), or the human fibrosarcoma 
cell line HT10-80 (Oh et al. 2017). However, higher doses of blue light between 
30 to 80 J/cm2 have a negative effect on migration of dermal fibroblasts 
(Masson-Meyers et al. 2016), while migration of the human fibrosarcoma cell 
line HT10-80 is inhibited at even lower doses, 11 J/cm2 (Oh et al. 2017). This 
current study is the first report the effect of blue light on primary human 
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epidermal keratinocyte migration. Since the response was similar to published 
studies on primary dermal fibroblasts (Mamalis et al. 2015a; Masson-Meyers et 
al. 2016; Oh et al. 2017) this suggests similar molecular mechanism in both cell 
types may be involved in this response. Low doses (2 J/cm2) of blue light did 
not modulate epidermal keratinocyte migration, while higher doses (30 J/cm2) 
reduced the speed of epidermal keratinocyte migration by approximately 20% 
after 12h and 21h in a scratch-wound assay (Figure 3-8). Although OPN1-SW 
and OPN3 are both present in primary epidermal keratinocytes, as well as in 
dermal fibroblasts, so that they could be mediating the decrease in migration of 
these cell types, the doses of light producing this effect are high. This suggests 
that a chemical, rather than a biological effect might be involved, such as the 
increase in ROS production after blue light irradiation seen in primary dermal 
fibroblasts (Mamalis et al. 2015a). While ROS was increased by blue light as 
low as 5 J/cm2, the effect was dose-dependent, reaching levels that could 
impact on migration following exposure to 30 J/cm2 of blue light (Mamalis et al. 
2015a). An increase in ROS production has been demostrated in the 
keratinocyte HaCaT cell line after high irradiation with 41 J/cm2 of blue light 
(Becker et al. 2016). No positive effect of blue light in migration has been shown 
with any of the doses used in this study, similarly to what was found in primary 
dermal fibroblasts (Figure 3-8). Although blue ligh is not the right wavelength to 
induce migration and re-epithelialisation during wound healing, the absence of 
inhibition of migration with low doses of blue light (2 J/cm2) (Figure 3-8) makes 
blue light an interesting wavelength for treatment during other stages of the 
wound healing process; for example, blue light has been shown to prevent 
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infection during the inflammatory phase of wound healing (Lipovsky et al. 2010; 
Dai et al. 2013), as well as prevent scarring during the long and last 
remmodelling phase of wound helaing through the effect of blue light in the 
fibroblasts residing in the dermis (Mamalis et al. 2015a). Other type of skin 
conditions could also be improved by blue light treatment by directly targeting 
the epidermal keratincytes such as psoriasis (Weinstabl et al. 2011). Athopic 
dermititis can also improve with blue light treatment although exact machanism 
of action has not been uncovered yet (Becker et al. 2011).  
The effect of red light on keratinocytes has previously been studied; a 
helium neon laser (632.8 nm) increased migration of primary human 
keratinocytes after three treatments of 0.8 J/cm2 each (Haas et al. 1990). A 
more recent study on the HaCaT keratinocyte cell line showed an increase in 
migration after exposure to 0.6 J/cm2 of red light (638 nm) after 24h in a 
scratch-wound assay (Fushimi et al. 2012). On the other hand, very high doses 
of red light have been shown to decrease the migration of primary human 
dermal fibroblasts at 320 to 640 J/cm2 (Mamalis et al. 2015b). However, impact 
of doses between 2 to 200 J/cm2 of red light in keratinocyte migration has never 
been established. Although metabolic activity increased after red light treatment 
at 30 J/cm2 (Figure 3-7), no significant effect was observed on cell migration 
(Figure 3-8) at either 12 or 21h after light treatment. While red light is known to 
be absorbed by CCO (Karu and Kolyakov 2005), and has been shown to induce 
wound healing in vivo (Minatel et al. 2009; Kajagar et al. 2012) through the 
activation of NF-κB and AP-1 transcription factors, 30 J/cm2 of 656 nm light did 
not modulate migration of primary human epidermal keratinocytes in culture 
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(Figure 3-7). As response to light normally follows a biphasic dose response 
(Huang et al. 2009), it is possible that this dose is too high to have a beneficial 
effect on keratinocyte migration, but not enough to produce a negative effect. A 
wider range of doses of red light on the migration of epidermal keratinocytes 
need to be studied in order to better understand the biphasic dose response of 
this effect and identify whether there is a stimulatory dosage-range as it has 
been suggested (Haas et al. 1990; Fushimi et al. 2012). It is possible that since 
photobiomodulation effects are normally small, differences are difficult to 
establish in a scratch-wound assay and more sensitive assays, such as the 
Boyden chamber assay is required. Furthermore, photobiomoduluation has 
shown to improve the inflammatory phase of wound healing due to its anti-
inflammatory effects in vivo (Hamblin 2017). Therefore, more relevant models, 
such as co-cultures with dermal fibroblasts or macrophages and lymphocytes, 
or a human ex vivo wound healing model would be required to further test the 
effect of red light in re-epithelialisation. Cell communication in the skin, an organ 
with a high amount of different cell types, is essential for a proper wound 
healing response (Werner et al. 2007).  
Finally, blue light (453 nm) at low doses (2 J/cm2) increased the 
percentage of KRT10 positive cells (Figure 3-9), while the percentage of EdU 
positive cells was decreased (Figure 3-9), a dye which is incorporated only by 
cells synthesising DNA during the S phase of the cell cycle. Interestingly, these 
light parameters were previously shown to increase the metabolic activity in 
terms of redox potential of epidermal keratinocytes (Figure 3-6), which would 
enable epidermal keratinocytes to leave the cell cycle and go into differentiation 
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(Wanet et al. 2015). Interestingly, Buscone and co-workers (2017), also 
reported an increase the metabolic activity of outer root sheath hair follicle 
keratinocytes in response to 3.2 J/cm2 blue light, however, it induced 
proliferation in these cells as measure by EdU incorporation assay. This 
difference in response is possibly related to the different function of epidermal 
keratinocytes in comparison to outer root sheath hair follicle keratinocytes. 
While epidermal keratinocytes undergo continuous self-renewal, outer root 
sheath keratinocytes are more quiescent cells and have less proliferative 
potential (Tanaka et al. 1998). Other published studies using primary human 
epidermal keratinocytes reported an increase in early differentiation under low 
level blue light (5 J/cm2), while only high doses (66 and 100 J/cm2) induced late 
differentiation (Liebmann et al. 2010). Furthermore, blue light has also been 
reported to delay epidermal barrier recovery in mice in vivo (Denda and 
Fuziwara 2008), which support the anti-proliferative and pro-differentiation effect 
of blue light seen in this study. In general, the anti- proliferative effect of blue 
light as well as the blue light induced differentiation suggest the use of blue light 
to be more suitable for the treatment of psoriasis, and fibrotic skin conditions, as 
well as to prevent keloids or hypertrophic scar formation in the latter stages of 
wound healing. 
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4.4 Physiological significance of OPN3 and CRY1 in primary 
skin cells 
A good understanding of the function of photoreceptors in skin is key to 
determine whether they have a role in photobiomodulation of human skin. This 
study has confirmed the expression of OPN3 in human facial and abdominal 
skin (Figure 3-1), but beyond the skin, OPN3 has been reported to be widely 
expressed in non-photoreceptive tissues such as brain, testis, liver, placenta, 
heart, lung, skeletal muscle, kidney and pancreas (Terakita 2005). However, the 
specific function of OPN3 in human cells, and specifically in the human 
epidermis is unclear.  
CRY1 and CRY2 are two important transcription factors that are part of the 
molecular transcription loop of the circadian clock. They may also be involved in 
light reception, either directly as suggested by Hoang et al., (2008), or indirectly 
by regulating the circadian clock after photoentrainment by another 
photoreceptor such as one of the OPNs (Poletini et al. 2015).   
4.4.1 The synchronisation and transfection conditions of 
cultured cells 
4.4.1.1 Synchronisation of cultured human primary dermal 
fibroblasts 
As a result of the involvement of CRYs in the peripheral clock of human 
skin (Plikus et al. 2015) and the inconsistency of localisation of CRY1 in non-
synchronised epidermal keraitnocytes in culture (Table 3-2), synchronisation of 
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primary cell cultures is desirable to further study the mechanism of action of 
OPN3, CRY1 and CRY2.  
Unlike other organisms such as drosophila and zebrafish, mammalian 
peripheral clocks are entrained by neuronal and hormonal signals, whose 
production is controlled by the SCN pacemaker (Balsalobre et al. 2000). In 
culture, primary cells maintain circadian oscillations but they lose their 
synchrony which is regulated by the SCN in vivo. Therefore, an input signal that 
synchronises circadian clock gene expression is needed. Previous studies have 
shown that clock gene expression was induced by serum shock and oscillations 
were maintained for three days in serum-free conditions in rat-1 fibroblasts and 
H35 hepatoma cell lines (Balsalobre et al. 1998). It has also been hypothesised 
that one or more blood-borne factors are responsible for clock gene stimulation, 
therefore another study has shown that glucocorticoid hormones, specifically 
dexamethasone can entrain the circadian clock in rat dermal fibroblasts in 
culture (Balsalobre et al. 2000).  
To determine the best way of synchronisation of human skin cells, the 
effect of different methods of synchronisation on circadian clock gene 
expression in human dermal fibroblasts derived from facial skin was analysed 
by RT-qPCR. Cells were treated with either dexamethasone (dex), serum 
starvation (SS) or 10% FBS (S+) to establish whether the circadian clock is 
synchronised in culture. Ideally a number of time points should be analysed to 
determine a typical circadian curve of mRNA expression (Benegiamo et al. 
2016). Although the total RNA expression of clock genes was only analysed 
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after 4h and 24h, the data shows different levels of expression at these two time 
points for CRY1, PER1 and BMAL1 following all three synchronisation 
conditions (Figure 3-10), indicating that the expression of clock gene are cycling 
in vitro after a successful synchronisation. In non-synchronised cells, the level 
of expression of clock genes varies from cell to cell,  making it more difficult to 
establish differences in expression at different time points, as reported for rat-1 
fibroblasts (Balsalobre et al. 2000). Synchronised cultures of dermal fibroblasts 
(Balsalobre et al. 2000) and epidermal keratinocytes (Janich et al. 2013) 
showed a drop in clock gene expression between 4 and 24h after 
synchronisation. Similarly, dermal fibroblasts in this study showed a dramatic 
drop in gene expression of CRY1, PER1 and BMAL1 between 4 and 24h after 
synchronisation with serum starvation or Dex (Figure 3-10), while cells 
incubated with 10% FBS (S+) only showed a similar drop in level of expression 
of BMAL1. Only small or non-significant differences in CRY2 mRNA expression 
was seen between 4 and 24 h after synchronisation, which could be a 
consequence of similar oscillation levels of CRY2 at the selected time points 
(Figure 3-10), illustrating the need of extra time points in order to study 
circadian clock oscillations.    
These results demonstrate that synchronisation in similar in response to 
SS or Dex groups. However, glucocorticoids both natural and synthetic have a 
huge impact on skin physiology (Zouboulis 2004), while they have significant 
anti-inflammatory properties, they can also result in dermal atrophy because of 
their effect on dermal fibroblasts, producing less collagen and elastin (Kahari et 
al. 1995). Due to the possible indirect impact of dexamethasone in skin 
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physiology, serum starvation appears to be the best method of synchronisation 
of human primary dermal fibroblasts. 
4.4.1.2 KL001 and longdaysin modulate the circadian clock in 
cultured dermal fibroblasts: changes in expression of 
circadian clock genes 
In order to investigate whether the circadian clock of primary dermal 
fibroblasts in culture can be modulated pharmacologically, two different 
molecules were identified and used; longadaysin (LD) and KL001. Both are 
pharmacological tools developed to regulate the CRY/PER feedback loop of the 
molecular clock; LD is a casein kinase I (CKI) inhibitor, preventing PER protein 
degradation (Hirota et al. 2010), while KL001 prevents the degradation of both 
cryptochromes through FBXL3, stabilising the proteins (Hirota et al. 2012) 
(Figure 1-12). Previously, LD has been shown to modulate circadian clock 
mRNAs and protein oscillations at concentrations of 3 and 9 µM (Hirota et al. 
2010), while KL001 has been reported to downregulate mRNA of CRY1, CRY2, 
PER1 and PER2 at concentrations between 0.9 to 8 µM in the human epithelial 
osteosarcoma cell line U2OS, although it had no effect on CLOCK and BMAL 
(Hirota et al. 2012).  
Circadian clock mRNA expression was assessed in serum-starved 
synchronised and scratched cultures of dermal fibroblasts 36 h after 
synchronisation/scratching. KL001 at 8 µM strongly downregulated most of the 
clock genes except for CLOCK (Figure 3-11). This confirms that KL001 can 
modulate clock genes in cultured dermal fibroblasts. At the same time, it also 
reflects the robustness of this biological network, as no change was seen in the 
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expression of CLOCK, one of the core circadian clock genes. These data are 
consistent with the effect of KL001 in U-2 OS cells, with the exception of 
BMAL1.  BMAL1 is the other circadian clock core protein of the molecular clock 
machinery, which was downregulated in primary dermal fibroblasts, while 
KL001 reputedly did not modulate changes in BMAL1 expression in U-2 OS 
cells (Hirota et al. 2012), so that primary dermal fibroblasts seem to be more 
susceptible than U-2 OS cells to experience circadian clock changes. Contrary 
to KL001, LD upregulated most clock genes studied; CRY1, PER1, PER2 and 
PER3 with the exception of BMAL1, which was down regulated. All clock genes 
showed a higher level of expression in cells treated with LD in comparison to 
the ones treated with KL001 (Figure 3-11). While both compounds have been 
shown to lengthen the circadian clock (Hirota et al. 2012), this cannot be 
confirmed with the present data, however the effect of both compounds in 
modulating the circadian clock was verified in dermal fibroblasts reflecting their 
differential mechanisms of action on clock gene expression 36 h after scratch-
wounding. This differential effect of KL001 and LD in dermal fibroblasts is in 
agreement with the effect seen in the human embryonic kidney cell line, 
HEK293 by St John and co-workers (2014). The HEK293 cell line constitutively 
expressed the PER1-LUC and CRY1-LUC reporters; levels of PER1-LUC were 
only increased by LD, while levels of CRY1-LUC were repressed by KL001 (St 
John et al. 2014). This data confirms that although both pharmacological tools 
can modulate the CRY-PER feedback loop of the circadian clock, the fact that 
KL001 inhibits FBXL3 while LD inhibits CKI (Figure 1-12), results in a different 
type of regulation of circadian clock oscillations, not only in cell lines such as 
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HEK293 or U-2 OS, but also in primary human dermal fibroblasts in culture 
(Figure 3-11). This will probably impact circadian clock functions of human 
dermal fibroblasts in a different way, showing a different therapeutic potential for 
treatment of circadian clock disorders. Interestingly, KL001 was proposed to be 
used for diabetes as a result of the KL001 control of fasting hormone-induced 
gluconeogenesis in U-2 OS cells (Hirota et al. 2012). However, more work has 
to be done in order to use these drugs pharmaceutically. In the meanwhile, they 
are an extremely good tool for the study of circadian oscillations in primary cells 
in culture.  
4.4.1.3 Viability of transfected epidermal keratinoctyes with 
lipofectamine-siRNA complexes 
Synchronisation of the circadian clock (Figure 3-10) and its modulation 
with KL001 and LD (Figure 3-11) has been confirmed in primary dermal 
fibroblasts. However, there is a high level of expression of OPNs and CRYs in 
epidermal keratinocytes and a lack of knowledge of the effect of light on primary 
keratinocytes in comparison with dermal fibroblasts; therefore, the effect of 
OPN3 and CRY1 knockout was studied in primary human epidermal 
keratinocytes.  
The only way to specifically control OPN3 and CRY1 expression is with 
siRNA technology (Dana et al. 2017). siRNA technology can target OPN3 and 
CRY1 only by the design of specific siRNA sequences against the RNA of 
interest. Following the transfection protocol previous described (Section 2.9.3), 
the cell viability of non-transfected keratinocytes (negative control), 
keratinocytes transfected with no siRNA (lipofectamine control), transfected with 
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non-target siRNA (NTR) control and keratinocytes transfected with siRNA 
against OPN3 (siOPN3), were compared. The viability of primary human 
epidermal keratinocytes decreased as soon as lipofectamine® RNAiMAX was 
added (Figure 3-12), similar to what has been reported in other cell types, e.g. 
the MCF-7 cell line (Majid et al. 2002). However, no differences were found 
between the lipofectamine control, NTR control and siOPN3 treated 
keratinocytes (Figure 3-12), where viability remained above 60% in all cases 
(Figure 3-12). Therefore, transfection using siRNA technology is a useful 
approach to further study photoreceptors in primary human epidermal 
keratinocytes.  
4.4.2 OPN3 and CRYs regulation in synchronised epidermal 
keratinocytes 
4.4.2.1 Transfection efficiency and effect of KL001 in primary 
epidermal keratinocytes  
While the effect of 8 µM of KL001 on the expression of clock genes in 
primary dermal fibroblasts has been confirmed (Figure 3-11), its effect on 
primary epidermal keratinocytes is unknown.  
Knockdown of OPN3 was highly efficient (Figure 3-13, A) with 
keratinocytes treated with siOPN3 showing an 83% reduction of OPN3 mRNA 
expression in comparison to the non-target siRNA control (NTRC). Interestingly, 
efficiency of CRY1 silencing, although still significant was not as high at 66% 
(Figure 3-13, B). The same conditions were followed for silencing both proteins 
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so the different results may be due to different specificity of the siRNA 
sequences to the different proteins (Kurreck 2006).  
Interestingly, KL001 treatment downregulated both CRYs in scratched 
epidermal keratinocytes 24 h after serum synchronisation (Figure 3-13, C), as 
was also demonstrated in primary fibroblasts (Figure 3-11). In response to 
KL001, there was a 71% reduction in CRY1 mRNA expression, while CRY2 
mRNA was reduced by 40% (Figure 3-13, C). This difference implies a different 
molecular mechanism for both CRYs. Although both can be degraded through 
FBXL3, CRY2 is also able to go through a double phosphorylation in the 
Ser557/Ser553, which triggers an FBXL3-independent mechanism for 
proteasomal degradation in mice (Kurabayashi et al. 2010; Lowrey and 
Takahashi 2011). Therefore, under the action of KL001, CRY2 still may be able 
to go through proteosomal degradation unlike CRY1, which may explain the 
different level of downregulation of the two CRYs after KL001 treatment.  
4.4.2.2 Knockdown of OPN3 modulates CRY1 expression, while 
KL001 upregulates OPN3 
In order to have a better understanding of the molecular mechanisms 
behind the knockdown of OPN3 and KL001 treatment, the level of expression of 
the photoreceptors, OPN3, CRY1 and CRY2 was investigated after the scratch-
wound assay was on silenced and KL001 treated epidermal keratinocytes 
(section 3.4.2.2).  
Interestingly, silencing of OPN3 induced levels of expression of CRY1, 
while KL001 treatment induced expression of OPN3 (Figure 3-14, A and B). 
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One possible mechanism which could connect OPN3 to circadian clock 
regulation is through the activation of the cAMP-responsive element (CRE), 
which has been found in the promoter region of PER1 and PER2 in the HuH-7 
human hepatoma cell line (Motzkus et al. 2007), and in the SCN of mice (O'Neill 
et al. 2008) (Figure 4-1, A). Although CRE elements have not been found in the 
CRY promoter yet (Koyanagi et al. 2011), it may be possible they also exist in a 
similar way to the PER promoter. Alternatively, the changes produced by CREB 
proteins in PER mRNA expression are likely to affect CRY1 expression as a 
consequence. Furthermore, activation of CREB signalling pathway may happen 
through different mechanisms; e.g. cAMP signalling, Ca2+ signalling, and Ras 
signalling (Figure 4-1, A). Both cAMP and Ca2+ signalling are regulated by 
GPCRs (Figure 4-1, B) (Syrovatkina et al. 2016). Indeed, it has been reported 
that knockdown of OPN3 blocked the calcium flux and the phosphorylation of 
CREB and Ca2+/calmodulin-dependent protein kinase II (CAMKII) in human 
epidermal melanocytes in both non-irradiated and blue light-irradiated cultures 
(Regazzetti et al. 2017), which was probably mediated by Go protein (Table 4-
1).  Furthermore, OPN2 has been shown to contribute to the induction of UV-
dependent Ca2+ mobilisation in epidermal melanocytes (Wicks et al. 2011). In 
human epidermal keratinocyte, a non-canonical OPN2 signalling pathway 
mediated through Gi protein has been reported (Kim et al. 2013) (Table 4-1). 
Therefore, CREB signalling may be involved in the upregulation of CRY1 seen 
after silencing of OPN3 in primary epidermal keratinocytes (Figure 3-14), which 
makes OPN3 a target for the regulation of the peripheral circadian clock of the 
epidermis. 
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Figure 4-1: Signalling pathway regulating the molecular clock in mammals.  
(A) Per1 promoter in mice includes three different regulatory elements; CRE element is 
regulated by phosphorylated CREB after cAMP, Ca2+ or Ras inputs. E-box is regulated by the 
clock transcription factors BMAL and CLOCK. The D element is regulated by the feedback of 
the clock output, through the proline and acidic amino acid– rich (PAR) and E4BP4 transcription 
factors. Adapted from Travnickova-Bendova et al., (2002). (B) GPCR through activation of 
adenylate cyclase and N-methyl-D-aspartate receptor (NMDAR) through activation of CAMKII 
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can induce phosphorylation of CREB to regulate PER and CRY expression in a CLOCK-
independent manner. Adapted from Golombek and Rosenstein (2010).  
Family 
Gα 
protein 
Pathway Opsins (OPNs) 
I 
Gs 
Activation of AC NA 
Golf 
II 
Gi 
Inhibition of AC 
Independent kinases 
actions: activation of K+ 
channels 
OPN2 (Kim et al. 2013) 
OPN3 (Koyanagi et al. 
2013) and OPN5 
(Yamashita et al. 2010) 
Go 
Activation of PLC and 
increase in Ca2+ 
Independent kinases 
actions: activation of K+ 
channels&inhibition of 
Ca2+ channels 
OPN3 (Koyanagi et al. 
2013; Regazzetti et al. 
2017) 
 
Gt 
Activation of cGMP 
phosphodiesterase 
OPN1 and OPN2 
(Terakita 2005) 
III Gq 
Activation of PLC and 
Ca2+ increase 
OPN4 (Koyanagi and 
Terakita 2008) 
IV G12-13 
Activation of GTPases of 
the Rho family 
NA 
Table 4-1: OPNs activate different type of Gα proteins which are in charge of 
different downstream signalling pathways.  
The activation of adenylyl cyclase (AC) by Gs or Golf induces the intracellular cAMP levels and 
phosphorylates CREB. Go and Gq activate the inositol phospholipid signalling pathway through 
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phospholipase C (PLC), increasing the intracellular Ca2+ concentration and activating different 
protein kinases such as CAMKII, which can also phosphorylate CREB . The activation of cGMP 
phosphodiesterase by Gt closes Na+ channels creating an electrical signal. G12-13 activates a 
monomeric GTPase of the Rho family which alters the active cytoskeleton. Adapted from 
Alberts et al., (2007). NA indicates not applicable. 
Knockdown of CRY1 did not induce a significant change in OPN3 
expression (Figure 3-14, A), suggesting there is no feedback in the regulation of 
OPN3 and CRY1. However, an upregulation of CRY2 was seen in order to 
compensate for the lack of CRY1, in a similar manner to what was previously 
reported in the U-2 OS cell line (Baggs et al. 2009).  
Finally, differences in expression of photoreceptors between KL001 
treatment in non-silenced and silenced cells was only found for OPN3 mRNA 
expression, presumably as a result of the knockout of OPN3. However, there 
were no differences in the expression of CRY1 or CRY2 (Figure 3-14, A, B and 
C). Although knockdown of OPN3 suggests a role for OPN3 in mediating, or 
even gating the circadian clock oscillations of epidermal keratinocytes, it was 
not enough to reverse the effect of KL001 in the regulation of the expression of 
CRYs (Figure 3-14, B and C). This observation highlights the strong effect of 
KL001 in regulating CRYs, but it also discards the hypothesis of CRYs 
mediating the abrogation of the decrease in migration and increase in 
differentiation shown after knockdown of OPN3 in KL001 treated keratinocytes. 
In order to further understand the molecular mechanism behind those, 
chromatin immunoprecipitation sequencing (ChIP-Seq) of CREB in normal and 
OPN3 knockdown epidermal keratinocytes is recommended. This experiment 
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will show which genes are regulated by OPN3-CREB signalling, and whether 
they are related to keratinocyte migration and differentiation.  
4.4.2.3 Effect of OPN3 and CRY1 knockdown and treatment with 
KL001 on the migration of epidermal keratinocytes  
In order to elucidate whether OPN3, CRY1 or CRY2 have any role in the 
migration of epidermal keratinocytes, two strategies have been investigated; 
modulation of CRYs with the chemical KL001, and selected silencing of the 
photoreceptors OPN3 and CRY1. However, in order to have a better idea about 
the interconnection of these proteins, if any, a combination of KL001 with gene 
silencing was also performed.  
Knockdown of OPN3 or CRY1 did not have any effect on epidermal 
keratinocyte migration, suggesting that neither protein has a main role in the 
migration of keratinocytes. Although an impaired circadian clock has been 
previously shown to impair mouse wounds healing (Kowalska et al. 2013), 
silencing of only CRY1 would probably not be enough to affect oscillations of 
the core clock proteins BMAL1 and CLOCK, since the robustness of the 
circadian clock probably maintains some circadian oscillations, keeping the 
migratory ability of keratinocytes in place. Robustness of the circadian clock has 
previously been shown in the U-2 OS cell line, where BMAL1 oscillations were 
still present after knockdown of CRY1 (Baggs et al. 2009) but they were gone 
after knocking down both CRYs at the same time. However, this study shows 
how KL001 significantly inhibited migration of keratinocytes (Figure 3-15). 
Unlike direct silencing of CRY1, KL001 has been shown to stop PER2 
oscillations almost completely, while it lengthened the period and reduced the 
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amplitude of BMAL1 oscillations until they were also lost 72h later in   the U-2 
OS cell line (Hirota et al. 2012). A similar effect may be occuring in primary 
epidermal keratinocytes,  since the presence of KL001 but not the silencing of 
CRY1 inhibited keratinocyte migration (Figure 3-15). The molecular 
mechanisms by which disruption of circadian oscillations by KL001 could impact 
cell migration has not been identified, however a similar effect of KL001 was 
found in re-epithelialisation in mice retina (Xue et al. 2017). Interestingly, one of 
the propsed mechanisms was through the negative regulation of the mitotic 
rhythm of the corneal epithelium, which led to a decrease in both mitosis and re-
epithelialisation after wounding. Furthermore, an effect of KL001 on 
inflammation after wounding was also hypothesised as a result of the 
rhythmicity of different inflammatory cytokines, such as IL4RA and CXCL14 
(Gibbs et al. 2012; Plikus et al. 2015). 
Interestingly, silencing of OPN3 abrogated the effect of KL001 on 
keratinocyte migration (Figure 3-15). The molecular mechanism of this exciting 
observation will need further investigation. A direct effect of OPN3 in circadian 
clock could be behind this behaviour. OPN3 could activate downstream 
signalling pathways with the ability of regulating circadian clock genes such as 
the transcription factor cAMP response element-binding protein (CREB) 
(Motzkus et al. 2007). Another possibility is the indirect effect that knocking 
down OPN3 has on proliferation (Buscone et al. 2017) and inflammation (White 
et al. 2008) which could be responsible for reversing the delayed migration 
induced by KL001 (Figure 3-15). More specifically, silencing of OPN3 in the 
Jurkat cell line resulted in upregulation of interleukin 2 (IL-2) mRNA (White et al. 
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2008). Although IL-2 is mainly secreted by T helper cells and is required for 
survival of regulatory T cells (Barron et al. 2010; Sharma et al. 2011), so that, 
OPN3 might have a similar function in epidermal keratinocytes. Epidermal 
keraintocytes have not been shown to secreate IL-2, but OPN3 might induce 
the secreation of other interleukins with similar functions IL-7 or IL-15 (Gröne 
2002). An enzyme-linked immunosorbent assay (ELISA) after OPN3 silencing in 
epidermal kerainocytes would be recommended in order to investigate this 
hypothesis.  
4.4.2.4 Effect of siOPN3, siCRY1 and KL001 treatment on the early 
differentiation of epidermal keratinocytes  
In order to understand the mechanism behind the inhibition of epidermal 
keratinocyte migration after KL001 treatment and how knock down of OPN3 can 
abrogate that effect, mRNA was extracted 21 h after the scratch-wound to 
investigate any changes in the expression of genes for differentiation. It has 
been previously described that there is an induction of involucrin (INV), a late 
differentiation marker, in primary epidermal keratinocytes after silencing of 
CRY1 and CRY2, in addition to a reduction in the number of small colonies and 
an increase in the number of large colonies (Janich et al. 2013). This 
demonstrates a role for CRYs in the regulation of differentiation in epidermal 
keratinocytes (Janich et al. 2013) which may be the reason for the inhibition of 
migration in primary kerainocytes following treatment with KL001. However, the 
role of CRYs in the early differentiation of epidermal keratinocytes has never 
been studied. Knockdown of OPN3 did not modulate the expression of the early 
differentiation markers KRT1 or KRT10, however silencing of CRY1 upregulated 
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KRT10 (Figure 3-12, A and B respectively) in line with the increase of INV 
reported by Janich and co-workers (2013). KL001 upregulated both KRT1 and 
KRT10 expression suggesting a strong induction of early differentiation by this 
stabilisation of CRY. Since epidermal keratinocytes have to downregulate 
cytokeratins to enable motility (Haensel and Dai 2017), this may explain the 
delay in migration seen by KL001. Further evidence is provided by the 
observation that silencing of OPN3 in combination with KL001 also neutralised 
these effect on differentiation. On the other hand, since the knockdown of OPN3 
did not have a significant effect on KRT1 and KRT10 expression (Figure 3-12, A 
and B), the neutralisation of the KL001 effect on differentiation may be an 
indirect consequence of the knock down of OPN3, possibly through the 
circadian clock.    
4.4.3 The role of OPN3 and the circadian clock in the blue light 
response of epidermal keratinocytes  
To establish whether the modulation of keratinocytes by blue light is 
modulated by OPN3 or the circadian clock, the effect of low doses of blue light 
(2 J/cm2) on the differentiation and proliferation of OPN3-knockdown and 
KL001-treated keratinocytes was investigated.  
Interestingly, the decrease in DNA synthesis induced by blue light (Figure 
3-9) also occurred in OPN3 knockout keratinocytes, but not in KL001 treated 
cells, indicating that OPN3-independent circadian clock oscillations mediate the 
blue light inhibition of DNA synthesis in epidermal keratinocytes (Figure 3-18). 
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In contrast, the increase in keratinocyte differentiation after blue light 
irradiation already reported (Figure 3-9) was only seen in the non-target siRNA 
control cells, but not in OPN3 knockout keratinocytes, KL001 treated 
keratinocytes or OPN3 knockout in combination with KL001 (Figure 3-19). This 
indicates the role of OPN3 and circadian clock in mediating early differentiation 
of epidermal keratinocytes after blue light irradiation (Figure 4-2), in a similar 
manner OPN2 induces differentiation of epidermal keratinocytes following 
irradiation with violet-light (Kim et al. 2013). 
Circadian clock has shown to regulate cell cycle at the G1/S, G2/M and 
mitosis checkpoints. Interestingly, one of the checkpoints which is highly 
affected by circadian oscillations is the restriction point G1/S through the 
regulation of CSK-homologous kinase1/2 (CHK1/2) proteins, p21 and NONO 
(Kowalska et al. 2013). Furthermore, Per1/Per2 knockout mouse showed 
defects in wound healing mainly related to re-epithelialisation, dermal 
organisation and collagen deposition (Kowalska et al. 2013). In conclusion, the 
circadian clock and DNA synthesis downregulation by 2 J/cm2 of blue light 
might probably happen through any of the G1/S checkpoints and could have a 
negative impact in re-epithelialisation and wound healing. The use of blue light 
seems to have a great potential to reduce proliferation and DNA synthesis for 
hiperproliferative chronic wound edges or psoriatic skin. However, the 
investigation of lower doses of blue light, and its translation ex vivo and in vivo 
would be useful to understand whether blue light could have a proliferative 
effect through circadian clock regulation of the skin in humans. For example, 
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DNA synthesis of outer root sheath keratinocytes was stimulated after blue light 
irradiation (Buscone et al. 2017) as previously discussed.  
 
Figure 4-2: Blue light induction of early differentiation in human primary epidermal 
keratinocytes.  
OPN1-SW, OPN3 and OPN5 expression in primary epidermal keratinocytes. OPN3 is able to 
respond to blue light and activate the Go signalling pathway which led to the phosphorylation of 
CREB and regulation of CRY1 and CRY2 circadian oscillations to finally induce early 
differentiation of primary human epidermal keratinocytes in culture. Dotted arrows indicate 
findings reported in literature, full arrows indicate findings reported in this study.    
4.5 Effect of blue and red light in a human ex vivo wound 
healing model  
Scratch assays have been shown to mimic cell migration during wound 
healing especially in terms of cell-matrix and cell-cell interactions in 
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epithelial/endothelial cells (Liang et al. 2007). However, they do not recapitulate 
the whole physiology of keratinocytes in vivo as a result of different gene 
expression profiles (Katayama et al. 2015), and lack of communication with 
other skin cells such as fibroblasts, melanocytes and immune cells. To 
overcome these issues, an ex vivo human skin wound healing model was 
modified from Stojadinovic and Tomic-Canic (2013). Expression of OPN1-SW, 
OPN3 and OPN5 in the migrating epithelial tongue and blue and red light 
effects were studied using this more representative model.  
4.5.1 Epidermal KRT17 expression is increased in ex vivo wounds 
after two days in culture 
Human ex vivo wound healing models are difficult to establish. The lack 
of blood flow makes it difficult for oxygen and nutrients to diffuse inside the 
tissue. Irregularities while making the wound will consequently have a 
significant impact in accessibility to all these important factors and influence the 
wound healing response. Because of this, confidence and reliability of the 
model is very important. In order to confirm the appearance of re-
epithelialisation the epithelial tongue was identified after two days in culture by 
H&E staining (Figure 3-20). In addition, the expression of the re-epithelialisation 
markers KRT17 and KRT14 was also analysed. Induction of KRT17 normally 
occurs in activated keratinocytes thereby makes this an excellent marker for re-
epithelialisation (Stojadinovic and Tomic-Canic 2013). Furthermore, while 
KRT14 is normally expressed in the basal layer of the epidermis it is also 
upregulated during re-epithelialisation of human skin ex vivo (Mendoza-Garcia 
et al. 2015). The expression of KRT17 in the epidermis of ex vivo wounded skin 
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was confirmed in this study (Figure 3-20). KRT17 was present in the basal layer 
in basal keratiocytes in epidermis of wounds at day 0, although expression was 
not as prominent as for KRT14 (Figure 3-20, A). After 2 days in culture, 
expression of both KRT17 and KRT14 was found in the new epithelial tongue 
as well as all thoguhout the sourranding epidermis (Figure 3-20, B and C). 
These results verified that the cell phenotype was comparable to migrating 
keratinocytes seen in wound repair (Pastar et al. 2014; Mendoza-Garcia et al. 
2015) and therefore validating the use of this model to study re-epithelialisation 
in human wound healing. 
4.5.2 Expression of photoreceptors in the epithelial tongue of human 
ex vivo wounds 
Once the ex vivo wound healing model was successfully established, two 
techniques were used to identify photoreceptors in the newly formed epithelial 
tongue; mRNA expression after laser microdissection of the epithelial tongue 
(Figure 3-21) and immunohistochemistry of OPN1-SW, OPN3 and OPN5. The 
expression of mRNA for OPN3 and CRY1 was confirmed by the melt curves 
from the RT-qPCR reaction (Figure 3-22 B and D respectively). However, no 
amplification of mRNA was seen for OPN1-SW, OPN5 and CRY2 (Figures 3-22 
A, C and E respectively). These transcripts were the most difficult to amplify in 
primary keratinocytes in culture by RT-qPCR, where amplification only occurred 
during the last cycles. This may indicate the low abundance of the transcripts of 
interest, and why there was no amplification of mRNA in the epithelial tongue. 
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Photoreceptor protein expression was also confirmed by 
immunofluorescence. In agreement with the RT-qPCR data, OPN3 was present 
in the epithelial tongue. Interestingly, the OPN1-SW and OPN5 proteins were 
also expressed in the epithelial tongue. The presence of OPN3 mRNA and 
protein suggests a role for this receptor in re-epithelialisation. While OPN1-SW 
and OPN5 were not detected at the mRNA level, protein expression was 
confirmed by immunohistochemistry. The low abundance of the OPN1-SW and 
OPN5 transcripts may explain why they were not identified by RT-qPCR, but 
were still detectable at the protein level.  Further quantification of OPN1-SW 
and OPN5 expression could be done with another technique such as a Western 
Blot after detachment of the epidermis from the dermis of ex vivo wounds, with 
non-wounded ex vivo epidermis included as a negative control.  
4.5.3 The effect of blue and red light on wound closure  
In order to potentially translate light therapy to in vivo treatments, the 
same light parameters studied in human primary epidermal keratinocytes in 
culture were used for the ex vivo models; 2 and 30 J/cm2 of blue light and 30 
J/cm2 of red light.  
One of the main issues with ex vivo wounds was the reproducibility of the 
wounds. Even with standarised tools, the wound area varied from 3 to 15 mm2 
at day 0. Firstly, the rate of closure was analysed 2 and 5 days after wounding 
in non-irradiated controls to study differences in the speed of closure between 
donors under basal conditions. Donor 1 showed the highest speed of closure, 
0.132 mm2/h at day 2, while wounds generated from donor 2 showed closure 
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that was almost 3 times slower, 0.048 mm2/h, although tissue was from the 
same anatomical site and from women of a similar age (Table 3-3). These big 
differences could be technical, such as the length of time passed since the 
tissue was outside the body until it was put in culture (between 6 to 12 h), but 
mainly biological, such as variability between different donor material. Donor 
variability has been previously reported in skin ex vivo cultures, which may be 
due to different inflammatory responses induced by tissue removal (D'Orazio 
and Wolf Horrell 2014). Variation in speed of closure within donors was not 
such a big issue as standard deviation was always below 0.017 (Table 3-3), 
which makes the model reproducible. In general, the speed of closure 
decreased at day 5 (Table 3-3). This observation could be due to two main 
factors; first of all, few wounds appeared closed before day 5, which makes 
speed of closure less informative so that they have to be discarded. 
Furthermore, the decline in viability of the skin explants has been previously 
shown after 7 days in culture, while it remained viable during the first three days 
(Park et al. 2015). Probably, the loss of viability in the papillary dermis, the one 
less exposed to the environmental oxygen, will have a negative impact on the 
keratinocytes immediately above, reducing re-epithelialisaion. This extensive 
variability makes it difficult to interprete data from all donors together, therefore 
the effect of light was studied independently in each donor.   
Although different donors seemed to have a varied predisposition to the 
level of response to different light parameters, a similar trend was observed in 
the different donors. Furthermore, the results are in line with the scratch-wound 
assay; high doses of blue light slowed wound closure in Donor 1 after both 2 
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and 5 days in culture, however no significance was seen in Donor 3 (Figure 3-
23). This downregulation of wound closure with 30J/cm2 of blue light is less 
effective than in cells in vitro. This may be due to the fact that the ex vivo model 
presents a 3D organisation which includes all types of different skin cells 
(Lebonvallet et al. 2010) and therefore the induction of ROS by high doses of 
blue light, which has been reported in epithelial and dermal cells (Lockwood et 
al. 2005; Opländer  et al. 2013; Becker et al. 2016) is less effective than in 
isolated cells in culture, since there may be other mechanisms in place to 
counteract it. The mechanism of high doses of blue light to induce ROS has 
been shown by the direct effect of short wavelength light on flavoproteins and 
nitrosated proteins (Oplander et al. 2013).  
Although low doses of blue or red light did not influence keratinocyte 
migration in vitro (Figure 3-8), both light parameters induced wound closure in 
ex vivo wounds in Donor 2 after 2 days in culture (Figure 3-23). Red light also 
induced wound closure in Donor 1 at day 5 only, while low doses of blue light 
induced wound closure in donor 3 two days after wounding only (Figure 3-23). 
In contrast to the high doses of blue light, these two parameters seem to be 
more effective at stimulating re-epithelialisation in ex vivo wounds than in 
scratch wounds in vitro. However, molecular mechanism used by blue and red 
light are likely to be highly different.  
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4.5.4 Expression of the re-epithelialisation marker, KRT17 and the 
photoreceptors OPN3 and CRY1 in the epithelial tongue of ex 
vivo wounds after light treatment 
Expression of the re-epithelialisation marker KRT17 as well as the 
photoreceptors OPN3 and CRY1 were analysed by RT-qPCR in epithelial 
tongue RNA isolated from non-irradiated and irradiated ex vivo wounds after 
two days in culture. Expression of KRT17 was highly expressed in all samples 
analysed (Figure 3-24), indicating a normal re-epithelialisation process. 
Activation of KRT17 happens immediately after wounding and is required for re-
epithelialisation (Patel et al. 2006), however no differences in expression were 
found in tissue exposed to the different light parameters, suggesting that light is 
not modulating KRT17 to activate keratinocytes to migrate. Rather than 
studying a protein which is essential for re-epithelialisation, other markers might 
be more useful to study. Keratinocytes at the leading edge have to go through 
EMT to be able to migrate and create the epithelial tongue, therefore, markers 
such as vimentin which is needed for epidermal keratinocyte migration only, or 
E-cadherin, which is not downregulated during migration but it is essential in 
epidermal haemostasis (Haensel and Dai 2017). Furthermore, study of those 
markers in situ by immunohistochemistry is highly recommended to ensure 
results.  
 The delay in migration seen with high doses of blue light may be due to 
an increase in ROS production, so that changes in the expression of superoxide 
dismutase (SOD) may be a more relevant endpoint to measure. SODs are 
induced during wound healing in order to keep the level of ROS within a 
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beneficial range. However, when ROS production is excessive, there is 
induction of lipid peroxidation, protein modification and DNA damage, delaying 
the wound healing process (Schäfer and Werner 2008). In order to understand 
the beneficial effect of blue and red light, other mechanisms such as 
desmosome disruption, or integrin switch from α6β4 to α3β1 required for re-
epithelialisation (Pastar et al. 2014) may also be worth investigating.  
New molecular targets related to light reception are of particular interest 
for further study in the regulation of wound healing. Interestingly, expression of 
OPN3 and CRY1 were both upregulated following exposure to low levels of blue 
light. Since they both have their peak of absorption in the blue light part of the 
spectra (Hoang et al. 2008; Koyanagi et al. 2013), it makes sense that red light 
is not able to stimulate them. Furthermore, 30 J/cm2  probably provides too 
much exposure to blue light and other phenomena such as bleaching 
(Morshedian and Fain 2017) might interfere with stimulation of the mRNA of the 
selected photoreceptors.  
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5 Conclusion 
The photobiochemical effects driven by photobiomodulation, together with 
its non-invasive nature of light and the lack of systemic side effects make this 
treatment modality a very appealing therapy for skin disorders.  
Photobiomodulation has been proposed for treatment of chronic wound 
healing, but most studies have focused on red light. On the other hand, blue 
light therapies have been proposed for the treatment of other skin conditions 
such as psoriasis. The different wound healing stages, the large variety of 
wounds, as well as the lack of knowledge in the molecular mechanisms 
involved in light reception in human skin, makes development of light-based 
therapies for this condition difficult to put forward.  
The identification and localisation of different photoreceptors, OPN1-SW, 
OPN3, OPN5, CRY1 and CRY2 in human skin in situ and in primary cells in 
vitro is a step forward in understanding the potential role of these proteins in 
photobiomodulation of human skin. 
Both a wavelength and dose dependent response to light was seen in 
cultures of primary epidermal keratinocytes. While low doses stimulated 
metabolism, higher doses suppressed metabolic activity. Light stimulation 
occurred within a larger dose range for long wavelengths such as NIR and red 
light, while stimulation with shorter wavelengths, such as blue and cyan light 
only occurred at extremely low doses. Migration of keratinocytes in culture was 
inhibited with high doses of blue light, while low doses of blue and red light had 
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no effect. Different molecular mechanisms are probably involved in the light 
responses seen in epidermal keratinocytes. While effects on cytochrome c 
oxidase could be mediated by any wavelength of visible light as a consequence 
of its different peaks of absorption throughout the spectra, ion channels are not 
likely to be involved since they also respond to green light. Interestingly, OPNs 
and CRYs are able to absorb short-wavelength light, so that they are potential 
candidates for mediating the increase in metabolic activity seen after exposure 
of low doses of blue and cyan light in cultures of human epidermal 
keratinocytes.   
The lack of knowledge about the functionality of OPN3, CRY1 and CRY2 
in primary human epidermal keratinocytes required the study of these 
photoreceptors under non-irradiated conditions. CRYs were important for 
maintaining circadian clock oscillations. Alteration of these circadian oscillations 
by stabilising CRY1 and CRY2 protein with KL001 disrupted migration and 
induced early differentiation of epidermal keratinocytes. These alterations were 
abrogated after knockdown of OPN3, which may be due to an effect of OPN3 in 
the regulation of the circadian clock. Although downstream signalling pathway 
still needs further investigation, the activation of the transcription factor CREB 
which can be phosphorylated by the OPN3 signalling pathway and it is able to 
bind to the PER1 promoter, might be a good candidate. The peripheral 
circadian clock of the skin is directly connected to the cell cycle, mainly through 
the G1/S checkpoint and can control re-epithelialisation and dermal 
organisation during wound healing.  
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The photoreceptors OPN3, CRY1 and CRY2 all have their absorption 
peak in the blue part of the light spectra; therefore, 453 nm of light was used to 
study the role of OPN3 and the circadian clock, including CRY1 and CRY2 in 
the blue light response of human epidermal keratinocytes in culture. 
Interestingly, the increase in metabolic activity previously seen with 2 J/cm2 
increased early differentiation of human epidermal keratinocytes, while DNA 
synthesis was decreased and epidermal differentiation increased. The effect of 
low doses of blue light on early differentiation was partially mediated by OPN3 
signalling and the circadian clock, while downregulation of DNA synthesis may 
be affected by an OPN3-independent regulation of the circadian clock. These 
results are consistent with the reported anti-proliferative effect of blue light in the 
literature, which confirms the use of blue light for psoriasis and 
hyperproliferative edges of some type of chronic wounds. However, a new 
molecular mechanism of action of blue light through OPN3 and circadian clock 
is proposed in this report, which could have an impact on the 
photobiomodulation treatment regimes, such as time of the day to deliver light 
treatment as well as number of treatments recommended per day. A proper 
regulation of the peripheral skin clock is essential to maintain skin homeostasis 
and to produce a healthy granulation tissue and enable re-epithelialisation 
during wound healing. 
Finally, in order to move forward in the translation of studied parameters in 
vitro to the in vivo situation, light exposure was studied in an ex vivo human skin 
wound healing model.  Two J/cm2 of blue light and 30 J/cm2 of red light had a 
small, but beneficial effect in wound re-epithelialisation. However, the 
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expression of different photoreceptors, which absorb light of different 
wavelengths in human skin, suggests that different mechanisms of action may 
be involved in this effect. While red light probably mainly affects cytochrome c 
oxidase, the increase in mRNA expression of OPN3 and CRY1 after stimulation 
with 2 J/cm2 blue light only in the epithelial tongue of the ex vivo wounds, 
strongly suggests a role for OPN3 signalling and circadian clock oscillations in 
the regulation of migration and differentiation of the epidermal keratinocytes at 
the wound edge. On the other hand, 30 J/cm2 of blue light impaired wound 
healing ex vivo but had no effect on either OPN3 or CRY1 expression. It is 
possible that at this dose there is a high level of ROS production, which impairs 
the migratory capacity of wound edge keratinocytes. The present data suggests 
that 2 J/cm2 blue light and 30 J/cm2 red light show a beneficial potential for 
wound healing ex vivo but not in vitro, indicating a collaborative role of 
epidermal keratinocytes with other skin cell types such as dermal fibroblasts in 
mediating re-epithelialisation in response to light. As different OPNs were found 
in different cell types, it is likely that their response to different wavelengths of 
light would be needed to see a clear response during wound healing. Further 
work using more advance wound healing models and combination of the 
studied light parameters has to be done in order to achieve the most efficient 
photobiomodulation treatments for different type of chronic wound healing.  
In conclusion, this work unravels new molecular targets for 
photobiomodulation of the skin, especially during wound healing processes. 
Furthermore, the role of OPN3 and the circadian clock in epidermal migration 
and differentiation, as a novel molecular mechanism in response to blue light 
186 
has been established. Finally, a step forward in translating light parameters 
from in vitro to ex vivo human wound healing models suggests the use of 2 
J/cm2 blue light or 30 J/cm2 red light to improve re-epithelialisation. Further 
research deciphering underlying signalling pathways activated by OPNs and 
CRYs in response to photobiomodulation, as well as the translation of light 
parameters to in vivo will help to develop more reliable and scientific based-
photobiomodulation therapies for human wound healing, as well as the 
establishment of treatment regimes and protocols in order to achieve its 
maximum efficacy.  
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